{
    "0": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Low Back Pain Patient Education Evaluation\n\nInclusion criteria:\nMust live in the United States\nMust understand and write English\nMust have access to a computer with e-mail and expect to have this access for at least 3 years\nMust be 18 years old\nMust have seen a doctor for back pain at least once in the",
        "label": 0
    },
    "1": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Beta-Blocker Heart Attack Trial (BHAT)\n\nInclusion criteria: Men and women, ages 30 to 69. Documented myocardial infarction.\n\nAssessment of eligibility:\n\n1. Age: The patient is 58 years old, which is within the inclusion criteria of 30",
        "label": 1
    },
    "2": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Hypertension Prevention Trial (HPT) Feasibility Study\n\nInclusion criteria: Men and women, ages 25 to 49. Diastolic blood pressure between 78 and 89 mm Hg. Free of major disease. Not on a special diet or antihypertensive medication at entry. Some mild to moderately",
        "label": 0
    },
    "3": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Diabetes and Heart Disease Risk in Blacks\n\nInclusion criteria:\n\n* Ethnicity: Black\n* Age: 18-70 years\n* Medical History: Healthy\n* Exclusion criteria:\n\t+ Black Ethnicity other than American or African.\n\t+ Medications that alter parameters under investigation.\n\t+ Di",
        "label": 0
    },
    "4": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Antiplatelet Therapy to Prevent Stroke in African Americans\n\nInclusion criteria:\nAfrican Americans are eligible if they had a non-cardioembolic ischemic stroke at least 7 days, but no more than 90 days before entering the trial.\nAfrican American\n29-85 years of age\nNon-",
        "label": 0
    },
    "5": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Muscatine Heart Study\n\nSummary: To conduct longitudinal and cross-sectional studies of risk factors for coronary heart disease and hypertension in school age children and adults who had been examined in previous screens.\nInclusion criteria: No eligibility criteria\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this",
        "label": 2
    },
    "6": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: The Jackson Heart Study of Cardiovascular Disease Among African Americans\n\nSummary: This is a prospective study of the environmental and genetic factors that influence the development of cardiovascular disease (CVD) in African American men and women. The cohort is a collaboration among multiple institutions (Jackson State University, Mississippi State Department of Health, Tougal",
        "label": 2
    },
    "7": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Racial Variation in ACE--Genetic and Physiologic Bases\n\nSummary: To determine whether differences in the activity of the renin-angiotensin and bradykinin systems are involved in the pathogenesis of blood pressure variation in African Americans.\n\nInclusion criteria: No eligibility criteria\n\nAssessment of eligibility:",
        "label": 2
    },
    "8": {
        "output": "Patient note:\n\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis, and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\n\nTitle: Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure\n\nInclusion criteria:\n\n* Inclusion criteria:\n* Subjects must be competent to provide informed written consent.\n* Subjects must sign an IRB/IEC approved informed consent form prior to the init",
        "label": 0
    },
    "9": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Efficacy of Tailored Cognitive-Behavioral Therapy for Chronic Back Pain\n\nInclusion criteria:\n\n* Chronic back pain for at least 6 months\n* Treatment by medication or physical therapy\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.",
        "label": 0
    },
    "10": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure\n\nInclusion criteria:\nEnd-stage renal disease\nHemodialysis\nHypertension\nWritten informed consent\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.",
        "label": 0
    },
    "11": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance\n\nInclusion criteria:\nClinical diagnosis of hypertension\nClinical diagnosis of type 2 diabetes or impaired glucose tolerance\n\nTrial-level eligibility: 0) Would",
        "label": 1
    },
    "12": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study\n\nInclusion Criteria:\n\n1. Outpatients aged 65 years or older, and less than 85 years (at the time of informed consent), regardless of sex\n2. Current antihypertensive treatment with monotherapy\n3. SB",
        "label": 0
    },
    "13": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: The Renin-Angiotensin System in Essential Hypertension\n\nInclusion criteria:\nEssential Hypertension\nSBP 140-159 mmHg\nDBP 90-99 mmHg\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further",
        "label": 1
    },
    "14": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina\n\nInclusion criteria:\nOutpatients > =18 years of age with diagnosed clinically stable angina pectoris\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe",
        "label": 2
    },
    "15": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)\n\nInclusion criteria:\nClinical diagnosis of hypertension\nClinical diagnosis of one or more risk factors, such as diabetes, smoking habit, lipid metabolism abnormality, history of ischemic heart",
        "label": 1
    },
    "16": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.\n\nInclusion criteria:\nHistory of diabetes for at least 5 years, with at least 2 risk factors (i.e. hypertension, elevated cholesterol levels, history of or current smoker, obese,",
        "label": 1
    },
    "17": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Understanding Pediatric Chest Pain and Other Symptoms\n\nInclusion criteria:\n8-18 years of age\nPediatric patients with referrals for innocent heart murmurs\nPediatric patients experiencing chest pain\nEnglish speaking\n\nTrial-level eligibility: 0) Would not refer this patient for this clin",
        "label": 0
    },
    "18": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease\n\nInclusion criteria:\nPatients with HF or IHD who are not currently taking the study medications of interest (ACE",
        "label": 2
    },
    "19": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker\n\nSummary: A comparison of 2 different combinations of high blood pressure medications to treat hypertension\nInclusion criteria: Inclusion Criteria:\nGreater than 18 years",
        "label": 0
    },
    "20": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer\n\nInclusion criteria:\n\n* Hormonal therapy-resistant MBC\n* ER (-), failure of hormonal therapy for MBC, or re",
        "label": 0
    },
    "21": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris\n\nInclusion criteria:\n\n* Chronic stable angina pectoris\n* Documented coronary artery disease\n* Previous treatment with atenolol or other beta-blocker agent\n* Exercise tolerance test posit",
        "label": 0
    },
    "22": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Rosiglitazone Versus Placebo in Chronic Stable Angina\n\nInclusion criteria:\n\n* Chronic stable angina\n* Previous positive exercise tolerance test\n* Disease not suitable for coronary intervention (Coronary artery bypass grafting or angioplasty)\n* Do not have overt diabetes",
        "label": 1
    },
    "23": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: The Nitrate and Bone Study: Effects of Nitrates on Osteoporosis\n\nInclusion criteria:\nWomen aged 50 and older\nLumbar spine BMD (L1 to L4) T score between 0 and -2.0\nAt least 3 years postmenopausal\n\nTrial-level",
        "label": 0
    },
    "24": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Predicting Patients' Response to Spinal Manipulation\n\nInclusion criteria:\nAge 21 to 55\nIdiopathic mechanical low back pain (LBP) matching classification 1-4 of the Quebec Task Force.\nLBP classified as subacute (onset 4-12 weeks previous) or chronic (",
        "label": 0
    },
    "25": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients\n\nInclusion criteria:\nAge > 18 years or older.\nAdmission to the ICCU with ACS (non-",
        "label": 0
    },
    "26": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Gene Mutations in Secondary Pulmonary Hypertension\n\nInclusion criteria:\nDiagnosis of CTEPH and patient consent\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of chest pain, nausea, diaphoresis, and",
        "label": 0
    },
    "27": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Evaluating the Link Between Neighborhood Environments and Obesity Among African American Women\n\nInclusion criteria:\nParticipating in the BWHS study\nResiding in New York, Los Angeles, or Chicago\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe",
        "label": 0
    },
    "28": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis.\n\nInclusion criteria:\nAcute episode of chest pain of less than 7 days duration as primary reason for admission to a chest pain clinic.\nAdmitted to a chest pain clinic, suspected",
        "label": 2
    },
    "29": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity\n\nInclusion criteria:\nIndividuals enrolling in the Prader-Willi syndrome group will have a confirmed diagnosis of Prader-Willi syndrome, as confirmed by molecular and cytogenetic testing\nIndividuals enrolling in the Early-",
        "label": 0
    },
    "30": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Effectiveness of Calcium Channel Blockers and Adenosine in the Emergency Management of SVT\n\nInclusion criteria:\nMore than 10 years old\nElectrocardiographic diagnosis of SVT\nSVT not converted by the vagal manoeuvres\n\nTrial-level eligibility: 1) Would consider referring this",
        "label": 0
    },
    "31": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: Intrapleural Minocycline After Simple Aspiration for the Prevention of Primary Spontaneous Pneumothorax\n\nInclusion Criteria:\nMale or female.\nAge between 15 and 40 years old.\nFirst episode of spontaneous pneumothorax.\nSymptomatic (dyspnea or chest",
        "label": 0
    },
    "32": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension\n\nInclusion criteria:\n\n* Must have completed Visit 14/Week 24 of the NCT00046319 study.\n* Women of childbearing potential must have a negative urine pregnancy test at",
        "label": 0
    },
    "33": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)\n\nInclusion criteria:\n\n* Outpatients aged 65 years or older, and less than 85 years (at the time of informed consent), regardless of sex",
        "label": 0
    },
    "34": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest Pain\n\nInclusion criteria:\n\n* Inclusion Criteria:\nTo be included in the project the participant must\nHave chest pain as their primary complaint.\nHave an acute episode of pain of less than 7 days duration",
        "label": 0
    },
    "35": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With Angina\n\nInclusion criteria:\nMale\nStable angina with one of:\nClassical history of exertional angina pectoris\nPrevious diagnostic exercise test\nAngiographic evidence of CAD\nA",
        "label": 1
    },
    "36": {
        "output": "Patient note:\n\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\n\nTitle: Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer\n\nInclusion criteria:\n\n* Signed informed consent\n* Male or female; \u2265 20 years (at the time of giving consent)\n* Histologically or cytologically confirmed gastr",
        "label": 0
    },
    "37": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Chest Pain Observation Unit Risk Reduction Trial\n\nSummary: The purpose of this study is to determine whether a brief counseling intervention initiated in the chest pain observation unit has a significant impact upon the health attitudes (readiness to change) and cardiovascular risk-related behaviors (diet, exercise, and smoking)",
        "label": 0
    },
    "38": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Quality of Life Among Survivors of Hodgkin Lymphoma\n\nInclusion criteria:\nBiopsy-proven HL\nParticipation in IRB-approved protocols for the first-line treatment of HL between 1975-2000 (IRB #75-104, #75-",
        "label": 0
    },
    "39": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Non Cardiac Chest Pain and Benign Palpitations\n\nInclusion criteria:\n\n* Investigated for chest pain or palpitation 6 month ago at Cardiological Out-patient Clinic, Molde Hospital\n* Suffer from chest pain or palpitations\n\nTrial-level eligibility: 1) Would consider referring",
        "label": 0
    },
    "40": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis\n\nInclusion criteria:\nDigital gangrene, ulcers in patients with severe secondary Raynaud's phenomenon\nStable therapy with vasoactive drugs, such as calcium channel blockers, angiotensin inhibitors/AT II receptor",
        "label": 0
    },
    "41": {
        "output": "Sure, I'd be happy to help you with that! Here's the assessment of eligibility for the patient in the given scenario:\n\nPatient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion\n\nInclusion Criteria:\n\n* DISEASE CHAR",
        "label": 0
    },
    "42": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Trial of a Cardiac Rehabilitation Program Delivered Remotely Through the Internet\n\nInclusion criteria:\nMen and women admitted for an IHD event (acute coronary syndrome or revascularization procedure) who are at low or moderate risk.91\nRegular Internet access (home, work or other environment).\nOver 18",
        "label": 2
    },
    "43": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.\n\nInclusion criteria:\nNew onset of Type 2 Diabetes.\nBMI>25kg/m2\n\nAssessment:\nThe patient's BMI is not specified in the given information, but based on the inclusion criteria, the patient must have",
        "label": 0
    },
    "44": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)\n\nInclusion criteria:\nPatients with metastatic breast cancer\n\nTrial-level eligibility: 0) Would not refer",
        "label": 0
    },
    "45": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) Study\n\nInclusion criteria:\nClinical diagnosis of COPD\n> 40 years of age\n> 15 pack year smoking history\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial",
        "label": 0
    },
    "46": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Neuromuscular Balance in Low Back Pain\n\nInclusion criteria:\nPatients with low back pain between 20 and 55 years old, submitted to a physical therapy treatment.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms do not match",
        "label": 0
    },
    "47": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Case Management Alternatives for African American Women at High Risk for HIV\n\nSummary: The purpose of this study is to test two innovative case management approaches designed to increase linkages and engagement with drug abuse treatment, HIV-related care, and other health services among an underserved population of African American women at risk for HIV.\n\nInclusion criteria:",
        "label": 0
    },
    "48": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina\n\nInclusion criteria:\nPatient must be between the ages of 18 and 80 years.\nFemales of childbearing potential must have a negative pregnancy test, not be breastfeeding, and established on a method of contraception that,",
        "label": 1
    },
    "49": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart Failure\n\nInclusion criteria:\nPatients eligible for the study had objective evidence of systolic dysfunction (ejection fraction \u226440%), were >18 years of age, and were on stable optimal medical heart failure therapy excluding the use of",
        "label": 1
    },
    "50": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Prevalence and Outcome of Brachial Artery Endothelial Function in Morbidly Obese Patients Undergoing Bariatric Surgery\n\nInclusion criteria:\nMorbidly obese patients who fulfill the NIH criteria for surgical intervention.\n\nAssessment of eligibility:\n\n1. Age: The patient",
        "label": 1
    },
    "51": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study\n\nInclusion Criteria:\n\n* Lean (BMI 20-25 kg/m2) subjects with normal glucose tolerance\n* Obese",
        "label": 2
    },
    "52": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure\n\nInclusion criteria:\nRandomised control trials of beta-blocker versus control in patients with documented heart failure\nUnconfounded trials only (in which one treatment group differed from another only by the beta-blocker ther",
        "label": 2
    },
    "53": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Prospective, Randomised Long-term Follow-up of Operative Versus Non-operative Treatment of Gr. 3 Acromioclavicular Dislocation\n\nInclusion criteria:\nPatient with Tossy grade 3 AC-dislocation was recruited between the years 1989 and 1991 at Kuop",
        "label": 0
    },
    "54": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children\n\nSummary: The purpose of this study is to determine whether ACE inhibitors alter the fibrinolytic, inflammatory, and hemodynamic response to cardiopulmonary bypass in infants and children with",
        "label": 0
    },
    "55": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Osteopathic Treatment of Low Back Pain\n\nInclusion criteria:\n\n* Age between 19 and 55 years old\n* Able to walk without assistance and/or assistive devices at least 4.7 meters\n* Have adequate hearing acuity to detect verbal instructions\n* Have adequate visual acuity",
        "label": 0
    },
    "56": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: The First Therapeutic Intervention in Malignant Pleural Effusion Trial\n\nInclusion criteria:\nClinically confident diagnosis of malignant pleural effusion requiring pleurodesis. The diagnosis may be established by one of:\nHistologically proven pleural malignancy OR\nTypical features of pleural malignancy",
        "label": 0
    },
    "57": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes\n\nInclusion criteria:\nType 2 diabetes\nPre-Diabetes\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion",
        "label": 0
    },
    "58": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment\n\nInclusion criteria:\n\n* Patients over 18 years of age\n* Arterial hypertension (SBP < 160",
        "label": 0
    },
    "59": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Pregnancy-Related Low Back Pain and Complementary and Alternative Medicine (CAM) Treatment\n\nInclusion criteria:\nHealthy\n20-49 years old\nPregnant with a singleton\nLow back pain began during pregnancy and has lasted more than one week\nLow back pain is reproducible with pal",
        "label": 0
    },
    "60": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis, and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Preventing Acute Chest Syndrome by Transfusion Feasibility Study\n\nInclusion criteria:\n\n* Hemoglobin diagnosis of SS (two copies of the hemoglobin S gene), SC (one copy of the hemoglobin S gene and one copy of the hemoglobin C gene), or S-\u03b2 thalass",
        "label": 0
    },
    "61": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction\n\nInclusion criteria:\n\n* The subject must be 18 years of age or older.\n* The subject must present to the Emergency Department with symptoms consistent with acute coronary syndromes (e.g., chest discom",
        "label": 2
    },
    "62": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Trial of the MEND Childhood Obesity Treatment Program\n\nInclusion criteria:\nChildren enrolled in the MEND Programme who are yet to be given a start date for the programme.\nAged between 7-13 years old.\nOverweight or obese as defined by a BMI which falls above the 91st centile on",
        "label": 0
    },
    "63": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease\n\nInclusion criteria:\nPatients with intermediate (>20%, <90%) risk of IHD based on age, gender, symptoms and exercise stress test results\n\nAssessment:\n\nBased on the patient's symptoms and medical history, it is",
        "label": 1
    },
    "64": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain\n\nInclusion criteria:\nAt Visit 1 (study entry) patients must have a medical history and physical and neurological examinations that support a clinical diagnosis of acute",
        "label": 0
    },
    "65": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Should the Joint Capsule of the Painful Stiff Shoulder be Ruptured During Intra-articular Hydraulic Distension?\n\nInclusion criteria:\n\n* Shoulder discomfort for at least one month\n* Limited range of motion of the glenohumeral joint in at least two directions\n\nTrial-level el",
        "label": 0
    },
    "66": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)\n\nInclusion criteria:\nApnea and hypopnea index of more than 20/hr, and treated with CPAP\nUncontrolled hypertension (defined as systolic blood pressure of more than 130 mm",
        "label": 0
    },
    "67": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Resistant Hypertension in Patients With Type-II-Diabetes Mellitus\n\nInclusion criteria:\n18-80 years, informed consent, hypertension, type-II-diabetes mellitus\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.",
        "label": 0
    },
    "68": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Vitamin D and Zinc Levels in Patients Undergoing Ergometry Test\n\nInclusion criteria:\nOver 18 years old\nCCT > 60 ml/min\nNo IHD\nNo hyper/hypoparathyroidism\nNo active malignancy\nNot taking calcium, phosphate\n\nAssessment of el",
        "label": 0
    },
    "69": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial: European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial\n\nInclusion criteria:\n\n* The decision to randomize participants was made by a qualified physician or paramedic who was present at the time.\n* Participants were included in the study if they presented either via ambulance or to a center where PCI was not performed and",
        "label": 0
    },
    "70": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC\u2122 Model\n\nSummary: The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in",
        "label": 0
    },
    "71": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation\n\nInclusion criteria:\n\n* Stable angina patients whose coronary lesions are confirmed by angiography or receive PCI\n* Unstable Angina/NSTEMI patients who",
        "label": 1
    },
    "72": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults\n\nInclusion criteria:\nSubjects with BMI over 25.0 kg/m2\nNon-smoker\n\nAssessment of eligibility:\n\n1. Age: The patient is",
        "label": 0
    },
    "73": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery\n\nInclusion criteria:\n\n* Diagnosis of unstable angina and non-Q wave myocardial infarction\n* Age 18-75 yr.",
        "label": 0
    },
    "74": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Megadyne Ace Incision/Dissection Study\n\nInclusion criteria:\nSubject is >18 years of age or < 60 years old\nSubject is undergoing abdominoplasty, bilateral breast reduction, bilateral breast lift, bilateral brachioplasty, bilateral lateral thigh and buttocks lift, or",
        "label": 0
    },
    "75": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease\n\nInclusion criteria:\n\n* Ischemic heart disease patient\n* Given loading or maintenance dose of clopidogrel and in need of it for 1 or more month\n* In need of additional drug for optimal BP",
        "label": 1
    },
    "76": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland\n\nInclusion criteria:\n\n* Hypertension\n* Age > 18\n* ACE-I related cough\n\nExclusion criteria:\n\n* Current treatment with tel",
        "label": 0
    },
    "77": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer\n\nInclusion criteria:\nHistologically confirmed squamous cell carcinoma (with biopsy on the primary and / or lymph node metastases) of the oral cavity, oropharynx",
        "label": 0
    },
    "78": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Clinical Trial Comparing Continuous Versus Intermittent Hemodialysis in ICU Patients\n\nInclusion criteria:\nAll ICU patients requiring renal replacement therapy\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical",
        "label": 0
    },
    "79": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: Treatment of Coronary Heart Disease With Amiloride\n\nInclusion Criteria:\nMale or female; age 35-75 years having angina (Canada Cardiovascular Society Class II-IV)\nEssential Hypertension defined as taking at least 1 anti-hypertensive medication, or average syst",
        "label": 1
    },
    "80": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Resistance Exercise Effects on Fear Avoidance and Physical Function in Obese Older Adults With Low Back Pain\n\nInclusion criteria:\n\n* Chronic low back pain for >6 months\n* >3 pain episodes per week\n* Waist circumferences \u2265102 cm for men\n* Waist circumferences \u2265",
        "label": 0
    },
    "81": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Expressive Writing for Heart Healing\n\nSummary: This study will determine whether the psychological and physical benefits of expressive writing extend to obese in-patients with Ischemic Heart Disease (IHD) referred to cardiac rehabilitation\n\nInclusion criteria:\n\n* Obesity\n* Ischemic Heart disease\n* Signed",
        "label": 2
    },
    "82": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol\u00ae-PM Plus Carboplatin\u00ae Compared to Genexol\u00ae Plus Carboplatin\u00ae as a Firstline Treatment in Subjects With Ovarian Cancer\n\nInclusion criteria:\n\n* Subjects who aged",
        "label": 0
    },
    "83": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Home Hypnotherapy for Refractory Functional Chest Pain: A Pilot Study\n\nInclusion criteria:\nAge 18 to 80, male or female.\nPatients must fulfill the Rome III criteria for Functional Chest Pain of Presumed Esophageal Origin for the previous 3 months (with symptom onset at least",
        "label": 0
    },
    "84": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Search a Correlation Between Lp(a) Rate and TFPI Activity in Obese Patients With Chest Pain Like Angina\n\nInclusion criteria:\n\n* Major\n* Men\n* Obese BMI>30\n* No aspirin treatment before inclusion\n* Coronary exploration: coronary angiography or tomography coronary",
        "label": 0
    },
    "85": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Osteopathic Treatment in Adult Patients With Cystic Fibrosis\n\nInclusion criteria:\n\n* Diagnosis of cystic fibrosis (positive sweat test and/or presence of 2 disease-causing mutations in the CFTR gene)\n* Age > 18 years\n* Patient with chron",
        "label": 0
    },
    "86": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model\n\nInclusion criteria:\nPositive bilateral conjunctival allergen challenge (CAC) reaction\n\nTrial-level eligibility: 0) Would not refer this patient",
        "label": 0
    },
    "87": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)\n\nInclusion criteria:\n\n* Written informed consent\n* Males and females aged 18",
        "label": 0
    },
    "88": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease\n\nInclusion criteria:\n\n* Documented diagnosis of asthma or COPD in accordance with guidelines\n* Stable condition, defined as a disease without exacerbation for at least",
        "label": 0
    },
    "89": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.\n\nInclusion criteria:\n\n* Patients of chronic stable angina with abnormal Exercise Myocardial Perfusion Spect Scan with reversible and partially reversible ischemic changes.",
        "label": 1
    },
    "90": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study\n\nInclusion criteria:\n\n* Acute myocardial infarction\n* Acute coronary syndrome\n* Unstable angina\n* Men & women\n* All races & ethnicities\n\nExclusion criteria:\n\n* Age",
        "label": 1
    },
    "91": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: The ACE Follow-up Study\n\nInclusion Criteria:\nSubject, male or female, is age 18 to 50 years of age.\nSubject must be able to understand and be willing to sign an informed consent document.\nSubject must be willing and able to participate in all aspects of the study and agree to comply with all study requirements for the",
        "label": 1
    },
    "92": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker\n\nInclusion criteria:\n\n* Essential hypertension\n* ACE inhibitors\n\nTrial-level eligibility: 1) Would consider referring this patient to",
        "label": 0
    },
    "93": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors\n\nInclusion criteria:\n\n* Patient age 18 years or older who self-identifies as African-American\n* In early survivorship phase, defined as being 1-12 months post completion of treatment for stage 0-",
        "label": 0
    },
    "94": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Phase II Study of STA-2 in Patients With Chronic Stable Angina\n\nInclusion criteria:\n\n* Male or female aged > 20\n* Patients who had effort-induced angina which was relieved by rest or nitroglycerin, or who had catheterization-documented coronary artery disease or previous my",
        "label": 0
    },
    "95": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Management of Acute Myocardial Infarction in the Presence of Left Bundle Branch Block\n\nInclusion criteria:\nAge 18 - 75 years\nIschemic discomfort (ie, ischemic chest pain or equivalent) at rest \u226520 minutes within previous 24 hours.\nAny (new, presumably new,",
        "label": 0
    },
    "96": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Genetic Mapping for Cardiac Risk Assessment\n\nInclusion criteria:\n\n* Patients affected by history of IHD with a non-fatal evolution (angina or AMI as first manifestation), age at the onset of the disease (<50 or >60 years).\n* Patients with acute coronary syndrome as first manifest",
        "label": 0
    },
    "97": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Effectiveness of the Compression Belt for Patients With Sacroiliac Joint Pain\n\nInclusion criteria:\n\n* Unilateral pain near the sacroiliac joint that does not extend pass the knee\n* Positive result on 2 of 6 sacroiliac joint provocation tests:\n\t+ Compression test\n\t+ Dist",
        "label": 0
    },
    "98": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy With Collagen Implant\n\nInclusion criteria:\n\n* Diagnosis of POAG\n* Documented glaucomatous VF damage with mean defect (MD) > 3 dB\n* Progressing glaucomatous damage",
        "label": 0
    },
    "99": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Hatha Yoga Exercises in Pelvic and Lumbar Back Pain in Pregnant Woman\n\nInclusion criteria:\nLower back pain and / or posterior pelvic pain when completing the interview. Gestational age greater than or equal to 12 weeks.\n\nTrial-level eligibility: 1) Would consider referring this patient to",
        "label": 0
    },
    "100": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia\n\nInclusion criteria:\nInappropriate sinus tachycardia (HR >100 bpm at rest ECG and/or medium Holter ECG HR >90 bpm)\nAge >",
        "label": 0
    },
    "101": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients\n\nInclusion criteria:\n\n* Age >= 18 years\n* Eastern Cooperative Oncology Group (ECOG) performance status (PS) <=2 and a life expectancy >=",
        "label": 0
    },
    "102": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: CT Calcium Scoring in Suspected Stable Angina\n\nInclusion criteria:\nnon-acute chest pain\nthose who underwent CT calcium scoring\navailability of all relevant risk factor information\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient",
        "label": 1
    },
    "103": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?\n\nInclusion criteria:\nWell functioning kidney (serum creatinine <1.2 mg",
        "label": 0
    },
    "104": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension\n\nInclusion criteria:\n\n* Diagnosis of severe hypertension must be made on the basis of current findings, medical history, and physical examination\n\nTrial-level eligibility: 1",
        "label": 1
    },
    "105": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin\n\nInclusion criteria:\nViable, singleton pregnancy \u2265 37 weeks gestation undergoing EL LSCS.\nLow risk for post-partum hemorrhage, such as no proven abruptio placentae, placent",
        "label": 0
    },
    "106": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training\n\nInclusion criteria:\n\n* Stable Ischemic Heart Disease\n* BMI 28 - 40 kg/m2\n\nExclusion criteria:\n\n* Known Diabetes Mellitus",
        "label": 2
    },
    "107": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Usefulness of Chest Wall Tenderness as Bedside Test to Exclude Acute Coronary Syndrome in Different Demographic Groups\n\nInclusion criteria:\n\n* All patients over the age of 18 years presenting with the leading symptom of first time or recurrent acute chest pain in the emergency room of the Department of",
        "label": 0
    },
    "108": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Biomarkers for Breast Cancer Risk in African American Women\n\nInclusion criteria:\nINCLUSION CRITERIA:\nAny woman who identifies as African American, Black, or African\nCurrently nursing a baby\nAble and willing to sign written informed consent\nWilling to be contacted by study personnel for follow-up to determine",
        "label": 0
    },
    "109": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Efficacy of Euminz\u00ae for Tension-Type Headache\n\nInclusion criteria:\nMale and female patients from 18 years onwards\nHistory of ETTH for at least one year. The number of days with such a headache is \u22652 per month\nOnset of TTH below 65 years of age\nAt least 1",
        "label": 0
    },
    "110": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: The ACS Ethnicity Platelet Function Study\n\nInclusion criteria:\nFemale (postmenopausal or surgically sterile) and/or male aged 18 years or older\nPresenting with ACS fulfilling the following:\nSymptoms or new ECG changes (ST segment elevation or depression of at least 1",
        "label": 1
    },
    "111": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.\n\nInclusion criteria:\nInformed consent signed.\nMale or female 18 years of age or older.\nWomen of childbearing potential",
        "label": 0
    },
    "112": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument\n\nInclusion criteria:\nSigned informed consent prior to any study-mandated procedure.\nPatients with PAH who completed study AC-055-401\nWomen of childbearing potential must",
        "label": 0
    },
    "113": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease\n\nInclusion criteria:\nThey had to have normal glucose tolerance.\nThey had to have either angiographically documented coronary artery disease or a previous history of myocardial infarction.\nThey were required to have an office B",
        "label": 0
    },
    "114": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study\n\nInclusion criteria: Inclusion Criteria:\nEssential hypertension subjects, aged 18-70 years, blood pressure > 140/90 mm Hg even used to be on 3 or more medications for",
        "label": 0
    },
    "115": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients\n\nInclusion criteria:\nProvision of subject informed consent\nPatients hospitalized and diagnosed with STEMI or NSTEMI\nHospitalized within 24 hours of onset of symptoms or transferred from another hospital within",
        "label": 1
    },
    "116": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: Healthy Body Study\n\nInclusion Criteria:\n\n* \u2265 12 years old\n* Body image concerns\n* Sub-threshold Eating disorder symptomatology\n* Overweight but not obese (BMI between the 85th and 95th percentile for children/adolescents and BMI between 25",
        "label": 0
    },
    "117": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Pain During Chest Tube Withdrawal: Evaluation Using Pan Monitor\n\nInclusion criteria:\npatients undergoing removal of a chest tube after lung surgery,\npatients able to indicate the pain score.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.",
        "label": 0
    },
    "118": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Diet and Prevention of Ischemic Heart Disease: a Translational Approach\n\nInclusion criteria:\nhealthy men and women aged 30 to 65 years who have one or more self-assessed ischemic heart disease risk factors at screening: physical inactivity, overweight or obese (BMI \u2265 25",
        "label": 1
    },
    "119": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Cerebral Blood Flow Changes in People With Obesity After Glucose Consumption\n\nInclusion criteria:\n\n* Live in Ribeir\u00e3o Preto, S\u00e3o Paulo - Brazil.\n* Age between 18 and 40 years old.\n* Female gender.\n* Regular menses.\n* Weight inferior than 12",
        "label": 0
    },
    "120": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: The Effects of Inorganic Nitrate on Cardiac Muscle in Angina\n\nInclusion criteria:\nPatients aged 18 and over with chronic stable angina (\u22652 months duration).\nA positive exercise ECG (1mmSTD at J+0.08 seconds) on a modified Bruce protocol treadmill exercise test.\nA positive",
        "label": 0
    },
    "121": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Chest Wall Influence on Respiratory System Mechanics in Morbidly Obese Patients\n\nInclusion criteria:\n18 years or older\nRequiring intubation and mechanical ventilation\nBMI\u226540 kg/m2 or IAP\u226512 mmHg\n\nTrial-level eligibility: 1) Would consider",
        "label": 0
    },
    "122": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Protein Supplementation and Weight Loss\n\nSummary: This randomized control trial of diet with protein supplementation is being conducted to test the hypothesis that in overweight/obese subjects high protein diet may lead to weight loss and improvement in cardio-metabolic profile.\nInclusion criteria: Inclusion Criteria:\nSubjects aged between 2",
        "label": 1
    },
    "123": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Dietary Nitrate in COPD\n\nInclusion criteria:\nInformation consenting out-patients with a previous physician diagnosis of COPD\nClinically stable\nAmbulatory\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's diagnosis of",
        "label": 0
    },
    "124": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: Empowered Sisters Project Making Choices Reducing Risks\n\nInclusion Criteria:\n\n* Woman: African American/ African Caribbean/African heritage/Mixed\n* Age 18 - 44 (A.1)\n* Abused (physical, sexual, emotional abuse) by an intimate male",
        "label": 0
    },
    "125": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: Abdominal Compression Elastic Support (ACES)\n\nInclusion Criteria:\nMust be able to give informed consent for participation in this study\nAge \u2265 18 years\nA body weight > 100 lb or a body mass index > 18.5.\nEnd-stage renal disease with hemodialysis in-center",
        "label": 0
    },
    "126": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.\n\nInclusion criteria:\n\n* Female or male aged \u226518 years\n* A patient",
        "label": 0
    },
    "127": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease\n\nInclusion Criteria:\nAged 18 years or over\nParticipant willing and able to give informed consent.\nDocumented Ischaemic Heart Disease: either angio-graph",
        "label": 0
    },
    "128": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Efficacy and Safety of Lacidipine in Chronic Stable Angina\n\nInclusion criteria:\nAge 18 to 80 years\nHistory of stable, exertional angina pectoris (Canadian Cardiovascular Society functional class II to III) for at least 3 months duration prior to enrolment in the study",
        "label": 0
    },
    "129": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Prospective Cohort Study of the Effect of Bariatric/Metabolic Surgery on Morbid Obesity Patients With Metabolic Syndrome\n\nInclusion criteria:\nMorbid obesity (BMI>30) patients with one of comorbidity (type 2 diabetes, dyslipidemia,",
        "label": 1
    },
    "130": {
        "output": "Patient Note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical Trial:\nTitle: PCI and Renal Denervation in Hypertensive Patients With Acute Coronary Syndromes\n\nInclusion Criteria:\nProvision of informed consent prior to any study specific procedures\nFemale and/or male aged 18-80 years\nPatients with ACS, i.e. STEMI, non-ST",
        "label": 1
    },
    "131": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Comparison of Calcium Channel Blockers and Beta Blockers on Tourniquet-induced Hypertension During Intravenous Regional Anesthesia\n\nInclusion criteria:\nPatients operated due to carpal tunnel syndrome under intravenous regional anesthesia between January 2009 and January 2010.\n\nT",
        "label": 0
    },
    "132": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation\n\nInclusion criteria:\n\n* Inclusion Criteria:\n\n1. \u2265 18 years of age\n2. Patients of African, European, and Hispanic descent\n3. History of typical or early-onset symptomatic (\u22652",
        "label": 0
    },
    "133": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Early Invasive Versus Conservative Therapy in Women With an Acute Coronary Syndrome\n\nInclusion criteria:\nWomen age 18 years or older\nNon-ST-elevation acute coronary syndrome (defined as new onset chest discomfort that occurs at rest or with low levels of activity/or emotion within the",
        "label": 1
    },
    "134": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: ACE Stapler Sub Study\n\nInclusion criteria:\nInclusion Criteria:\nSubject must be able to understand and be willing to sign an informed consent document.\nSubject must be willing and able to participate in all aspects of the study and agree to comply with all study requirements for the duration of the study. This includes availability of reliable transportation and sufficient time",
        "label": 2
    },
    "135": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Changes in Skin Conductance Measurement as an Endpoint Monitor for Sympathetic Blocks\n\nInclusion criteria:\nPatients presenting for sympathetic block of the lower extremity (lumbar sympathetic block)\nAges 18-99\n\nAssessment of eligibility:\n\n1. The patient is not taking",
        "label": 0
    },
    "136": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Electrical Skin Conductance Monitoring as an Assessment of Post Operative Pain Scores\n\nInclusion criteria:\nPatients undergoing unilateral THR and TKR who are between the ages of 18 and 85 regardless of the anesthesia and postoperative analgesia type.\nPatients participating in",
        "label": 0
    },
    "137": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis\n\nInclusion criteria:\nParticipants with RRMS (McDonald criteria, 2010",
        "label": 0
    },
    "138": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Ivabradine and Post-revascularisation Microcirculatory Dysfunction\n\nInclusion criteria:\n\n* Symptoms of Angina Pectoris\n* Angiographic evidence of epicardial coronary artery stenosis referred for PCI\n* Flow limiting lesion (Fractional Flow Reserve \u22640.80)",
        "label": 0
    },
    "139": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: PACIFIC: Providing Adults Collaborative Interventions For Ideal Changes\n\nInclusion criteria:\n\n* All participants will be between the ages of 18-65 meeting criteria for overweight, with a BMI between 25 and 45.\n* Participants will provide written informed consent for study participation.\n*",
        "label": 0
    },
    "140": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Anti-hypertensive Effect of Mycelia of Antrodia Cinnamomea\n\nInclusion criteria:\nEligible subjects were untreated hypertensive men or women aged between 20 and 80 years old with SBP between 130 and 179 mmHg and/or DBP between 85 and",
        "label": 2
    },
    "141": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage\n\nInclusion criteria:\n\n* Subject with compatible symptoms with an acute coronary syndrome, for at least 15 minutes and not older than 3 hours (eg discomfort, tightness or chest pain, pain radi",
        "label": 1
    },
    "142": {
        "output": "Patient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Effect of a Meal Replacement on Weight Loss in Obesity Patients With Metabolic Syndrome\n\nInclusion criteria:\n\n* Body mass index more than or equal to 25 kg/m2\n* Patients with metabolic syndrome\n* Patients who are on anti-hypertensive drugs, oral hypogly",
        "label": 0
    },
    "143": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Study Of Angiomax In Infants Under Six Months With Thrombosis\n\nInclusion criteria:\n\n1. Parent/legal-guardian has provided written informed consent before initiation of any study-related procedures.\n2. Objectively confirmed thrombotic event by either doppler ultrasound, echocardiogram, CT scan, MRI, MR angiogram, MR venogram, venogram, or arteriogram.\n3. Age less than 6 months.\n4. Gestational age greater than 35 weeks.\n5. Expected life expectancy at least 14 days.\n6. No contraindication to anticoagulation, i",
        "label": 0
    },
    "144": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Use of Activated Recombinant FVII in Spinal Surgery\n\nInclusion criteria:\nElective spinal fusion surgery.\n\nAssessment of eligibility:\n\nBased on the patient's symptoms and the clinical trial's inclusion criteria, it appears that the patient may be eligible for the clinical trial. The patient is experiencing a vascular issue (cool right foot, pulsatile mass in the right groin, and loss of distal pulses) that may be related to the cardiac catheterization procedure, and the clinical trial is focused on reducing bleeding and blood",
        "label": 0
    },
    "145": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Safety and Feasibility of Endovascular Cooling Device in Patients With Hypothermic Cardiopulmonary Resuscitation\n\nInclusion criteria:\nNon-traumatic collapsed patients, whose pulsation continues and persists more than 5 minutes after return of spontaneous circulation from cardiopulmonary resuscitation and consciousness level is less than GCS 5 points.\n\nAssessment of eligibility:\n\n1. Age: The patient is 67 years old, which meets the inclusion criterion of being 18 years or older.\n2. Medical history: The patient has a history of cardiac catheterization, which does not",
        "label": 0
    },
    "146": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension\n\nInclusion criteria:\n\n* Postmenopausal women\n* Mild to moderate hypertension\n* Statin therapy or LDL \u2264 4.1 mmol/L\n\nAssessment of eligibility:\n\nBased on the patient's history of cardiac catheterization and the presence of a pulsatile mass in her right groin, it is likely that she has a vascular condition that may be related to her hypertension. However, the patient's age and medical history do not meet the",
        "label": 0
    },
    "147": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical Trial:\nTitle: Catheter Thrombectomy in Patients With Massive Pulmonary Embolism\n\nInclusion Criteria:\n\n* Patients >= 18 years of age with pulmonary embolism and cardiogenic shock, defined as a systolic arterial pressure <= 90 mmHg, a drop in systolic arterial pressure >= 40 mmHg for >= 15 minutes, or ongoing administration of catecholamines for systemic arterial hypotension\n* Subtotal or total filling defect in the left and/or right main pulmonary artery due to massive PE, as assessed by chest computed tomography",
        "label": 0
    },
    "148": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Evaluation of Residual Urine After Intermittent Catheterisation\n\nInclusion criteria:\nMale\n18 years and above\nA negative urine dip-stick\nHave signed informed written consent to participate\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is a female and not male, and her age is 67, which is above the age limit of 18 years specified in the inclusion criteria. Additionally, the patient's medical history and current symptoms do not match the requirements of the clinical trial, which is focused on evaluating",
        "label": 0
    },
    "149": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study)\n\nInclusion criteria:\n\n* Age between 18 and 79 years old\n* Out-of-hospital cardiac arrest (OH-CA) due to a presumed cardiac etiology\n* Delay between OH-CA and return of spontaneous circulation (ROSC) < 60 minutes\n* Delay between ROSC and starting cooling < 240 minutes\n* Patient not obeying verbal command after ROSC and prior to starting cooling\n* Availability of the CoolGard device (",
        "label": 0
    },
    "150": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia\n\nInclusion criteria:\n\n* Written informed consent\n* Age > 18 years\n* If female patient with childbearing potential, patient may not be pregnant at the study entry and must utilize reliable birth control for the duration of her participation in the study\n* Patient is willing and able to comply with the specified follow-up evaluation\n* Critical Limb Ischemia, this is Fontaine stage III (ischaemic rest pain) and IV (ischaemic ulcers or gangrene) or",
        "label": 0
    },
    "151": {
        "output": "Patient Note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical Trial:\nTitle: Stenting Versus Best Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis\n\nInclusion Criteria:\nAtherosclerosis is the underlying disease\nPatients with an asymptomatic stenosis >80% (NASCET) with a documented progression of the degree of stenosis to >80% within 6 months with a very tight stenosis \u226590% at initial presentation with a >80% stenosis plus silent ipsilateral ischemia documented by CCT or MRI with ipsilateral >80% stenosis plus contralateral >80% sten",
        "label": 0
    },
    "152": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: Plug Arterial Closure System (PACS, 7F)\n\nSummary: The purpose of this study is to assess the safety and feasibility of the 7F Ensure Medical Vascular Closure Devices to facilitate hemostasis in patients undergoing diagnostic or interventional coronary procedures using a standard 7F introducer sheath.\n\nInclusion criteria:\n\n* Scheduled for a coronary diagnostic or interventional procedure\n* Able to undergo emergent vascular surgery if a complication requires it\n* 7F arterial puncture located in the common femoral artery\n* Femoral artery has a",
        "label": 1
    },
    "153": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical Trial:\nTitle: Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy\n\nInclusion Criteria:\n\n* Adult patients planned to undergo reconstructive surgery using either a pedicle or free tissue transfer flap seen by The Plastic Surgery Service on either an in-patient or outpatient bases.\n* Adult patients that are planned to undergo reconstructive surgery as above and able to receive information regarding the study and provide informed consent to enrollment in the study.\n\nExclusion Criteria:\n\n* All emergency reconstructive surgery patients.\n* Patients planned to undergo radiation therapy in the region of the",
        "label": 0
    },
    "154": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: Femoral Arterial Access With Ultrasound Trial\n\nSummary: This study is designed to evaluate the routine use of vascular ultrasound as an aid for proper placement of a femoral arterial sheath during cardiac catheterization and peripheral arterial angiography.\n\nInclusion criteria:\n\n* Adults age 18 and over\n* Patients undergoing left heart catheterization or peripheral arterial angiography from the retrograde femoral approach\n* Willingness and ability to sign consent form\n* Scheduled to have the procedure performed by an operator trained in the ultrasound technique\n\nTrial-level el",
        "label": 1
    },
    "155": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Prospective Registry on Vascular Access in Interventions in Lazio Region\n\nInclusion criteria:\nAll patients undergoing any percutaneous cardiovascular procedure\n\nAssessment:\nThe patient's recent cardiac catheterization via the right femoral artery and subsequent complaint of a cool right foot, along with the presence of a pulsatile mass in her right groin and loss of distal pulses, suggest that she may have suffered a vascular complication related to the procedure. The bruit over the entry site of the right femoral artery further supports this possibility. Given the potential severity of this complication, it is likely that the patient would be",
        "label": 1
    },
    "156": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: RISE: A Clinical Evaluation of the StarClose\u2122 Vascular Closure System\n\nInclusion criteria:\n\n* Subject must be 18-85.\n* Subject must be an acceptable candidate for an elective, non-emergent diagnostic procedure performed percutaneously via the common femoral artery through either a 5F or 6F procedural sheath.\n* Subject is an acceptable candidate for emergent vascular surgery.\n* Subject agrees to follow-up evaluations to assess complications related to femoral access site.\n* If among the 50 ultrasound sub-study Subjects enrolled,",
        "label": 1
    },
    "157": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: The Assessment of Right Ventricular Contractility in Response to Sildenafil\n\nSummary: The primary objective of this study is to examine the effects of Sildenafil, administered during cardiac catheterization, on right ventricular contractility in children with pulmonary arterial hypertension.\n\nInclusion criteria:\n\n* Significant pulmonary arterial hypertension (mean pulmonary artery pressure > 25 mm Hg)\n* Patients aged 4-18 years\n* Routine cardiac catheterization clinically indicated for deciding therapeutic treatment\n* Informed assent/consent",
        "label": 0
    },
    "158": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Comparing Therapeutic Hypothermia Using External and Internal Cooling for Post-Cardiac Arrest Patients\n\nInclusion criteria:\n\n* Sustained return of spontaneous circulation (ROSC) after cardiac arrest for more than 30 minutes\n* Patients aged between 18 to 80 years\n* Patients who are hemodynamically stable, with a systolic BP > 90 mmHg with or without inotropic support\n* Patients comatose or unresponsive post-resuscitation\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.",
        "label": 0
    },
    "159": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Characteristics Predictive of Success and Complications in the Use of Suture-Mediated Closure of Femoral Venous Access\n\nInclusion criteria:\nAll consented pts. over the age of 18 who received sutured mediated femoral vein following catheterization\n\nAssessment of eligibility:\n\n1. Age: The patient is 67 years old, which meets the inclusion criterion of being over the age of 18.\n2. Medical history: The patient has undergone cardiac catheterization via the right femoral artery, which meets the inclusion criterion of receiving sut",
        "label": 0
    },
    "160": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest\n\nSummary: Sudden cardiac arrest (SCA) remains one of the major leading causes of death. Cognitive deficits are common in survivors of SCA. Postresuscitative mild induced hypothermia (MIH) lowers mortality and reduces neurologic damage after cardiac arrest. The investigators evaluated the efficacy and side effects of therapeutic hypothermia in an unselected group of patients after SCA.\n\nInclusion criteria:\n\n* ROSC after SCA due to VF/VT or PE",
        "label": 0
    },
    "161": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: PROTECT Continued Access Post Marketing Surveillance Trial\n\nInclusion criteria:\n\n* Patient is > 18 years of age (or minimum age as required by local regulations).\n* The patient or patient's legal representative has consented to participate and has authorized the collection and release of his medical information by signing the Patient Informed Consent Form.\n* All lesions requiring interventions (target lesions - one to a maximum of four) in one or more native coronary arteries are amendable for implantation of one or more Endeavor\u00ae Zotarolimus Eluting Coronary Stent System.\n* Patient indication",
        "label": 0
    },
    "162": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: Response To Cardiac Resynchronization Therapy In Heart Failure: Role Of Arterial Stiffness\n\nSummary: To determine if arterial stiffness as measured by non-invasive pulse wave velocity can predict the response to resynchronization therapy in heart failure.\n\nInclusion criteria:\n\n* The patients receiving CRT are medically refractory, symptomatic, NYHA class III or IV disease and QRS duration of 130 m sec or greater, and a left ventricular ejection fraction of 30 percent or less.\n* All individuals are carefully selected after appropriate clinical evaluation as determined by the treating physicians to exclude possible reversible",
        "label": 0
    },
    "163": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Comparison of the FemoSeal\u00ae Arterial Closure Device to Manual Compression After Coronary Angiography\n\nInclusion criteria:\n\n* The patient must be at least 18 years old\n* Patients undergoing femoral access coronary angiography\n* Patient must be competent for providing informed, written consent\n* Only 6F sheath\n\nAssessment of eligibility:\n\n* Age: The patient is 67 years old, which meets the inclusion criterion of being at least 18 years old.\n* Medical history: The patient has undergone cardiac catheterization via",
        "label": 0
    },
    "164": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers\n\nInclusion criteria:\n\n* Diabetic foot ulcer\n* \u2264 80 years old\n* Diabetic foot ulcer Wagner 2-4 stage\n\nAssessment of eligibility:\n\n1. Does the patient have a diabetic foot ulcer?\nYes, the patient has a diabetic foot ulcer.\n2. Is the patient \u2264 80 years old?\nYes, the patient is 67 years old, which is \u2264",
        "label": 0
    },
    "165": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System\n\nInclusion criteria:\n\n* Patient/legal representative provides written informed consent\n* Patient is scheduled for a coronary or peripheral diagnostic or interventional procedure\n* Target vessel has a lumen diameter \u2265 6 mm\n* Patient must be willing to comply with follow-up requirements\n* Patient has a 5-7F arterial puncture located in the common femoral artery\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's current condition, with",
        "label": 1
    },
    "166": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Use of Local Anesthetic (0.25% Bupivacaine) for Pain Control in Pediatric Cardiac Catheterization\n\nInclusion criteria:\nAges 7-18 years\nScheduled for cardiac catheterization through the femoral artery and/or vein under general anesthetic\nAbility to speak and understand English\nNo apparent cognitive impairments\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is 67 years old, which is outside the age range of 7-18 years",
        "label": 1
    },
    "167": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: Feasibility of Peripheral Angioplasty in Type D TASCII Lesions\n\nSummary: This observational prospective study will evaluate, according to usual local clinical practice, the feasibility of endoluminal revascularization in diabetic patients with type C and D lesions, according to TASC II Criteria. About 300 patients will be treated with the usual revascularization procedure. Each patient will be followed at least 12 months to evaluate clinical outcome and limb salvage interventions.\n\nInclusion criteria:\n\n* Adult diabetic patients, type 1 or 2\n* Chronic critical ischemia as defined",
        "label": 0
    },
    "168": {
        "output": "Patient Note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical Trial:\nTitle: BES, EES, and ZES-R in Real World Practice\n\nInclusion Criteria:\n\n* Age > 19 years\n* Subject is able to verbally confirm understanding of risks, benefits, and treatment alternatives of receiving the drug-eluting stent(s) and he/she or his/her legally authorized representative provides written informed consent prior to any study-related procedure\n* Subject must have significant stenosis (>50% by visual estimate) on a native or in-stent coronary artery\n* Subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction,",
        "label": 0
    },
    "169": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents\n\nInclusion criteria:\n\n* Age \u226518 years\n* Symptomatic coronary artery disease including patients with chronic stable angina, silent ischemia, and acute coronary syndromes including NSTE-ACS and STE-ACS\n* Presence of one or more coronary artery stenoses >50% in a native coronary artery or a saphenous bypass graft which can be treated with a stent ranging in diameter from 2.25 to 4.0 mm and can be",
        "label": 0
    },
    "170": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Venous Site for Central Catheterization\n\nInclusion criteria:\n\n* Patient admitted in the Intensive Care Unit\n* Requiring Central Venous Catheterization\n\nAssessment of eligibility:\n\nBased on the patient's history of cardiac catheterization via the right femoral artery and the current complaint of a cool right foot, it appears that the patient may have developed a vascular complication related to the catheterization. The patient's age and the fact that they are in the intensive care unit also suggest that they may be at higher risk for complications. However, without further information,",
        "label": 0
    },
    "171": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.\n\nInclusion criteria:\nControl group:\n\n* Male or female aged at least 18 years\n* Matched on age, sex, and cardiovascular risk factors (smoking, hypertension, diabetes, and treated dyslipidemia) with septic patients\n* Normal clinical examination and normal 12-lead ECG\n* Routine biological tests in the normal range of the laboratories\n* Body mass index between 18 and 27 kg/m\u00b2\n* Writ",
        "label": 0
    },
    "172": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis\n\nInclusion criteria:\nage 19-90 years\nhaving clinical ultrasound evaluation of carotid or femoral artery\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age (67 years) and the presence of a pulsatile mass in the right groin with loss of distal pulses and a bruit over the point at which the right femoral artery was entered, suggest that she may have carot",
        "label": 2
    },
    "173": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)\n\nSummary: The objective of the CELT ACD\u00ae Vascular Closure Device study is to evaluate the safety and effectiveness of the CELT ACD\u00ae device to achieve hemostasis of the common femoral artery access site in patients on anticoagulation who are undergoing a percutaneous intervention (PCI) procedure using a 6F sheath.\n\nInclusion criteria:\n\n1. Over 18 years of age.\n2. Each patient, or his or her guardian or legal representative, is willing to give informed consent.\n3.",
        "label": 1
    },
    "174": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplantation\n\nInclusion criteria:\nPatients candidates to renal transplantation\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's current symptoms and medical history do not necessarily disqualify her from participating in the clinical trial. However, further investigation is needed to determine if she meets all the inclusion criteria for the trial, such as age, renal function, and other medical conditions. Additionally, the patient's cardiac history and recent cardiac catheterization may also need to be taken into consideration",
        "label": 0
    },
    "175": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery\n\nInclusion criteria:\n\n* All cardiac surgical patients\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent cardiac catheterization and complaint of a cool right foot may indicate a potential complication related to the procedure, such as a pulmonary embolism or arterial injury. The patient's age and history of cardiac surgery also increase the risk of complications. While the clinical trial is focused on perioperative medications and their impact on card",
        "label": 0
    },
    "176": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Preconditioning Shields Against Vascular Events in Surgery\n\nInclusion criteria:\nAge greater than 18 years\nPatient willing to give full informed consent for participation\nPatients undergoing elective carotid endarterectomy or\nPatients undergoing open abdominal aortic aneurysm repair or\nPatients undergoing endovascular abdominal aneurysm repair or\nPatients undergoing surgical lower limb revascularisation (suprainguinal or infrainguinal)\n\nAssessment of eligibility:\n\n1. Age: The patient is 67 years old,",
        "label": 2
    },
    "177": {
        "output": "Sure, I'd be happy to help you with that! Here's the assessment of eligibility for the given patient note and clinical trial:\n\nPatient Note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical Trial:\nTitle: Pragmatic Ischaemic Stroke Thrombectomy Evaluation\n\nInclusion Criteria:\n\n* Clinical diagnosis of supratentorial acute ischaemic stroke\n* Male or nonpregnant female \u226518 years of age\n* Clinically significant neurological deficit and NIHSS score \u22656.\n* Eligible for IV rtPA according to standard guidelines and able to be commenced on IV treatment <4.",
        "label": 0
    },
    "178": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)\n\nInclusion criteria:\n\n* Simultaneous co-enrollment in the START study\n* Signed informed consent\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's current condition does not meet the inclusion criteria for the clinical trial. The patient has a cardiac issue and is experiencing symptoms related to a pulsatile mass in her right groin, which is not related to the study's focus on arterial elasticity and the effect of anti-retro",
        "label": 0
    },
    "179": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism\n\nInclusion criteria:\n\n* Diagnosis of hematologic neoplasm (acute leukemia, myelodysplastic syndrome, lymphoma, multiple myeloma, chronic myeloid leukemia, Ph-negative chronic myeloproliferative neoplasms) independently of the stage of disease or treatment (including transplant procedures)\n* Platelet count <50 x109/L at the time of starting antithrombotic prophylaxis or platelet count <50",
        "label": 0
    },
    "180": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Effects of High Voltage Electrical Stimulation, Shortwave Diathermy and Kinesiotherapy on Arterial Blood Flow in the Lower Limbs of Diabetic Women\n\nInclusion criteria:\n\n* Women\n* Diagnosis of diabetes\n* Diagnosis of peripheral arterial disease\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's diagnosis of peripheral arterial disease meets one of the inclusion criteria for the clinical trial. However, the patient's recent cardiac catheterization and compla",
        "label": 0
    },
    "181": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Renal Denervation in Patients With Heart Failure and Severe Left Ventricular Dysfunction.\n\nInclusion criteria:\n\n* Patients over 18 years of age with chronic heart failure, ischemic and non-ischemic etiology.\n* NYHA (New York Heart Association) class II-IV.\n* LVEF (Left Ventricular Ejection Fraction) \u2264 35%.\n* Patients treated with maximum tolerated doses of standard pharmacotherapy for heart failure, who were stable for at least four weeks without acute decompensated heart failure.\n* Prior to en",
        "label": 0
    },
    "182": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Safety and Performance Study of Large Hole Vascular Closure Device\n\nInclusion criteria:\n\n1. Over 18 years of age.\n2. Each patient, or his or her guardian or legal representative, is willing to give informed consent.\n3. Clinically indicated for an endovascular procedure involving access through the femoral artery, with an access puncture of 18 - 24 F.\n4. Females who are not pregnant or lactating, and not planning to become pregnant \u2264 12 months. A pregnancy test may be performed to confirm this.\n\nAssessment of eligibility:",
        "label": 1
    },
    "183": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Study of Survivors of Different Types of Cardiac Arrest and Their Neurological Recovery\n\nInclusion criteria:\nAdmission to adult ICU (age \u226518 years) at London Health Sciences Centre\nPrimary reason for ICU admission: postcardiac arrest\nBoth in-hospital and out-of-hospital cardiac arrest will be included\nICU admission between Jan 2008 and Dec 2012.\n\nAssessment of eligibility:\n\n1. Age: The patient is 67 years old, which meets the inclusion criterion of age \u226518 years.\n2. Reason for ICU admission: The",
        "label": 0
    },
    "184": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: Immediate Mobilization After Cardiac Catheterisation\n\nInclusion criteria:\n\n* CAG or PCI performed via the femoral artery\n* No hematoma in the groin (> 5 cm in diameter)\n* Heparin reversed with protamine after PCI\n\nAssessment of eligibility:\n\nBased on the patient's history of cardiac catheterization via the right femoral artery and the presence of a pulsatile mass in her right groin with loss of distal pulses, it appears that she may meet the inclusion criteria for the clinical trial. However, further investigation is needed to confirm the absence of a h",
        "label": 0
    },
    "185": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Postoperative Respiratory Depression After Cardiac Surgery\n\nInclusion criteria:\n\n* Patients of both sexes older than 18 years submitted to CABG with CPB\n* Presence of coronary disease confirmed by coronary angiography\n* Use of the left internal thoracic artery and/or saphena\n* Patients who remained in spontaneous ventilation on the first postoperative day\n* Absence of chronic or acute pulmonary disease\n* Giving written informed consent to participate in the study\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.",
        "label": 0
    },
    "186": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Preconditioning Shields Against Vascular Events in Surgery\n\nInclusion criteria:\nAge greater than 18 years\nPatient willing to give full informed consent for participation\nPatients undergoing elective carotid endarterectomy or\nPatients undergoing open abdominal aortic aneurysm repair or\nPatients undergoing endovascular abdominal aneurysm repair or\nPatients undergoing surgical lower limb revascularisation (suprainguinal or infrainguinal)\n\nAssessment of eligibility:\n\n1. Age: The patient is 67 years old,",
        "label": 2
    },
    "187": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Left vs. Right Radial Approach for Routine Catheterization of Heart Transplant Patients\n\nInclusion criteria: Inclusion Criteria: eligible transplanted patients scheduled for a routine coronary angiography with age >18 years old.\n\nAssessment of eligibility:\n\n1. Age: The patient is 67 years old, which meets the inclusion criterion of age >18 years old.\n2. Medical history: The patient has a history of heart transplantation, which meets the inclusion criterion of being a transplanted patient scheduled for a routine coronary angiography.\n3. Presenting sympt",
        "label": 0
    },
    "188": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Randomized Comparison of Radiological Exposure With TRIPTable\u00ae in Patients With Acute Coronary Syndromes\n\nInclusion criteria:\n\n* Unstable angina with an indication for invasive stratification\n* Acute coronary syndrome without ST-segment elevation\n* Acute coronary syndrome with ST-segment elevation\n* Patient informed of the nature of the study and have signed the Informed Consent\n* Patient suitable for coronary angiography and / or percutaneous coronary intervention either by radial access as the femoral\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon",
        "label": 1
    },
    "189": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: HAL-RAR Versus Hemorrhoidectomy in the Treatment of Grade III-IV Hemorrhoids. Prospective, Randomized Trial\n\nInclusion criteria:\nPatients with symptomatic grade III or IV hemorrhoids (bleeding, pain, itching, soiling or prolapse) that are eligible for surgical treatment with both methods.\n\nAssessment:\nThe patient's symptoms and examination findings suggest a possible arterial injury or complication related to the cardiac catheterization procedure. The patient's age and medical history may also be relevant to the patient's overall health status and potential eligibility for",
        "label": 0
    },
    "190": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\n\nTitle: Randomized Comparison of MynxGrip Vascular Closure Device and Manual Compression for Closure After Femoral Access Angiography. The Closure Devices Used in Every Day Practice Study, CLOSE-UP III Trial\n\nInclusion criteria:\n\n* Age \u2265 18 years\n* Should be able to provide valid informed signed consent\n* CAG, possibly including intracoronary measurement (FFR) or intracoronary imaging (IVUS, optical coherence tomography (OCT), NIRS)\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial",
        "label": 0
    },
    "191": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Safety and Performance Study of Large Hole Vascular Closure Device\n\nInclusion criteria:\n\n* Over 18 years of age\n* Each patient, or his or her guardian or legal representative, is willing to give informed consent\n* Clinically indicated for an endovascular procedure involving access through the femoral artery, with an access puncture of 18 - 24 French (F)\n* Females who are not pregnant or lactating, and not planning to become pregnant in \u2264 12 months\n\nTrial-level eligibility: 1) Would consider referring this patient",
        "label": 1
    },
    "192": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis\n\nInclusion criteria:\n\n1. Chronic renal failure requiring hemodialysis.\n2. No medical history of central vena catheterization.\n3. Maintenance hemodialysis after central vena catheterization.\n4. Signed informed consent.\n\nAssessment of eligibility:\n\n1. The patient has chronic renal failure and requires hemodialysis, meeting inclusion criterion 1.\n2. The patient has a history of cardiac catheterization via the right femoral",
        "label": 1
    },
    "193": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Randomized Clinical Trial of Polyester vs. Polyurethane Patch for Carotid Endarterectomy\n\nInclusion criteria:\nCarotid stenosis > 60% NASCET criteria\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nExplanation:\nThe patient's complaint of a cool right foot and the presence of a pulsatile mass in her right groin with loss of distal pulses suggests that she may have a peripheral arterial occlusion. The fact that she underwent cardiac cath",
        "label": 0
    },
    "194": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery\n\nInclusion criteria:\nAge \u2265 18\nPatient undergoing vascular surgery that would include a groin incision as a standard part of the operation. Infrainguinal bypass, including femoral popliteal/tibial/pedal artery bypass with autogenous or prosthetic conduit.\nFemoral endarterectomy with or without patch angioplasty involving the common femoral artery and/or profunda and/or proximal superficial artery. The",
        "label": 1
    },
    "195": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Evaluating the Effect of Surgical Safety Checklists on Perioperative Complications in Children\n\nInclusion criteria:\nSurgical admission, with a noncardiac surgical intervention\nAged between >28 days and <18 years on the day of the surgical intervention\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient in the given note is a 67-year-old woman who underwent cardiac catheterization, which does not meet the inclusion criteria of the clinical trial, which specifies patients aged between >28 days",
        "label": 0
    },
    "196": {
        "output": "Patient note:\nA physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Intracardiac Echocardiography in Atrial Flutter Ablation\n\nInclusion criteria:\nIndication for atrial flutter ablation\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of a cool right foot, pulsatile mass in the right groin, and loss of distal pulses, along with the presence of a bruit over the entry point of the right femoral artery, suggest that she may have an arterial injury or complication related to the cardiac catheterization. This could potentially make her inel",
        "label": 0
    },
    "197": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Continuous Adductor Canal Blocks Vs. Low Dose Femoral Nerve Blocks For Early Rehabilitation After Total Knee Arthroplasty\n\nInclusion criteria:\nAble to consent to regional anesthesia and having primary total knee arthroplasty/replacement\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's current condition, with a pulsatile mass in her right groin and loss of distal pulses, may indicate a potential complication related to the cardiac catheterization procedure. It is essential to investigate this further to ensure",
        "label": 0
    },
    "198": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: A Comparison of mNT-BBAVF and BCAVF in Hemodialysis Patients\n\nInclusion criteria:\nAge from 18 to 75 years;\nRadial artery diameter <2.0 mm or cephalic vein diameter in the forearm <2.5 mm;\nBrachial artery diameter \u2265 2 mm\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial. The patient's age is 67 years, which is above the upper limit of 75 years specified in the inclusion criteria. Additionally, the patient",
        "label": 0
    },
    "199": {
        "output": "Patient Note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical Trial:\nTitle: Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension\n\nInclusion Criteria:\n\n* Patients with pulmonary artery hypertension (group 1 of the Nice classification of pulmonary hypertension)\n* Aged over 18 years old\n* NYHA class III or IV\n* Not controlled by optimal medical management as defined by:\n\t+ Dual therapy including a prostacyclin.\n\t+ Dual therapy including an endothelin receptor antagonist and a 5-phosphodiesterase inhibitors, in patients with contra-indication of prostacyclin, poor toler",
        "label": 0
    },
    "200": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment\n\nInclusion criteria:\n\n* Minimum 18 years old\n* Diagnosed with PAH or non-operable CTEPH or operated CTEPH with persistent pulmonary hypertension\n* Diagnosis of PAH based on cardiac catherisation\n* Diagnosis of CTEPH confirmed by contrast-enhanced spiral chest CT, pulmonary angiography, and V/Q scintigraphy\n* Recent diagnosis of sleep disordered breathing (polysomnography realized within 3 months before inclusion showing AHI",
        "label": 0
    },
    "201": {
        "output": "Patient note:\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence\n\nInclusion criteria:\n\n* Newly healed leg or diabetic foot ulcer within the past 7-14 days\n* Ankle brachial index 0.8-1.3mmHg (rule out the absence of arterial disease)\n* Willing to wear compression stockings and appropriate footwear\n* Working freezer\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent cardiac catheterization and complaint of a cool right foot may indicate that they",
        "label": 0
    },
    "202": {
        "output": "Patient note:\n\nA 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning is complaining of a cool right foot. Upon examination, she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.\n\nClinical trial:\nTitle: Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia\n\nInclusion criteria:\n\n* Willing, able, and committed to participate in the procedures for the full length of the study.\n* All ethnic groups, male or female above the age of 18 years.\n* Diagnosis of non-reconstructable arterial disease and critical limb ischaemia (with a minimum of duplex ultrasound and an MDT discussion to have reached this diagnosis).\n* Be of non-childbearing potential; OR using adequate contraception and have a negative urine pregnancy test result within 24 hours if appropriate",
        "label": 2
    },
    "203": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI\n\nInclusion criteria:\n\n1. 18-60 years of age\n2. Right-handed non-smokers\n3. Diagnosed with facial pain\n4. Continuous pain for more than 3 months\n5. Spontaneous pain greater than 3 of 10\n6. Allodynia to brush greater than 5 of 10\n\nAssessment of eligibility:\n\n1. Age: The patient is 40 years old, which",
        "label": 0
    },
    "204": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)\n\nInclusion criteria:\n\n* Have pain due to bilateral peripheral neuropathy caused by Type I or Type II diabetes with the pain beginning in the feet and present for at least 6 months.\n* May not be pregnant and agree to utilize medically acceptable and reliable means of birth control during participation in the study.\n* Score of 4 or greater on the Brief Pain Inventory on the 24-hour average",
        "label": 0
    },
    "205": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Study to Investigate Effects of Antiischemic Drug Therapy in Silent Ischemia\n\nInclusion criteria:\n\n* Documented silent myocardial ischemia type I\n* At least one cardiovascular risk factor\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of excruciating pain in her right arm and tachypneic and tachycardic behavior indicate that she may be experiencing cardiac ischemia, which aligns with the clinical trial'",
        "label": 1
    },
    "206": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Laparoscopic Appendectomy for Chronic Right Lower Abdominal Pain\n\nInclusion criteria:\nPatients were eligible if they were between 15 and 45 years of age, and if they suffered from chronic or recurrent right lower abdominal quadrant pain for more than three months. They were to experience continuous pain, or should have endured at least one pain attack in the month prior to inclusion.\n\nAssessment of eligibility:\n\n1. Age: The patient is 40 years old, which is within the inclusion criteria of 15-45 years",
        "label": 0
    },
    "207": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma\n\nInclusion criteria:\nPatients of acute moderate brain trauma\n\nAssessment:\nThe patient's symptoms, such as excruciating pain in her right arm, pale and moderate discomfort, tachypneic and tachycardic, and normal body temperature and blood pressure, do not meet the inclusion criteria for the clinical trial, which",
        "label": 0
    },
    "208": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Detection of Ischemia in Asymptomatic Diabetics\n\nInclusion criteria:\nAge 50-75 years\nType 2 diabetes mellitus\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is 40 years old, which is below the required age of 50-75 years. Additionally, she does not have a history of Type 2 diabetes mellitus. Therefore, she is not eligible for",
        "label": 0
    },
    "209": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Low Level Laser Therapy to Reduce Chronic Pain\n\nInclusion criteria:\n\n* Muscular-skeletal pain in the neck/shoulder region\n* Acute and chronic pain in the neck/shoulder region\n* Restricted range of motion in the neck/shoulder region\n* Fibrosis or scar tissue in the neck/shoulder region\n* Inflammation in the neck/shoulder region\n* Altered function in the neck/shoulder region\n* Muscle strains in the neck/shoulder region\n* Rating of 30 or greater on the",
        "label": 0
    },
    "210": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy\n\nInclusion criteria:\n\n* Diagnosis of angina pectoris as defined by Canadian Cardiovascular Society Classification (CCS I, II, III, IV) OR unstable angina pectoris (Braunwald Classification B&C, I-II-III) OR patients with documented silent ischemia, all treated with a second generation drug-eluting stent\n* Presence of one or more de novo stenosis equal or greater than 7",
        "label": 1
    },
    "211": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy\n\nInclusion criteria:\n\n* IVIG-untreated subjects:\n\t+ Either subjects with newly diagnosed CIDP (developing over at least 2 months) or subjects with an IVIG treatment interruption for at least 1 year with a progressive disease (deteriorating in the last 2 months) prior to enrolment.\n\t+ Actual diagnosis (including electrophysiology) of CIDP with progressive or relapsing",
        "label": 0
    },
    "212": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Transpulmonary Thermodilution and Transesophageal Echocardiography in Early Septic Shock\n\nInclusion criteria:\n\n* Ventilated patient in sinus rhythm with septic shock requiring a hemodynamic assessment\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of tachypnea, tachycardia, and pale appearance suggest that she may be experiencing septic shock, which meets the inclusion criteria for the clinical trial. However, further investigation is needed",
        "label": 0
    },
    "213": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: DEPITAC : Short Screening Scale for Psychotraumatic Disorders After Motor Vehicle Accident\n\nInclusion criteria:\nRoad traffic accident victims hospitalized in surgical department less than 2 weeks\nCan be called by phone\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of excruciating pain in her right arm and tachypneic and tachycardic behavior may indicate a psychotraumatic disorder related to the motor vehicle accident. However, further investigation is needed",
        "label": 0
    },
    "214": {
        "output": "Patient Note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical Trial:\nTitle: Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil\n\nInclusion Criteria:\n\n* Receiving capecitabine or sunitinib as part of routine standard care.\n* CTCAE version 4.0, grade 1-3 PPE.\n* Adults age \u2265 18\n* Karnofsky (KPS) performance status of \u226570%\n* Adequate organ and marrow function as defined below:\n\t+ ANC > 1000/mL",
        "label": 0
    },
    "215": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Comparison of a Tissue Perfusion Guided Hemodynamic Protocol With a Standard Hemodynamic Protocol in Septic Shock Patients\n\nInclusion criteria:\n\n* 2 or more SIRS criteria according to ACCP/SCCM definition\n* Documented infection or strong suspicion of infection with adequate antibiotic treatment\n* Shock according to ACCP/SCCM definition with the necessity of vasopressor treatment\n\nExclusion criteria:\n\n* Patients admitted with central nervous diseases\n* ST elevation myocardial infarction",
        "label": 1
    },
    "216": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Angiomax\u00ae or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention\n\nInclusion criteria:\n\n* The patient is male or female \u2265 18 years of age.\n* The patient presents with stable angina pectoris or silent ischemia (positive stress test without chest pain).\n* The patient is scheduled for coronary angiography, with possible angioplasty.\n* The patient is able to tolerate dual anti-platelet therapy with aspirin and clopidogrel for a minimum of 30 days and is on",
        "label": 1
    },
    "217": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory Distress Syndrome\n\nInclusion criteria:\nPatients were included if they were diagnosed with Shock, Acute respiratory distress syndrome (ARDS), or both.\nShock was defined by the presence of 4 criteria:\nHeart rate of at least 90/min;\nA respiratory rate of at least 20/min or a PaCO2 of 32mmHg or lower or the use of mechanical ventilation;\nThe use of vasop",
        "label": 1
    },
    "218": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)\n\nInclusion criteria:\n\n* Inclusion Criteria:\n* Men and women, age 18-60.\n* Participants must have a level of understanding sufficient to agree to all tests and examinations required by the protocol and must sign a written informed consent document.\n* Participants must fulfill DSM-IV criteria for current PTSD, based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID",
        "label": 0
    },
    "219": {
        "output": "Patient Note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical Trial:\nTitle: Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease\n\nInclusion Criteria:\n\n1. Have Chagas disease, confirmed by two serological tests.\n2. Provide evidence through any of the following diagnosis methods: Rest ECG, 24-hour Holter monitoring, electrophysiological study, stress test or loop monitoring, at least one electrical disorder consistent with sinus bradycardia greater than 45 and lower than 60 bpm, sinus arrest not greater than 2.0 seconds,",
        "label": 0
    },
    "220": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE\n\nInclusion criteria:\nPatients with signs or symptoms in favor of PTE who come to the Emergency department of Alzahra General Hospital.\n\nAssessment of eligibility:\n\n* The patient presents with sudden-onset severe pain in her right arm, which could be a sign of a pulmonary embolism.\n* The patient has no past medical history, which fulfills the inclusion criterion of no previous history of P",
        "label": 2
    },
    "221": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain\n\nInclusion criteria:\nAge greater than or equal to 21 years\nChest discomfort or other symptoms consistent with possible ACS\nThe treating physician feels the patient could be discharged home if cardiac disease was excluded\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of excruciating pain in her right arm and tachypneic and tachy",
        "label": 0
    },
    "222": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Physical Therapy for Women With Obstetric Trauma and Anal Incontinence\n\nInclusion criteria:\n\n* Primiparous women aged 18 years or older\n* Vaginal delivery, vacuum-assisted-vaginal-delivery (VAVD), or forceps-assisted-vaginal-delivery (FAVD) of a neonate of gestational age:\n27 completed weeks\n* Singleton or vaginal delivery of multiple gestation\n* Able to read and speak the English language\n\nTrial-level eligibility: 0)",
        "label": 0
    },
    "223": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Measuring Changes in Acute Pain in the Emergency Department Using Patient Reported Scales\n\nInclusion criteria:\nReported pain greater than or equal to 3 out of 10\n\nAssessment of eligibility:\n\n1. The patient reports excruciating pain in her right arm, which meets the inclusion criterion of reported pain greater than or equal to 3 out of 10.\n2. The patient has no past medical history, which does not contraindicate her participation in the clinical trial.\n3. The patient's vital signs, including temperature, blood pressure",
        "label": 2
    },
    "224": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Transcranial Magnetic Stimulation for Focal Hand Dystonia\n\nInclusion criteria:\n\n* Confirmed diagnosis of focal hand dystonia (patients only).\n* Between age 18 and 70 years.\n* Able to give informed consent.\n* Right-handed.\n* Agrees to not drink caffeine or alcohol for 48 hours before the study session.\n* No open scalp wounds or scalp infections.\n\nExclusion criteria:\n\n* Has used illegal drugs within the past 6 months based on history,",
        "label": 0
    },
    "225": {
        "output": "Patient Note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical Trial:\nTitle: Assessment of Fluid Responsiveness by Elevation of PEEP in Patients With Septic Shock\n\nInclusion Criteria:\n\n* Written informed consent by patient or relative\n* Time in ICU < 48 hours\n* Septic shock\n* Pulmonary artery catheter and radial arterial catheter\n* Age 18 - 75 years\n* Sinus rhythm\n* Need for norepinephrine over 0.1 ug/kg/min but otherwise hemodynamically stable, i.e., no need to change the do",
        "label": 0
    },
    "226": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Evaluation of Lung Doppler Signals in Pulmonary Hypertension\n\nInclusion criteria:\nProspective arm:\nMan or woman aged over 18.\nWith suspicion or diagnosis of pulmonary hypertension.\nScheduled to undergo right heart catheterization.\nAble and willing to give informed consent.\n\nRetrospective arm:\nMan or woman aged over 18.\nWith diagnosis of pulmonary hypertension confirmed by right heart catheterization in the past.\nAble and willing to give informed consent.\n\nTrial-level",
        "label": 0
    },
    "227": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients\n\nInclusion criteria:\nAdmitted to the hospital for care of injuries\nHave a greater than minimal (moderate to highest) level of VTE risk\n\nAssessment of eligibility:\n\n* The patient has no past medical history and presents with excruciating pain in her right arm, which suggests a potential injury.\n* The patient's vital signs, including tachypnea and tachycardia, indicate a moderate level of distress.\n* The patient",
        "label": 0
    },
    "228": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial: Title: Pilot Study for the SQUEEZE Trial\n\nInclusion criteria:\n\n1. Age 29 days to less than 18 years of age\n2a) Patient has Persistent Signs of Shock, including one or more of the following:\n\t* Vasoactive Medication Dependence\n\t* Hypotension (Systolic Blood Pressure and/or Mean Blood Pressure less than the 5th percentile for age)\n\t* Abnormal Perfusion (2 or more of: abnormal capillary refill, tachycardia, decreased level of consciousness",
        "label": 0
    },
    "229": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Diagnosing Pneumonia Under Low-resource Conditions\n\nInclusion criteria:\nAll children below 5 exceeding WHO age-dependent tachypnea criteria.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age and medical history do not meet the inclusion criteria for the clinical trial. The patient is an adult, and the trial is only for children below the age of 5. Additionally, the patient's symptoms do not match the criteria for pneumonia or wheezy diseases, which are the focus of the clin",
        "label": 0
    },
    "230": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Hypoalgesic Effects Neural Mobilization Techniques\n\nInclusion criteria:\nAsymptomatic subjects who met the inclusion criterion of being between 18 and 30 years old.\n\nAssessment:\nThe patient's age (40 years old) does not meet the inclusion criterion of being between 18 and 30 years old. Therefore, the patient is not eligible for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.</s>",
        "label": 0
    },
    "231": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Pre-discharge vs. Early Post-discharge Stress Testing and GRACE Score for Safe Discharge of ACS-patients With a Negative Hs-troponin T Result\n\nInclusion criteria:\n\n* Patients presenting to the emergency department (chest pain unit)\n* Typical angina pectoris\n* Absence of symptoms since presentation\n* At least 18 years\n* Low GRACE risk score (<140 points)\n* Informed consent, signed agreement\n\nTrial-level eligibility: 1",
        "label": 0
    },
    "232": {
        "output": "Patient Note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical Trial:\nTitle: Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949\n\nInclusion Criteria:\n\n* Signed informed consent prior to any study-mandated procedure.\n* Healthy Caucasian male subjects aged between 18 and 45 years (inclusive) at screening.\n* Subjects must agree to use reliable methods of contraception.\n* No clinically significant findings on physical examination at screening.\n* Body mass index (BMI) between 18",
        "label": 0
    },
    "233": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain\n\nInclusion criteria:\nAge 45 to 80 years old, inclusive\nClinical diagnosis of osteoarthritis in one target knee based on the following American College of Rheumatology (ACR) criteria:\nKnee Pain\nAt least 1 of 3:\nAge > 50 years\nMorning stiffness lasting < 30 minutes\nCrepitus on motion\nOsteophytes on radiograph\nSym",
        "label": 0
    },
    "234": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Cortisol Measurement During Intravenous Access With a Medical Clown\n\nInclusion criteria:\nPatients needing venous blood sampling or insertion of an intravenous canula\nNormal development according to parents\n\nAssessment of eligibility:\n\n1. Does the patient need venous blood sampling or insertion of an intravenous canula? Yes, the patient presents with excruciating pain in her right arm, which may require venous blood sampling or insertion of an intravenous canula.\n2. Does the patient have a normal development according to parents? Yes",
        "label": 0
    },
    "235": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical Trial:\nTitle: HEAVy HAT-HEAlthy Volunteers Heart to Arm Time. Haemorrhage Simulation Protocol in Healthy Volunteers\n\nInclusion Criteria:\n30 healthy volunteers with no assumption of coffee or any other substance with possible action on the autonomic nervous system.\n\nAssessment:\nThe patient's symptoms of excruciating pain in her right arm, tachypnea, and tachycardia, could be indicative of a potential bleeding or hypovolemic shock. However, the patient's vital signs, including her blood pressure and body",
        "label": 0
    },
    "236": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Efficacy Study of Assiut Femoral Compression Device Versus Manual Compression in the Achievement of Hemostasis\n\nInclusion criteria:\nPatients between 18 and 85 years of age, scheduled to undergo an elective PCI via arterial puncture of the common femoral artery, are eligible for enrollment in the study. Elective PCI was defined as any coronary revascularization in a low-risk patient who presents to the facility for a planned PCI or for a coronary angiogram followed by ad hoc PCI.",
        "label": 1
    },
    "237": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: The Effect of IV Clonidine on Pain Management in the Emergency Department\n\nInclusion criteria:\n\n* Age \u2265 18 years\n* Presenting to the emergency department with acute pain\n* Pain score \u2265 7/10\n* No history of chronic pain or chronic pain management\n* No history of clonidine use in the past 6 months\n* No known allergy to clonidine\n* No significant cardiovascular disease\n* No significant respiratory disease\n* No significant renal or hepatic impairment\n\nTrial",
        "label": 0
    },
    "238": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Pilot Study of Functional and Morphometric Brain Abnormalities Related to Adolescent Idiopathic Scoliosis (MOR-FO-SIA)\n\nInclusion criteria:\n\n* Female\n* Between 14 and 16 years old\n* Normal neurological examination\n* Right-handed\n* Informed consent\n* Informed consent form signed by a parent or a holder of parental authority\n* Affiliated to medical insurance\n* Negative urine pregnancy test\n\nFor patients (A-STD):\n\n* Right thoracic",
        "label": 0
    },
    "239": {
        "output": "Patient Note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical Trial:\nTitle: Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10\n\nInclusion Criteria:\n\n* Diagnosis of TB or non-TB lung disease\n* Age 18-65 years\n* Signed informed consent\n* Compliance with follow-up\n\nExclusion Criteria:\n\n* Advanced cancer\n* Diabetes\n* COPD in acute episodes\n* Acute/progressive liver or kidney disease\n* Congestive heart failure\n* History of allergy\n*",
        "label": 0
    },
    "240": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Trauma Patients and Hypothermia in the Emergency Room: ReadyHeat\u00ae Versus Cotton Wool Blanket\n\nInclusion criteria:\n- Trauma patients \u2265 18 years of all severity stages, including polytraumatized patients admitted through the emergency room\n\nAssessment of eligibility:\n\n1. Age: The patient is 40 years old, which meets the inclusion criterion of \u2265 18 years.\n2. Medical history: The patient has no past medical history, which does not contradict the inclusion criterion.\n3. Presenting sympt",
        "label": 0
    },
    "241": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Compression in Anklefracture Treatment, The CAT-study\n\nInclusion criteria:\nAll patients operated on Nordsj\u00e6llands Hospital, department of Orthopaedic surgery, during the inclusion period, for mono-, bi- and trimalleolar fracture, according to the AO-principles.\nAge above 18 years.\n\nAssessment of eligibility:\n\n1. Does the patient have a history of ankle fracture?\nNo, the patient presents with excruciating pain in her right arm, with no history of an",
        "label": 0
    },
    "242": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Prevention of Intrusive Memories and Posttraumatic Stress Symptoms After Emergency Cesarean Section\n\nInclusion criteria:\nFemale, aged 18+ years\nHad emergency caesarean section within the past 6 hours\nHave given birth to a live baby at \u2265 37 weeks gestation\n\nAssessment of eligibility:\n\n1. Age: The patient is 40 years old, which meets the inclusion criterion of being aged 18+ years.\n2. Emergency cesarean section: The patient has not had an emergency",
        "label": 0
    },
    "243": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)\n\nInclusion criteria:\n\n* Age \u2265 40 and \u2264 60 years\n* Familial hypercholesterolemia (FH) diagnosis\n* Asymptomatic\n* No personal history of coronary heart disease\n* High cardiovascular risk identified by one of the following criteria:\n\t+ Current smoking (1 cigarette a day)\n\t+",
        "label": 0
    },
    "244": {
        "output": "Patient note:\nA 40-year-old woman with no past medical history presents to the ER with excruciating pain in her right arm that had started 1 hour prior to her admission. She denies trauma. On examination, she is pale and in moderate discomfort, as well as tachypneic and tachycardic. Her body temperature is normal, and her blood pressure is 80/60. Her right arm has no discoloration or movement limitation.\n\nClinical trial:\nTitle: Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen\n\nInclusion criteria:\n\n* Inclusion Criteria of TB (tuberculosis) subjects:\n\t+ Judge the pulmonary tuberculosis patient according to Health industry standard of the People's Republic of China WS288-2008: Diagnostic Criteria for pulmonary tuberculosis;\n\t+ 18 to 65 years old, no gender limited;\n\t+ Consent and signed informed consent forms (ICF);",
        "label": 0
    },
    "245": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Prevention of Weight Gain\n\nInclusion criteria:\nBody mass index of 21 through 30\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's body mass index (BMI) is not provided in the patient note. However, based on the patient's complaint of weight gain during the previous 6 months, it is possible that her BMI may be within the inclusions criteria range of 21 through 30. Therefore, further investigation is needed to determine the patient's BMI and assess her eligibility for the clinical trial.</s>",
        "label": 0
    },
    "246": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Thyroxine Titration Study\n\nInclusion criteria:\nMale or female subjects >18 years of age\nPrimary hypothyroidism \u22656 months duration arising from autoimmune hypothyroidism, thyroidectomy, or radioiodine treatment\nThyroxine dose \u2265100 mcg/day\nNo change in thyroxine dose in past 2 months\nSerum TSH of 0.1-4.8 mU/L\nAdequate contraceptive measures for women of childbearing age\n\nAssessment of eligibility:\n\n1. Age: The patient",
        "label": 0
    },
    "247": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia\n\nInclusion criteria:\n\n* Age 25\n* Insomnia diagnosis\n* Stable sleep/wake schedule with a preferred sleep phase between 10:00 PM and 8:00 AM\n* Live in the Greater Rochester NY area\n* Meet diagnostic criteria for Psychophysiological Insomnia according to the International Classification of Sleep Disorders (ICSD)\n* Complain of fatigue and/or sleepiness at intake\n\nTrial-level eligibility: 1) Would consider referring",
        "label": 0
    },
    "248": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Sleep Apnea in Look AHEAD (Action for Health in Diabetes)\n\nInclusion criteria:\nEnrollment in LookAhead\nType II Diabetes and Sleep Apnea\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of fatigue, hair loss, voice change, and weight gain may be related to a thyroid disorder, which could potentially be a comorbidity with sleep apnea. The patient's complaint of cold intolerance may also be related to a thyroid disorder. The patient's prominent, soft, uniform",
        "label": 0
    },
    "249": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity\n\nInclusion Criteria:\n\n* 18 to 50 year old obese men and premenopausal women\n* BMI between 29-55\n* Chronically (for more than 6 months) sleep-deprived, defined as sleeping on a regular basis less than or equal to approximately 6-1/2 hours/night by history and objective devices (wrist activity monitors and sleep logs).\n\nExclusion Criteria:\n\n* Diagnosed sleep disorders including:\n\t+ Chronic insom",
        "label": 0
    },
    "250": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes\n\nInclusion criteria:\n\n* Diagnosis of type 2 diabetes HbA1C <= 12.0% within the past 12 months;\n* BMI <= 45.0 kg/m2\n* Initiation, addition of, change to, or continuation of basal insulin therapy with insulin detemir as deemed necessary by Investigator\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe",
        "label": 0
    },
    "251": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Selenium Treatment in Autoimmune Thyroiditis (AIT)\n\nInclusion criteria:\nClinically approved AIT patients who do not use any medication other than LT4 to keep TSH in the lower half of the normal range.\n\nAssessment of eligibility:\n\n1. The patient presents with fatigue, hair loss, voice change, weight gain, and cold intolerance, which are all symptoms of hypothyroidism.\n2. The patient has a prominent, soft, uniform anterior cervical mass at the midline, which is consistent with a thyroid nodule or goiter.\n3. The patient's",
        "label": 2
    },
    "252": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation\n\nInclusion criteria:\n\n* Hypopituitarism of at least 3 axes (TSH plus gonadotropin, somatotropin, corticotropin, or ADH deficiency)\n* Termination of surgical or radiation treatment of pituitary tumors at least six months before study entry\n* BMI of 20 - 39.9 kg/m2\n* Non-smoking status\n\nTrial-level eligibility: 1) Would",
        "label": 1
    },
    "253": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism\n\nInclusion criteria:\nThe diagnostic standard for manifest hypothyroidism and subclinical hypothyroidism was defined as follows:\nHypothyroidism - TSH > 40 mU/L and T3 and T4 below the reference range or TSH > 40 mU/L, T3 normal and T4 below the reference range [2]\nSubclinical hypothyroidism - TSH \u2265 20 mU/L, T3 and T4 normal or low-normal or TSH > 5.6 mU/L",
        "label": 2
    },
    "254": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia\n\nInclusion criteria:\n\n* Birth weight: less than 1500g\n* Gestation: 22 weeks 0 day \u2264\n* Serum free thyroxine level lower than 0.8 ng/dl\n* Serum thyrotropin lower than 10 \u03bcU/ml\n* Age of between 2 and 4 weeks after birth\n* Informed consent\n\nAssessment of eligibility:\n\n* Age: The patient is 25 years old, which is outside the inclusion criteria of 2",
        "label": 0
    },
    "255": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome\n\nInclusion Criteria:\n\n1. Females of childbearing potential who are sexually active must agree to use adequate contraception from screening throughout the duration of the study.\n2. Must have a diagnosis of Delayed Sleep Phase Syndrome according to International Classification of Sleep Disorders criteria for at least 3 months.\n3. Based on sleep history, the subject's habitual sleep time is more than 3 hours later than the desired sleep time.\n4. Must have had self-report",
        "label": 0
    },
    "256": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Weight Gain Prevention\n\nInclusion criteria:\nAge 18-35\nBody mass index between 23 and 30\nInterested in preventing weight gain\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of being between 18 and 35 years old.\n2. Body mass index: The patient's body mass index is not provided in the patient note. However, based on the patient's complaint of weight gain during the previous 6 months, it is likely that her body mass index is between 23 and 30, which meets",
        "label": 2
    },
    "257": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Pregabalin in the Treatment of Essential Tremor\n\nInclusion criteria:\n\n* Subjects must be between the ages of 18 and 80 inclusive.\n* Each subject must have current manifestations of ET symptoms based on the Tremor Investigational Group (TRIG) criteria for definite or probable ET: - Moderate or severe tremor in head or arms for at least 3 years duration. - No present causes of enhanced physiologic tremor. - No recent exposure to tremorogenic drugs or drug withdrawal states. - No direct or indirect trauma to the nervous system within 3 months",
        "label": 0
    },
    "258": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Role of Dairy Products in Weight Maintenance\n\nInclusion criteria:\n\n* Body mass index (BMI) 30-39.9 kg/m2\n* Age 25-50 years\n* No more than 3 kg weight loss during the past three months\n* Negative pregnancy test at entry; women of childbearing potential may be enrolled if they have had a tubal ligation or use one of the following means of contraception: condom, diaphragm, oral or implanted contraceptives, or intrauterine device. Women in exclusive relationships with male partners who have had a successful vas",
        "label": 2
    },
    "259": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone\n\nInclusion criteria:\nPremenopausal women with overt primary hypothyroidism (reduced T4 concentration accompanied by increased TSH concentration at the time of initial diagnosis) who did not receive thyroid hormones\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of being a premenopausal woman.\n2. Medical history: The patient has a history of prolonged fatigue, hair loss, change in",
        "label": 2
    },
    "260": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.\n\nInclusion Criteria:\n\n1. Written informed consent is obtained.\n2. The subject is English-speaking and 18 through 64 years of age inclusive.\n3. The subject is currently receiving a serotonergic agent or is scheduled to receive a new or change in serotonergic psychotropic agents for their psychiatric condition, or can document that they have been on a stable regimen without any weight gain in the last 3 months as a",
        "label": 0
    },
    "261": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Effects of Dietary Pork and Egg on Appetite, Meal-patterning, and Weight Loss in Men\n\nInclusion criteria:\nAge range: 21 years and older\nBody mass index between 25.0-39.9 kg/m2\nWeight stable (< 4.5 kg (10 lbs) weight gain or loss within last 6 months)\nBody fat >25% (assessed by skinfold and plethysmography (if needed))\nNon-smoking (within the last 6 months)\nConstant habitual activity patterns (within last 3 months)\nClinically",
        "label": 0
    },
    "262": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: A Study to Compare Two Ways of Completing Pain and Sleep Questions and to Evaluate a New Daily Questionnaire for Assessing Fatigue in Fibromyalgia Patients\n\nInclusion criteria:\nFibromyalgia using ACR diagnosis\n\nAssessment of eligibility:\n\n1. Does the patient meet the inclusion criteria of the clinical trial?\nYes, the patient meets the inclusion criterion of fibromyalgia using ACR diagnosis.\n2. Does the patient have any exclusion criteria?\nNo, the patient does not have any exclusion criteria mentioned in the clinical trial.\n3. Is the patient likely",
        "label": 0
    },
    "263": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Overnight Weight Loss and Sleep Structure\n\nInclusion criteria:\nInclusion Criteria:\nnormal and obese volunteers\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of being \u2265 18 years old.\n2. Medical history: The patient has a history of fatigue, hair loss, voice change, and weight gain, which may be related to a metabolic disorder. The patient also has a prominent cervical mass, which may indicate a thyroid disorder. These conditions may affect sleep quality and weight loss.\n3. Sleep structure:",
        "label": 0
    },
    "264": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Sleep and Immunity in Rheumatoid Arthritis: Remicade Substudy\n\nInclusion criteria:\n\n* Rheumatoid arthritis patients will meet American College of Rheumatology revised criteria (Arnett, Edworthy et al. 1988). This requires at least four of the following seven criteria:\n\t1. Morning joint stiffness\n\t2. Arthritis in 3 or more joint areas\n\t3. Arthritis of hand joints\n\t4. Symmetric arthritis\n\t5. Rheumatoid nodules\n\t6. Presence",
        "label": 0
    },
    "265": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery\n\nInclusion criteria:\n\n* Obese and morbidly obese women (BMI 30 - 50)\n* 25 years and older undergoing laparoscopic gastric bypass surgery\n* Present with at least either metabolic syndrome or diabetes\n\nAssessment of eligibility:\n\n* Age: The patient is 25 years old, which meets the inclusion criterion of being 25 years or older.\n* BMI: The patient's B",
        "label": 0
    },
    "266": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations\n\nInclusion criteria:\n\n* Male and female patients aged over 18 years\n* Histologically proven lung adenocarcinoma\n* Clinical stage IIIB/IV\n* ECOG performance status 0-2\n* Had no prior anticancer agent, radiation or surgical therapy for lung adenocarcinoma\n* At least one measurable lesion (according to RECIST)",
        "label": 0
    },
    "267": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France\n\nInclusion criteria:\nRecently diagnosed hypothyroid subject (either during the inclusion period or within the 6 previous months) for whom data related to the diagnosis is available if the diagnosis was not carried out initially by the investigating doctor\nSubject, who has given his/her oral consent for participation\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of being",
        "label": 2
    },
    "268": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder\n\nInclusion criteria:\n\n* Patients must be adults, diagnosed with major depressive disorder, and treated with pharmacotherapy.\n* Physicians must be either a psychiatrist or a primary care physician, a prescriber of Pristiq, have at least 3 charts representing the 4 identified patient types, have been in clinical practice between 4 and 35",
        "label": 0
    },
    "269": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: The Association of Costimulatory Molecules and PPAR-polymorphisms With Autoimmune Thyroid Disease in Taiwan\n\nInclusion criteria:\nAutoimmune thyroid patients\nPatients who cut Nodular Goiter in Wanfang Hospital\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of being \u2265 18 years old.\n2. Diagnosis: The patient has a prominent, soft, uniform anterior cervical mass at the midline, which suggests a possible thyroid nodule or goiter. This meets the inclusion criterion of having auto",
        "label": 0
    },
    "270": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Central Hypothyroidism, a Novel Laboratory Measurement\n\nInclusion criteria:\nClinical evidence of central hypothyroidism: status post pituitary surgery and/or radiotherapy plus laboratory documentation of central hypothyroidism, with or without concurrent hormonal deficiencies in other axes, such as ACTH, LH, FSH.\n\nAssessment of eligibility:\n\n1. Does the patient have clinical evidence of central hypothyroidism?\nYes, the patient presents with symptoms of prolonged fatigue, hair loss, change in voice, weight gain, and cold intolerance, which are",
        "label": 0
    },
    "271": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma\n\nInclusion criteria:\n\n* Patients must have histologically confirmed melanoma with evidence of metastatic disease either by radiologic or physical examination\n* Patients must have measurable disease\n* Life expectancy greater than or equal to 12 weeks\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky \u2265 80%)\n* Leukocytes \u2265 3,000/mc",
        "label": 0
    },
    "272": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia\n\nInclusion Criteria:\nMale, age 18 to 70 years old, in general good health\nExhibits male AGA based on a discernable hair loss in temple and vertex region rating Hamilton-Norwood Scale III vertex to VI\nSubjects who give their consent to the study after thorough explanation and who personally signed and dated the informed consent document indicating that the subject, has been informed of all pertinent aspects of the trial\nWilling to maintain the same hairstyle, hair length, and hair color throughout the study",
        "label": 0
    },
    "273": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)\n\nInclusion criteria:\n\n* Adults 18-70 years of age\n* Having positive antibodies against thyroid peroxidase\n* Having sonographic evidence consistent with a diagnosis of Hashimoto's thyroiditis\n\nAssessment of eligibility:\n\n* Age: The patient is 25 years old, which meets the inclusion criterion of being between 18-70 years old.\n* Positive antibodies against thyroid peroxidase",
        "label": 1
    },
    "274": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Central Hypothyroidism and Cardiovascular Risk\n\nInclusion criteria:\nAll patients with pituitary hypopituitarism\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of fatigue, hair loss, voice change, weight gain, and cold intolerance could be related to hypothyroidism, which is a condition of interest in the clinical trial. Additionally, the patient has an anterior cervical mass, which could be a sign of a pituitary tumor, which is a common cause of hypopituitarism. However",
        "label": 0
    },
    "275": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children\n\nInclusion criteria:\n\n* Patient with a karyotype demonstrating homogeneous, free or Robertsonian translocation trisomy 21\n* Patient having undergone a cardiac ultrasound not demonstrating any severe heart disease\n* Patient aged 6 to 18 months at inclusion\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age (25 years) does not",
        "label": 0
    },
    "276": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment\n\nInclusion criteria:\nPatients will be between the ages of 18 to 65 and will have been on levothyroxine for primary hypothyroidism for at least 6 months.\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of being between 18 and 65 years old.\n2. Diagnosis: The patient presents with symptoms of hypothyroidism, including fatigue, hair loss, change in voice, weight gain, and",
        "label": 0
    },
    "277": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Trastuzumab & Pertuzumab Followed by T-DM1 in MBC\n\nInclusion criteria:\n\n* Histologically confirmed breast cancer with distant metastases\n* HER2-positive tumor according to central pathology testing for HER2\n* Women aged \u226518 years\n* WHO performance status 0 to 2\n* Left Ventricular Ejection Fraction (LVEF) \u226550% as determined by either ECHO or MUGA\n* Adequate organ function, evidenced by the following laboratory results:\n\t+ Neutrophils >1.5x10",
        "label": 0
    },
    "278": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer\n\nInclusion criteria:\nDifferentiated thyroid cancer\nTreated by thyroidectomy and at least 1 ablation with 131-I > 5 months ago\nTSH < 4 imU/L\n\nAssessment of eligibility:\n\n1. Does the patient have differentiated thyroid cancer?\nYes, the patient's symptoms and examination findings suggest a possibility of thyroid cancer.\n2. Has the patient been treated by thyroidectomy and at least 1 ablation with",
        "label": 1
    },
    "279": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism\n\nInclusion criteria:\n\n* Age \u2265 40 years\n* Age \u2264 75 years\n* Diagnosis of overt or subclinical hypothyroidism in two occasions with a minimum interval period of three months\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of fatigue, hair loss, voice change, and weight gain, as well as the presence of a prominent anterior cervical mass, suggest a",
        "label": 0
    },
    "280": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Comparison of Biomarkers of Stress in Emergency Physicians Working a 24-hour Shift or a 14-hour Night Shift - the JOBSTRESS Randomized Trial\n\nInclusion criteria:\nInclusion Criteria:\nemergency physician\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is not an emergency physician. Additionally, the patient's symptoms of fatigue, hair loss, voice change, and weight gain do not seem to be related to stress caused by a 24-",
        "label": 0
    },
    "281": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Scalp Cooling to Prevent Chemo-induced Hair Loss\n\nInclusion Criteria:\n\n* New diagnosis of breast cancer stage 1-2\n* Planning to undergo neoadjuvant or adjuvant chemotherapy with curative intent\n* Chemotherapy must be planned for at least 4 cycles of full-dose anthracycline or taxane-based chemotherapy regimen\n* Defined as one of the following regimens:\n\t+ Adriamycin 60mg/m2 with cyclophosphamide 600mg/m2\n\t+ Epirub",
        "label": 0
    },
    "282": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Physical Activity for Advanced Stage Cancer Patients\n\nInclusion criteria:\n\n* Have stage III or IV cancer diagnosis\n* Able to understand English\n* Have a Karnofsky Performance Status (KPS) score of 60% (able to care for most of personal needs)\n* Have fatigue and/or two other target symptoms\n* Have been cleared by their provider to engage in low to moderate intensity physical activities\n\nAssessment of eligibility:\n\n* Age: The patient is 25 years old, which meets the inclusion criterion of being 18 years or older.\n* Cancer diagnosis: The patient has a",
        "label": 0
    },
    "283": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Evaluating a Small Change Approach to Preventing Long-Term Weight Gain in Overweight and Obese Adults\n\nInclusion Criteria:\n\n* Men and women between 25 and 65 years of age.\n* Overweight or Class I or Class II BMI.\n* Walk without assistance.\n* Commit to a schedule of assessment visits.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age, weight status, and ability to walk without assistance meet the inclusion criteria for the clinical trial. However, the patient's",
        "label": 0
    },
    "284": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Thyroid Hormones Treatment in Asthma Exacerbation\n\nInclusion criteria:\n1. 18 years of age or older\n2. Known Asthma\n3. The exacerbation is defined as moderate or severe.\n4. Not currently enrolled as an active participant in another clinical trial of a medical therapy or device.\n5. The patient or first-degree family relative (in cases where the patient is intubated) has authorized his/her consent to participate in this trial. The patient will be asked to give his consent only after initial bronchodilator therapy.\n\nAssessment of el",
        "label": 0
    },
    "285": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism\n\nInclusion criteria:\nConsecutive pregnant women with L-T4 treated hypothyroidism followed at the outpatient clinic at the Endocrinology Unit, Herlev Hospital, Denmark during 2012.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms of fatigue, hair loss, voice change, weight gain, and cold intolerance are not related to hypothyroidism, and she does not meet",
        "label": 0
    },
    "286": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: The Effect of Plaquenil on Serum Inflammatory Markers and Goiter in Euthyroid Young Women With Hashimoto's Thyroiditis\n\nInclusion Criteria:\n\n* Newly diagnosed (within 1 year) Hashimoto's thyroiditis by positive serum anti-TPO antibody or anti-thyroglobulin antibody\n* Euthyroid state by serum free T4 and TSH level within normal limit\n\nExclusion Criteria:\n\n* Pregnant, planning pregnant within 1 year, or lactating women\n* Renal insufficiency,",
        "label": 0
    },
    "287": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Thyroid Disorders in Malaysia: A Nationwide Multicentre Study\n\nInclusion criteria:\nAged equal or more than 18 years old at the time of sampling\nMalaysian citizen\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of fatigue, hair loss, voice change, and weight gain, as well as the presence of a cervical mass, suggest the possibility of a thyroid disorder. However, further investigation is needed to confirm the diagnosis and determine the patient's eligibility for the clinical trial. The patient's",
        "label": 0
    },
    "288": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: My Health Coach Study\n\nInclusion criteria:\n\n* Adults age 21 and over\n* Referred by primary care physician for health coaching\n* Have telephone for follow-up\n* English speaking\n\nAssessment of eligibility:\n\nBased on the patient's symptoms and the clinical trial's inclusion criteria, it seems that the patient may meet the age requirement and may be eligible for health coaching. However, the patient's prominent, soft, uniform anterior cervical mass at the midline may be a concern and could potentially disqualify the patient from participating in the study. Additionally, the patient's",
        "label": 0
    },
    "289": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers\n\nInclusion criteria:\n\n* Age 21 to 80 years\n* Insomnia sufferers enrolled, meeting Research Diagnostic Criteria for insomnia disorder\n* Insomnia Severity Index score > 14\n* Report insomnia for > 3 months\n* Have sleep difficulties > 3 nights per week\n* Epworth Sleepiness Scale (ESS) score < 3\n* Hyperarousal Scale score > 40, and report an inability to nap in the daytime\n\nTrial-",
        "label": 0
    },
    "290": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Hairstetics\u2122 Anchoring System in Female Pattern Hair Loss (HAS-FPHL)\n\nInclusion Criteria:\n\n* Age \u2265 19 yrs.\n* Female patients with androgenetic alopecia (FPHL).\n* Pre-treatment hematology and coagulation values within the limits:\n\t+ Hemoglobin \u2265 10 g/dl (g/100 ml)\n\t+ Platelets \u2265 150 x 10^9/L (10^3/mm^3)\n\t+ WBC \u2265 3.0 x",
        "label": 0
    },
    "291": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth\n\nInclusion criteria:\n\n* \u226518 years old\n* Low-risk singleton pregnancy\n* Entering the last trimester of pregnancy (in range 26-30 weeks of gestation)\n* Residing in the Greater Accra Metropolitan Area or area served by the Korle Bu Teaching Hospital\n* Fluent in either English, Twi, or Ga.\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of \u22651",
        "label": 0
    },
    "292": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: The GlasVEGAS Study (Glasgow Visceral & Ectopic Fat With Weight Gain in South AsianS)\n\nInclusion criteria:\nParticipants will be men of European (self-report of both parents of white European origin) or South Asian (self-report of both parents of Indian, Pakistani, Bangladeshi or Sri Lankan origin) with BMI <25 kg.m-2, who have been weight stable (\u00b1 2 kg) for >6 months.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion",
        "label": 0
    },
    "293": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: DNA Methylation and Autoimmune Thyroid Diseases\n\nInclusion Criteria:\nFor HT:\n\n* A positive titers of antithyroid peroxidase (anti-TPO) or antithyroglobulin (anti-Tg) antibodies and at least one of:\n\t+ Abnormal thyroid function that requires substitution treatment with L-thyroxine (TSH > 5 \u03bcIU/ml and decreased or normal levels of fT4 or fT3)\n\t+ Increased volume of thyroid gland (goiter)\n\t+ Morphological changes on ultrasound",
        "label": 1
    },
    "294": {
        "output": "Patient Note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical Trial:\nTitle: Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery\n\nInclusion Criteria:\n\n* Biopsy-proven head and neck cancer, as defined by AJCC staging system\n* Treated with surgery in Edmonton, Alberta\n* Treated with curative intent\n* Diagnosis of subclinical hypothyroidism after head and neck surgery (TSH 4-10 mIU/L, and free T4 10-24 pmol/L)\n\nAssessment of Eligibility:\n\n1. Does the patient have bi",
        "label": 0
    },
    "295": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: The Influence of Psychobiological Adversity to Children and Adolescents With Type 1 Diabetes\n\nInclusion criteria:\nInformed consent signed by a parent/legal guardian and informed assent signed by the study participant prior to study entry\nDiagnosed with Type 1 DM prior to signature of Patient Informed Consent (PIC) (for the T1D group).\nAge between 8-15 years old (inclusive) at signature of PIC\nTreated by the investigator's center prior to signature of PIC (For the T1D group).\nWilling to undergo all study procedures\n\nAssess",
        "label": 0
    },
    "296": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: LigaSure Small Jaw\u00ae Versus Conventional Neck Dissection in Head and Neck Cancer Patients\n\nInclusion criteria:\nPatients aged 20 to 80 years scheduled to receive neck dissection due to head and neck cancer\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which meets the inclusion criterion of being between 20 and 80 years old.\n2. Diagnosis: The patient has a prominent, soft, uniform anterior cervical mass at the midline, which suggests a possible diagnosis of thyroid cancer. This meets the inclusion criterion of being scheduled to",
        "label": 0
    },
    "297": {
        "output": "Patient note:\nA 25-year-old woman presents to the clinic complaining of prolonged fatigue. She denies difficulty sleeping and sleeps an average of 8 hours a night. She also notes hair loss, a change in her voice, and weight gain during the previous 6 months. She complains of cold intolerance. On examination, she has a prominent, soft, uniform anterior cervical mass at the midline.\n\nClinical trial:\nTitle: Clinical Predictors of Pediatric OSAHS\n\nInclusion criteria:\nChildren (younger than 18 years old and older than 2 years old) with symptoms of snoring and then were confirmed to have obstructive sleep apnea/hypopnea syndrome by a comprehensive polysomnography\n\nAssessment of eligibility:\n\n1. Age: The patient is 25 years old, which is outside the age range of the inclusion criteria (children younger than 18 years old).\n2. Symptoms: The patient presents with fatigue, hair loss, a change in voice, and weight gain, which are",
        "label": 0
    },
    "298": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Acupuncture for Shortness of Breath in Cancer Patients\n\nInclusion criteria:\nDiagnosis of local or metastatic breast or lung cancer\nShortness of breath with onset after cancer diagnosis\nLife expectancy of at least 4 weeks\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's shortness of breath started after the cancer diagnosis, which meets the inclusion criteria. However, the patient's history of natural",
        "label": 0
    },
    "299": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: BNP Testing in Patients With SOB on Presentation to ED\n\nInclusion criteria:\nWe plan to include all patients presenting to the ED with shortness of breath that are over 40 years old and present with an emergency department triage category of 3 or higher.\n\nAssessment of eligibility:\n\n1. Age: The patient is 30 years old, which is below the inclusion criteria of 40 years old.\n2. Presentation: The patient presents with shortness of breath, which",
        "label": 2
    },
    "300": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Study of Diagnosis and Pathophysiology of Pulmonary Embolism (APE 1 Trial)\n\nInclusion criteria:\nReferred from clinical departments at Odense University Hospital\nReferred to the Departments of Nuclear Medicine or Radiology for diagnostic evaluation of suspected pulmonary embolism\nReferred for lung scintigraphy, spiral computer tomography, or pulmonary angiography\n\nTrial-level eligibility: 1) Would consider referring this",
        "label": 1
    },
    "301": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension\n\nInclusion criteria:\n\n* All patients admitted to the ICU with pulmonary hypertension (mean PA > 35 mmHg).\n* All patients in ICU with post-operative pulmonary HTN (mean PA > 35 mmHg).\n* All patients with ARDS (PaO2/FiO2 < 200 - arter",
        "label": 0
    },
    "302": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Multi MERCI (Mechanical Embolus Removal in Cerebral Ischemia [MERCI\u2122])\n\nInclusion criteria:\n\n* Angiographically confirmed large vessel ischemic stroke (occlusion may include the following: internal carotid artery (ICA), M1/M2, vertebral, or basilar arteries)\n* Intervention is able to be performed within 8 hours of symptom onset\n* Patients > 18 years of age\n* NIH",
        "label": 0
    },
    "303": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Postpartum Uterine Regression\n\nInclusion criteria:\n\n* Participants in the Right From The Start Study must be 18 years old or older, pregnant, enrolled by 10 weeks of gestation, planning to carry pregnancy to term, no plans to move before delivery, and English speaking.\n* Those who are found to have fibroids at either their 7-week, or 22-week ultrasound examination are eligible for this further postpregnancy study.",
        "label": 0
    },
    "304": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Family Spirit Study\n\nInclusion criteria:\nNative American pregnant teens or young women ages 12-22 years old at the time of conception.\nWomen ages 20-22 years at the time of conception must be pregnant for the first time.\nPartners of pregnant teens must be between the ages of 12-24.\nPregnant <28 weeks gestation and able to meet the requirements for completing the program in a timely way.\nAn enrolled tribal",
        "label": 0
    },
    "305": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Echo-Cardiographic Assessment of Cardiovascular Characteristics During Pregnancy and Postpartum Periods\n\nInclusion criteria:\nHealthy women\nFirst trimester of a normal pregnancy\nNormal baseline echocardiogram\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's shortness of breath could be related to her recent pregnancy and postpartum period, which aligns with the clin",
        "label": 0
    },
    "306": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Effects of Targeting Lower Arterial Oxygen Saturations on the Development of Control of Breathing in Very Preterm Infants\n\nInclusion criteria:\n\n* Gestational age 23 0/7 - 27 6/7 weeks\n* Enrolled in the COT trial at the Health Sciences Centre and the St. Boniface General Hospital in Winnipeg\n* Postnatal age between 21 days and 70 days\n* Informed written consent obtained from at least one of the parents.",
        "label": 0
    },
    "307": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Long-term Oxygen Treatment Trial\n\nInclusion criteria:\nAge at least 40 years\nCOPD\nDyspnea, determined by Modified Medical Research Council (MMRC) scale of at least 1\nDyspnea and lung disease process dominated by COPD in judgment of the study physician\nParticipant must meet one of the following:\nPost-bronchodilator forced expiratory volume in 1 second (FEV1) percent less than or equal to 70% predicted",
        "label": 0
    },
    "308": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: X-Ray Computed Tomography and Blood Reactive Oxygen Species Level\n\nInclusion criteria:\nParticipants of health check program at our hospital who will receive a scheduled X-ray computed tomography examination for either lung (20 cases) or heart (20 cases).\n\nAssessment of eligibility:\n\n1. Age: The patient is 30 years old, which meets the inclusion criteria of being 18 years or older.\n2. Medical history: The patient has had no health problems in the past",
        "label": 0
    },
    "309": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Postpartum Anemia and Postpartum Depression\n\nInclusion criteria:\nWomen after term elective cesarean section\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent childbirth and symptoms of shortness of breath may indicate that she is experiencing postpartum anemia, which is within the inclusion criteria of the clinical trial. However, further investigation is needed to confirm the diagnosis and ensure that the patient meets all",
        "label": 1
    },
    "310": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals\n\nInclusion Criteria:\n\n* Inclusion Criteria for healthy controls:\n\t+ Normal lung function, defined as (Knudson 1976/1984 predicted set): FVC of > 80 % of that predicted for gender, ethnicity, age and height FEV1 of > 80 % of that predicted for gender",
        "label": 0
    },
    "311": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism\n\nInclusion criteria:\n\n* Diagnosis of acute PE requires symptoms of PE present <14 days with CT angiography interpreted as positive for acute PE.\n* Initial evaluation for PE must be predicated upon the investigation of new or unexplained cardiopulmonary or chest-related clinical features consistent with PE, including shortness of breath, chest pain",
        "label": 1
    },
    "312": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Relative Adrenal Insufficiency in Preterm Very Low Birth Weight Infants With Shock\n\nInclusion criteria:\nAll preterm (28 to 34 week gestation) very low birth weight (birth weight 750-1500grams.) infants born at AIIMS would be eligible for enrollment in the study. Of these infants, those who meet the following criteria would be enrolled.\nCases: Preterm (28 to 34 week gestation",
        "label": 0
    },
    "313": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism\n\nInclusion criteria:\nPatients who were treated with fondaparinux pre-, peri- and/or postpartum for more than 7 days for VTE prophylaxis or treatment, especially those with a history of abortion, and/or stillbirth, VTE, severe fetal and maternal comp",
        "label": 0
    },
    "314": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Safety and Feasibility Study of a Mechanical Ventilation Computerized Protocol: Intellivent\n\nInclusion criteria:\n\n* The attending physician thinks that the patient will be able to breathe spontaneously or the patient is already breathing spontaneously.\n* No vasopressor or inotropic medication, unless the patient is receiving some digitalin or small doses of dopamine or dobutamine (\u2264 5 \u00b5g/kg/min)\n* Slight or no end",
        "label": 1
    },
    "315": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT\n\nInclusion criteria:\nMust be Age greater than or equal to 18\nObtain informed written consent.\nDiagnosed with acute pulmonary embolism (PE) (< 14 days)\nCatheter-directed therapy (CDT) was performed to treat acute PE\n\nTrial-level eligibility: 1) Would consider referring this",
        "label": 1
    },
    "316": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Oxygen Saturation Monitoring During Surgery\n\nInclusion criteria:\nAge greater than 21 years\nPatients scheduled for a procedure that requires analgesia and/or sedation by any route (intravenous, intramuscular, oral, epidural or intrathecal).\nPatients with an anticipated length of sedation greater than or equal to one hour.\nPatients in the ASA category I through III.\nPatients who only receive propofol, benzodiazepines",
        "label": 0
    },
    "317": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: Identification of Early Predictors of Fetomaternal Hemorrhage\n\nInclusion Criteria:\nWomen admitted for term delivery (delivery between 37 0/7 and 41 6/7 weeks from the last menstrual period) to the Mount Sinai Medical Center\n\nAssessment of Eligibility:\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nReasoning:\nThe patient presents with short",
        "label": 0
    },
    "318": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Carbetocin at Elective Cesarean Delivery\n\nInclusion criteria:\nAll patients planned for elective cesarean delivery under spinal anesthesia;\nAll patients who gave written informed consent to participate in this study.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's current health status, specifically the shortness of breath, may be a concern for participating in the clinical trial. However, since the patient has no",
        "label": 0
    },
    "319": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot\n\nInclusion Criteria:\nWomen must be at high risk for thromboembolism for one of the following reasons:\nKnown low risk thrombophilia (Known = diagnosed prior to enrollment and low risk thrombophilia includes heterozygous factor V Leiden or prothrombin gene variant or protein C deficiency or protein S deficiency. If not",
        "label": 0
    },
    "320": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Venous Thromboembolism Prophylaxis Post Cesarean Section\n\nInclusion criteria:\nAge > 18 years old.\nDelivered by cesarean section (emergency or planned).\nSigned, informed consent.\nReady access to a local health service.\nCapable of using Tinzaparin.\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.\n\nExplanation:\nThe patient is a 30-year",
        "label": 0
    },
    "321": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Carbetocin at Elective Cesarean Delivery Part 2\n\nInclusion criteria:\nAll patients planned for elective cesarean delivery under spinal anesthesia.\nAll patients who give written informed consent to participate in this study.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's current health status, specifically the shortness of breath, may be a concern for participating in the clinical trial. However, since the",
        "label": 0
    },
    "322": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression\n\nInclusion criteria:\nAge > 18 years old and > 24 0/7 weeks pregnant at time of enrollment\nPlanning to deliver at Magee-Womens Hospital and to breastfeed\nPlans to use DMPA for postpartum contraception for at least 6 months\nWilling and able to provide informed consent in",
        "label": 0
    },
    "323": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Change in Peripheral Oxygen Saturation by Using Different Breathing Procedures in High Altitude\n\nInclusion criteria:\n\n* Age \u2265 18 years\n* No acute clinically significant inter-current diseases\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's shortness of breath and tachypnea may be related to the high altitude, but it is also possible that it could be related to",
        "label": 0
    },
    "324": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Study of High-flow Oxygen Therapy Against Standard Therapy in Bronchiolitis\n\nInclusion criteria: All children under 18 months of age with a clinical diagnosis of bronchiolitis requiring admission to hospital for observation and oxygen.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nReasoning:\nThe patient is a 30-year-old healthy woman who presents with shortness of breath, which started 2 hours before ad",
        "label": 0
    },
    "325": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus\n\nInclusion criteria:\nSubject is undergoing ERCP as part of their medical care\nSubject will be of age 19 or older\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is not undergoing ERCP as part of her medical care and is not of",
        "label": 0
    },
    "326": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and Mother-child Relationships\n\nInclusion criteria:\n\n* The patient must have given his/her informed and signed consent\n* The patient must be insured or beneficiary of a health insurance plan\n* The patient is available for 12 months of follow up\n* The patient has given birth this day to a premature child (< 36 weeks of gestation and/or < 2 kg birthweight)",
        "label": 1
    },
    "327": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Evaluation of Breastfeeding Support After Short Time Hospitalization\n\nInclusion criteria:\npregnant women (gestational week 35-36)\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient note describes a 30-year-old woman who is experiencing shortness of breath and has a history of two natural abortions. She recently gave birth to a healthy child three weeks ago. The patient's symptoms and medical history do",
        "label": 0
    },
    "328": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: Human Safety of Capsaicin Inhalation Challenge Testing for Young and Older Men\n\nInclusion Criteria:\n\n* Men of ages 18 and 30 (Dates of birth 1973-1985) or 55-92 years old (Dates of birth 1911-1948).\n* Must not currently be a cigarette smoker. If an ex-smoker, then has not smoked for at least 10 years and",
        "label": 0
    },
    "329": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: Bioequivalence Study of Torrent Pharmaceuticals Ltd's Felodipine Extended-Release Tablets Under Fasting Condition\n\nInclusion Criteria:\n\n* Healthy males within the age range of 18 to 50 years.\n* A body mass index within 18-25 Kg/m2.\n* Given written informed consent to participate in the study.\n* Absence of diseases markers of HIV 1 & 2, Hepatitis B & C virus",
        "label": 0
    },
    "330": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Phone-Based Postpartum Continuing Care for Smoking Cessation\n\nInclusion criteria:\nfirst or second trimester of pregnancy\nage 18 or older\nself-reported tobacco use in the past 90 days or nicotine-dependence in the past year\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is not in the first or second",
        "label": 0
    },
    "331": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: Be Healthy in Pregnancy (BHIP) With Nutrition and Exercise\n\nInclusion Criteria:\nHealthy pregnant females > 18 years of age with singleton pregnancies (either nulliparous or multiparous);\nless than 17 weeks gestation;\na pre pregnancy BMI < 40 kg/m2 (owing to the fact that severe obesity with BMI> 40 may have limitations with respect to physical activity",
        "label": 0
    },
    "332": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation\n\nInclusion criteria:\nMen and women aged between 18 and 35 years\nNonsmokers\nNormal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant\nNormal laboratory values unless the investigator considers an abnormality to be clinically irrelevant\nNormal ophthalmic findings, ametropy < 3 Dpt.\n\nAssessment",
        "label": 1
    },
    "333": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism\n\nInclusion criteria:\n\n* \u2265 18 years\n* Investigator judges caval filtration clinically indicated for prevention of pulmonary embolism in patient with venous thromboembolic disease or at high risk for venous thromboembolic disease. Patient must meet at least one of the following:",
        "label": 1
    },
    "334": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy\n\nInclusion criteria:\nAge: 18 years or older, and;\nPregnancy confirmed by urinary pregnancy test, and;\nGestational age < 14 weeks, and;\nPrevious objectively confirmed VTE, either unprovoked, in the presence of use of oral contraceptives or estrogen/progestagen",
        "label": 0
    },
    "335": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn\n\nInclusion criteria:\nLate preterm and term infants (post-menstrual age \u2265 34 weeks) delivered by cesarean section or vaginal delivery\nDiagnosis of TTN\nParents signed informed consent\n\nAssessment of eligibility:\n\n1. Age: The patient is 30 years old, which is outside the age range of 34 weeks to term",
        "label": 1
    },
    "336": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Nocturnal Breathing and Sleep in Patients With Chronic Obstructive Pulmonary Disease Staying at Altitude\n\nInclusion criteria:\nchronic obstructive pulmonary disease (COPD), GOLD grade 2-3\nresidents at low altitude (<800 m)\n\nAssessment of eligibility:\n\n1. Does the patient have chronic obstructive pulmonary disease (COPD)?\nYes, the patient has shortness of breath, which",
        "label": 0
    },
    "337": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli\n\nInclusion criteria:\nPatients referred for CT pulmonary angiogram to exclude pulmonary embolus\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of shortness of breath and recent history of childbirth may indicate a potential pul",
        "label": 2
    },
    "338": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation\n\nInclusion Criteria:\n\n* Infants at 24-36 weeks corrected gestational age\n* Already ventilated with high frequency ventilation\n* Requiring FiO2=21%-70% to maintain adequate oxygen saturation\n* Clinically stable\n* Parent(s) or guardian able",
        "label": 0
    },
    "339": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Using Nasal High Flow From Birth in Premature Infants - a Pilot Study\n\nInclusion criteria:\nParental consent\n24+0 to 30+0 weeks(agreed dates) gestation born alive\nBreathing spontaneously at birth or soon after with minimal resuscitation\nOxygen saturations >90% by 5 minutes\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age and gestation",
        "label": 0
    },
    "340": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: The Effect of a Father Inclusive Psychoeducation Program on Postnatal Depression\n\nInclusion criteria:\naged 18 or above;\nfirst-time parents;\nable to speak and read the Chinese language; and\nHong Kong residents.\n\nAssessment of eligibility:\n\n1. Age: The patient is 30 years old, which meets the inclusion criterion of being aged 18 or above.\n2. First-time parents: The patient has given birth to a healthy child",
        "label": 0
    },
    "341": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit\n\nInclusion criteria:\nPregnant women >-18 years of age with low-risk obstetric\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's shortness of breath and recent childbirth suggest that she may have a pulmonary or cardiovascular condition, which would not be related to the objectives of the clinical trial",
        "label": 0
    },
    "342": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: A Neurocognitive and Immunological Study of a New Formula for Healthy Infants\n\nInclusion criteria:\nFull-term newborns (>37 weeks and <41 weeks gestation)\nAdequate birth weight for his gestational age (between 3-97 percentiles)\nInclusion age: from 0 to 2 months (60 days) in the formula fed groups\nInclusion age: 2-6 months (180 days) in the breastfeeding group\nMaximum",
        "label": 0
    },
    "343": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep\n\nInclusion criteria:\nPrecapillary pulmonary hypertension, or interstitial lung disease.\nNew York Heart Association class 2-3.\nResidence at low altitude (<800m).\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe",
        "label": 0
    },
    "344": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales\n\nInclusion Criteria:\n\n* Inclusion Criteria:\n18-45 year old women who desire contraception postpartum for at least 6 weeks.\n18-45 year old women who choose not to use oral contraceptive medication postpartum for at least 6 weeks for the control group.\n\nExclusion Criteria (Medication groups):",
        "label": 0
    },
    "345": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months\n\nInclusion criteria:\nAge 18 or above at time of delivery\nDelivery of live born infant at estimated gestational age (EGA) \u226537wk\nPostpartum primiparous patients within the first 48 hours after delivery\nPatient intent to breastfeed\nBreastfeeding initiated within the first 48 hours of delivery and/or prior to hospital discharge (whichever occurs",
        "label": 1
    },
    "346": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: nuMoM2b Heart Health Study\n\nInclusion criteria:\nInterval Contact:\nAgreed to contact for future studies during nuMoM2b and not subsequently withdrawn from the cohort.\nHave pregnancy outcome data from the nuMoM2b study.\nAt least 18 years of age (to begin interval contact attempts once nuMoM2b participant reaches age 18).\nProvision of verbal consent for telephone interview or acknowledgement of consent with completion of the web-based self-admin",
        "label": 0
    },
    "347": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection\n\nInclusion Criteria:\n\n* Patient Inclusion Criteria:\n\t+ At least 18 years of age\n\t+ Either gender\n\t+ Diagnosed with resectable lung cancer or metastatic lung disease eligible to complete metastasectomy\n\t+ Undergoing one of the following surgeries:",
        "label": 0
    },
    "348": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Carbetocin at Elective Cesarean Delivery Part 4\n\nInclusion criteria:\nElective cesarean delivery under spinal anesthesia.\nWritten informed consent to participate in this study.\nTerm pregnancy\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nReasoning:\nThe patient does not meet the inclusion criteria for the clinical trial as she is not undergoing an elective cesarean delivery under spinal anest",
        "label": 1
    },
    "349": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia\n\nInclusion criteria:\nSevere preeclampsia or severe preeclampsia aggregated to chronic hypertension with > 24 weeks of gestation treated with 4-6 grams of magnesium sulfate for impregnation with a minimum of 8 hours continuous of magnesium sulfate before delivery\nThe study begins to terminate pregnancy\n\nAssessment of eligibility:",
        "label": 0
    },
    "350": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Involving Men in Maternity Care in Burkina Faso\n\nInclusion criteria:\nAge 16-18, married, or\nAge 18+, in a co-habiting relationship\nPregnant 24-36 weeks\nNo obstetric risk factors requiring hospital delivery\nLives no more than one hour away on foot, not planning to move from the city\nGives informed consent\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.",
        "label": 0
    },
    "351": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Randomized Trial of Amoxicillin Versus Placebo for (Fast Breathing) Pneumonia\n\nInclusion criteria:\nHistory of cough or difficult breathing < 14 days (observed or reported) AND\nRespiratory rate \u2265 50 breaths per minute in children 2 to <12 months (on two consecutive readings by independent physicians) OR respiratory rate \u2265 40 breaths per minute in children12- 59 months (on two consecutive read",
        "label": 0
    },
    "352": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Dental Support Device During Breastfeeding as a Mean for Pain Control\n\nInclusion criteria:\nMaternal age 18-45 years.\nNormal vital signs.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age and vital signs meet the inclusion criteria for the clinical trial. However, the patient's shortness of breath and recent childbirth may be a concern for the patient's health and ability to participate",
        "label": 0
    },
    "353": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: The Effects of Sound Energy on Pulmonary Gas Exchange\n\nInclusion criteria:\nHealthy male or female volunteers in the age group.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's shortness of breath and recent childbirth may be relevant to the study, but further investigation is needed to determine if she meets the inclusion criteria of being a healthy volunteer. Additionally, the study's focus on pulmonary gas exchange and",
        "label": 0
    },
    "354": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Using Sodium Lactate Ringer's Injection Resuscitate Septic Shock Patients\n\nInclusion criteria:\ndiagnosis in patients with septic shock\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of shortness of breath and tachypnea may indicate respiratory distress, which could be related to septic shock. However, the patient's history of recent childbirth and lack of any",
        "label": 0
    },
    "355": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia\n\nInclusion criteria:\nWomen above 18 years old after giving birth\nWomen who suffer from iron deficiency anemia, defined as hemoglobin< 9.5 g/dl without one of the conditions that are described in the exclusion criteria\n\nAssessment of eligibility:\n\n1. Age: The patient is 30 years",
        "label": 1
    },
    "356": {
        "output": "Patient Note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical Trial:\nTitle: Comparison of Pharyngeal Oxygen Delivery by Different Oxygen Masks\n\nInclusion Criteria:\n18 to 70 years of age\nMale and female volunteers\nASA physical status I, II and III\nCapable and willing to provide written informed consent in English\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is 30 years old, which",
        "label": 1
    },
    "357": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: The Impact of Creative Interventions on Symptoms of Postnatal Depression (Cohort Study)\n\nInclusion criteria:\nWomen who are more than 28 weeks pregnant OR up to 9 months post-birth\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of shortness of breath and tachypnea may indicate a potential medical condition that needs to be evaluated further. However, based on",
        "label": 2
    },
    "358": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial\n\nInclusion criteria: All pregnant women hospitalized.\n\nAssessment of eligibility:\n\n1. Age: The patient is 30 years old, which meets the inclusion criterion of being a pregnant woman.\n2. Medical history: The patient has had two natural abortions, but this does not exclude her from the study since the inclusion criterion only specifies \"All pregnant women hospital",
        "label": 0
    },
    "359": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Chest Pressure for Intubated Peds Patients\n\nInclusion criteria:\nAll pediatric patients between one and 18 years of age\nRequirement for insertion of an endotracheal tube\nAmerican Society of Anesthesiologists (ASA) class I to III\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she is an adult, aged 30,",
        "label": 0
    },
    "360": {
        "output": "Patient note:\nA 30-year-old generally healthy woman presents with shortness of breath that had started 2 hours before admission. She has had no health problems in the past besides 2 natural abortions. She had given birth to a healthy child 3 weeks before. On examination, she is apprehensive, tachypneic and tachycardic, her blood pressure is 110/70 and her oxygen saturation 92%. Otherwise, physical examination is unremarkable. Her chest x-ray and CBC are normal.\n\nClinical trial:\nTitle: Computed Tomography CT Venography During Postpartum Venous Thromboembolism\n\nInclusion criteria:\n\n* Women with clinically suspected pulmonary embolism (PE) during the first 6 weeks postpartum, without any sign of severe PE (shock, hypotension), referred for CT angiography\n* Absence of contraindication to iodinated contrast medium injection (Previous allergic reaction to iodinated contrast medium, renal insufficiency with creatine",
        "label": 1
    },
    "361": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The Relationship Between Vitamin D, Fingernail Thickness, and Bone Density\n\nInclusion criteria:\n\n* Females 25-75 years of age with no known bone disorders\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as he is an 85-year-old male, which is outside the age range specified in the inclusion criteria. Additionally, the patient's recent decrease in consciousness and history of a recent car accident suggest that they may have a serious underlying medical condition that would exclude",
        "label": 0
    },
    "362": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Biomarkers and Early Alzheimer's Disease\n\nInclusion criteria:\n\n* Individuals of either sex, with a high school education, and between the ages of 60 and 80 years living in the New York City metropolitan area.\n* Minimum of 12 years of education.\n* Participants will be classified as within normal limits on medical, psychiatric, and neuropsychological examinations (performance that is better than -1.5 sd of the NYU norm based WMS-R delayed memory index).\n* Participants will have a global deterioration scale (GDS)=1",
        "label": 0
    },
    "363": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Donepezil in Preventing Delirium in Hospitalized Elderly\n\nSummary: The purpose of this study is to explore the efficacy of a perioperative daily dose of Donepezil (a cholinergic enhancer) in reducing the incidence and severity of delirium.\n\nInclusion criteria:\n\n* Community-dwelling individuals aged 65 or older\n* Admitted to Methodist Hospital for surgical repair of hip fracture\n* No evidence of delirium at admission to hospital\n* MMSE total score below 24 points after adjustment for education and age\n* Consent to participate in",
        "label": 0
    },
    "364": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Effects of Pain on Driving Performance and Cognition.\n\nInclusion criteria:\n\n* Age \u2265 18 years\n* Driving license\n* Driving experience\n* Normal vision\n* Right-handed\n* Fluently Dutch speaking\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age and medical history do not meet the inclusion criteria for the clinical trial. The patient is 85 years old, which is above the age limit of 18 years specified in the inclusion criteria. Additionally, the patient has a history of a recent car accident and",
        "label": 0
    },
    "365": {
        "output": "Sure, I'd be happy to help you with that! Here's the assessment of eligibility for the given patient note and clinical trial:\n\nPatient Note:\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical Trial:\nTitle: Use of Beta Blockers in Elderly Trauma Patients\n\nInclusion Criteria:\nAll trauma patients admitted to the ICU > 55 years of age with a primary diagnosis of injury will be screened on admission as study candidates.\n\nAssessment of Eligibility:\nBased on the patient note, the patient is an 85-year-old man who has been involved in a car accident and has been experiencing a gradual decrease in his level of consciousness. He",
        "label": 1
    },
    "366": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Characteristics of Blood-Brain Barrier Permeability in Neurological Patients\n\nSummary: The main goal of the present study is to challenge the hypothesis that blood-brain barrier disruption following brain injury increases the risk for long-term disability, development of brain dysfunction, epileptic seizures, and neuroanatomical alterations.\n\nInclusion criteria:\n\n* One week following:\n\t+ Traumatic Brain Injury\n\t+ Cerebro-Vascular Accident\n\t+ Subsequent brain CT showed cerebral cortex injury.\n\nAssessment of eligibility:\n\nB",
        "label": 2
    },
    "367": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The Role of Total Body Imaging in Asymptomatic Pediatric Trauma Patients\n\nSummary: Whole-body imaging has no role in asymptomatic pediatric trauma patients\n\nInclusion criteria:\n\n* All asymptomatic trauma patients from 0 to 15 years old\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient is an 85-year-old man, which is outside the age range of the inclusion criteria (0-15 years old). Additionally, the patient has a history of a recent car accident and a decreased level of conscious",
        "label": 0
    },
    "368": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia\n\nSummary: The purpose of this study is to verify the efficacy of speed-feedback therapy in improving the cognitive function of elderly people with dementia by a randomized controlled trial and to demonstrate how that affects ADL and QOL.\n\nInclusion criteria:\n\n* Inclusion Criteria:\n\t+ Age 65 years or older\n\t+ Diagnosed with dementia by a physician\n\t+ Mini-Mental State Examination score of 23 points or less\n\t+ Capable of participating at",
        "label": 0
    },
    "369": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults\n\nInclusion criteria:\n\n* Valid Ontario driver's license\n* Active driver (greater than or equal to three times per week)\n* Written, informed consent\n* Lives in Toronto/Thunder Bay\n* Healthy\n* Male between 65-75 years old\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as he is not healthy, has a history of a recent car accident, and has",
        "label": 0
    },
    "370": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Delirium Recall in Advanced Cancer Patients\n\nInclusion criteria:\n\n1. Presence of advanced cancer, defined as local recurrent and/or metastatic.\n2. History of an episode of delirium during the patient's current inpatient admission, diagnosis of delirium will be made by one of the palliative care specialists according to DSM-IV-TR criteria.\n3. If the patient has a complete recovery from the episode of delirium, the patient must be approached within 3 days for the possibility of inclusion in the study. Complete recovery will be defined as a diagnosis of complete resolution of all symptoms of del",
        "label": 0
    },
    "371": {
        "output": "Patient Note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical Trial:\n\nTitle: Trial to Reduce Falls Incidence Rate in Frail Elderly\n\nInclusion Criteria:\n\n* Age \u2265 18 years\n* Multiple sclerosis (MS) diagnosis\n* Lower urinary tract symptoms with or without treatment\n* Expanded Disability Status Scale score between 1 and 6.5\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial. The patient is 85 years old, which is beyond the age range of 18-65 specified in the inclusion criteria",
        "label": 0
    },
    "372": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus\n\nInclusion criteria:\n\n* Walking difficulties in both legs which have developed gradually, not explained by other conditions, either in combination with mental impairment and urinary incontinence\n* Brain CT or MRI findings of enlarged ventricles compared to established standards (minimum Evans ratio of 0.30 as measured by reviewing films)\n* Mental impairment must be mild to moderate, emerging with or after the walking difficulties\n* Age > or = 18 years old\n* MMSE (Mini-mental status exam",
        "label": 0
    },
    "373": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)\n\nInclusion criteria:\n\n* Adults, 18-65 years old\n* One or more mild-moderate TBI's characterized by loss of consciousness due to blast injury that is a minimum of one year old and occurred after 9/11/2001\n* Absence of acute cardiac arrest or hemorrhagic shock at the time of T",
        "label": 0
    },
    "374": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Analysis of Balance in the Aging Process\n\nInclusion criteria:\n\n* Absence of basic pathology that interferes directly in the balance\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent decrease in consciousness and inability to walk or eat by himself could be related to the car accident he was involved in 3 weeks ago. However, the patient's age and the fact that he has had no fever, cough, rash, or diarrhea suggest that his condition may be related to an underlying medical condition rather than an acute injury. The patient",
        "label": 0
    },
    "375": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage\n\nInclusion criteria:\n\n* Spontaneous ICH (intraparenchymal), subdural hematoma (SDH) diagnosed by CT scanning \u2264 12 hours after onset of symptoms. In case of unknown time of symptom onset: time between last seen in healthy condition and first CCT \u2264 12 hours.\n* Therapy receiving vitamin K antagonists (VKA)\n* International Normalized Ratio (INR) \u2265 2\n* Signed informed consent form",
        "label": 0
    },
    "376": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Neural Correlates of Cognitive Rehabilitation in Post-Traumatic Stress Disorder (PTSD)\n\nSummary: Post Traumatic Stress Disorder (PTSD) is an emotional disorder that can also lead to problems with attention and memory. Cognitive training has been successfully used to improve attention and processing speed in other patient populations as well as healthy elderly. The purpose of this study is to examine how effective cognitive training will be in Veterans with PTSD.\n\nInclusion criteria:\n\n* OEF/OIF Veteran\n* Meets DSM-IV criteria for PTSD\n* Control group does",
        "label": 0
    },
    "377": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder\n\nInclusion criteria:\n\n* At least 18 years of age and non-active duty\n* Either:\n\t+ Normal (no history of head injury)\n\t+ TBI (injury since Jan. 1, 2002)\n\nAssessment of eligibility:\n\nBased on the patient's history of a recent car accident and gradual decrease in consciousness, it is likely that they have sustained a traumatic brain injury. The patient's age and non-active duty",
        "label": 2
    },
    "378": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Delirium in the Emergency Department: Novel Screening\n\nInclusion criteria:\n\n* Age 65 years or greater\n* In the Emergency Department for less than 12 hours at the time of enrollment\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age meets the inclusion criteria, and the patient is in the Emergency Department for less than 12 hours, which also meets the inclusion criteria. However, the patient's condition, specifically the gradual decrease in level of consciousness, may require further investigation to determine if it is related to deliri",
        "label": 0
    },
    "379": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The Use of Virtual Reality for the Gait Training of Elderly Fallers\n\nSummary: The study aims to investigate the efficacy of gait training using virtual reality to decrease the risk of falls in elderly idiopathic fallers. The investigator hypothesizes that training with virtual reality would increase the ability to perform in the real world environment and decrease the risk of falls in elderly adults.\n\nInclusion criteria:\n\n* Between the ages of 65-85\n* Independent in activities of daily living\n* Able to walk without assistance for at least 10 minutes\n* Cognitively intact (Mini Mental State Exam",
        "label": 0
    },
    "380": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Imaging of Traumatic Brain Injury\n\nInclusion criteria:\n\n* Age 18 or older\n* Evidence of external head injury or facial trauma, or mechanism of injury consistent with brain trauma, including loss of consciousness or altered mental status.\n* Residence within 90 minutes driving time of University of Maryland Medical Center, and willingness to attend follow-up appointments.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent decrease in consciousness and previous car accident suggest a potential traumatic brain injury, which aligns with",
        "label": 2
    },
    "381": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Hip Fracture Surgery in Elderly Patients\n\nSummary: The objective of this study is to evaluate the incidence of Post-Operative Delirium (POD), diagnosed with the Confusion Assessment Method (CAM), in elderly patients undergoing hip fracture surgery under general anesthesia with xenon or sevoflurane, for a period of four days post-surgery.\n\nInclusion criteria:\n\n* Elderly patient (\u2265 75 years)\n* Patient with planned hip fracture surgery within 48 hours after the hip fracture\n* Patient willing",
        "label": 0
    },
    "382": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident\n\nSummary: The purpose of this study is to evaluate if lifespan integration (LI) therapy reduces posttraumatic stress symptoms following a motor vehicle accident (MVA) trauma.\n\nInclusion criteria:\n\n* Involved in or witnessed a car accident at least 6 months ago.\n* PTSD or distress or impairment in important areas of functioning following the car accident.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent",
        "label": 0
    },
    "383": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: Impact of a Multifaceted Program to Prevent Postoperative Delirium in the Elderly\n\nInclusion criteria:\n\n* Male or female subject aged over 75 years\n* Admission for a scheduled surgery (i.e., all oncologic digestive surgery, ureterostomy, nephrectomy or cystectomy, total hip or knee replacement)\n* Participation agreement\n\nAssessment:\n\nBased on the patient's age (85 years) and the fact that he is being admitted for a scheduled surgery (which meets the inclusion criteria), it is likely that he would be elig",
        "label": 0
    },
    "384": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The InChianti Follow-Up Study\n\nSummary: Background: Older persons are often referred to physicians because of mobility difficulties that grow worse as they age. To better understand the reasons for mobility difficulties in older persons, researchers conducted a population-based study of individuals living in the Chianti geographic area of Tuscany, Italy. Researchers are now interested in conducting a follow-up study on the original participants to assess the effects of aging on their mobility.\n\nObjectives: To conduct a follow-up study on the participants in the mobility study of older persons in the Greve in Chianti and Bagno a Ripoli areas near Florence, Italy",
        "label": 0
    },
    "385": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers\n\nInclusion criteria:\n\n* Japanese healthy elderly male and female \u226565 years old\n* Have a BMI of \u226518 and \u226427 kg/m2 and weigh \u2265 45 kg\n* Be able to understand and comply with the requirements of the study as judged by the investigator(s)\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age (85 years",
        "label": 0
    },
    "386": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: A Trial of Non-operative Versus Operative Management of Olecranon Fractures in the Elderly\n\nInclusion criteria:\n\n* Age \u226575 years\n* Minimal, moderate, or severe fragmentation of the olecranon\n* Within two weeks of olecranon fracture\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as he is 85 years old and has a history of a recent car accident, which could potentially have caused a head injury. Additionally, the patient's",
        "label": 0
    },
    "387": {
        "output": "Patient Note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical Trial:\n\nTitle: Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?\n\nInclusion Criteria:\n\n* Completion of informed consent by the patient or a legally appointed guardian\n* Age \u2265 50 years\n* Sustained mild head trauma with a visit to the emergency department of the Hadassah-Hebrew University Medical Center within 24 hours after trauma\n* Low-dose aspirin therapy (75-100 mg) at the time of head trauma\n* Admission non-contrast head CT with no evidence",
        "label": 0
    },
    "388": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN)\n\nInclusion criteria:\n\n* Subjects of 18 years old or older\n* CKD stage 3 according to GFR-MDRD equation\n* Two consecutive stable plasma Creatinine levels during the last 2 months\n* Elective computed tomography (CT) with a nonionic low-osmolality radiographic contrast agent\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe",
        "label": 0
    },
    "389": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Impact of Impaired Cerebral Autoregulation on Postoperative Delirium in Elderly Patients Undergoing Spine Surgery\n\nInclusion criteria:\n\n* \u2265 70 years old\n* Undergoing any lumbar spine surgery, posterior cervical spine surgery, or anterior cervical spine surgery > 2 levels\n\nAssessment of eligibility:\n\nThe patient is 85 years old, which meets the age requirement of the clinical trial. However, the patient's medical history, including a recent car accident and decreased level of consciousness, may indicate that they are not in a",
        "label": 0
    },
    "390": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The Neuromarker S-100B in Patients With Different Types of Intracranial Injury\n\nInclusion criteria:\n\n* All patients with traumatic brain injury\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent decrease in consciousness and previous car accident suggest that they may have sustained a traumatic brain injury. However, the patient's age and medical history should be taken into account, as well as the fact that the clinical trial only includes patients with traumatic brain injuries. To determine whether the patient is elig",
        "label": 2
    },
    "391": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: To Scan or Not to Scan: The Role of Follow-up CT Scanning for Management of Chronic Subdural Hematoma After Neurosurgical Evacuation\n\nInclusion criteria:\n\n* Newly diagnosed chronic subdural hematoma by CT scan or MRI, operated within the last 48 hours\n* Age 18 years or older\n* Written informed consent from the patient to participate in the study\n\nExclusion criteria:\n\n* Moribund state of health prohibiting surgery\n* Foreseeable difficulties in follow-up due to geographic reasons (e.g., patients living abroad)\n* Recurrent",
        "label": 2
    },
    "392": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial\n\nInclusion criteria:\n\n* Over 60 years old\n* Delirium according to the CAM-ICU (Confusion Assessment Method for Intensive Care Unit)\n* Informed consent (legal representatives)\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age and the presence of delirium according to the CAM-ICU criteria match the inclusion criteria for the clinical",
        "label": 0
    },
    "393": {
        "output": "Sure, I can help you with that. Based on the patient's note and the clinical trial you provided, here is the assessment of eligibility:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's note mentions that the patient is an 85-year-old man who was brought to the ER because of a gradual decrease in his level of consciousness, and he has been diagnosed with breast cancer. However, the clinical trial is for patients with invasive breast carcinoma with positive estrogen (ER)- and/or progesterone-receptor (PR) status, and negative human epidermal growth factor receptor (HER)2, for whom standard adjuvant endocrine therapy is planned. The patient's note does not mention anything about the patient's ER, PR, or HER2 status, which is a crucial inclusion criterion for the clinical trial. Therefore, based on the information provided, it is unlikely that the patient would be eligible for the clinical trial.</s>",
        "label": 0
    },
    "394": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Incidence, Severity, and Treatment of Delirium in Cardiac Surgery Patients: A Before-after Study\n\nInclusion criteria:\n\n* Adult patients admitted for cardiac surgery at the Department of Cardiothoracic Surgery, Rigshospitalet, Denmark.\n\nAssessment of eligibility:\n\nBased on the patient's history of a recent car accident and gradual decrease in consciousness, it is likely that the patient has suffered a head injury or other medical condition that may have caused delirium. However, the patient's age and medical history may also increase their risk for complications from",
        "label": 0
    },
    "395": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Hair Cortisol Level as a Predictor of PTSD Development\n\nInclusion criteria:\n\n* Age 18-50\n* Experienced a traumatic event fitting criterion A1 (stressor), A2 (Reaction), and at least 1 out of the B criterion in the ASD criteria in the DSM-IV-TR\n* Brought to the ER within hours of the traumatic event\n* Signed an informed consent\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as he is",
        "label": 0
    },
    "396": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG\n\nSummary: The purpose of this study is to show if it is possible to detect secondary ischemic events in patients with severe brain injury or cerebral hemorrhage with the help of non-invasive near-infrared spectroscopy (NIRS) by using the indocyanine green measuring of cerebral perfusion.\n\nInclusion criteria:\n\n* Patients over 18 years\n* Onset of clinical symptoms of subar",
        "label": 0
    },
    "397": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: Continuous Video-EEG Monitoring in the Acute Phase in Patients With a Cerebrovascular Attack-Randomisation of a Subpopulation Regarding Treatment Strategy\n\nInclusion criteria:\n\n* Patients with ischemic arteria cerebri media infarct and spontaneous intraparenchymal bleeding\n\nAssessment of eligibility:\n\n* Age: The patient is 85 years old, which meets the inclusion criteria of being 18 years or older.\n* Diagnosis: The patient has been diagnosed with a cerebrovascular attack, which meets the inclusion criteria.",
        "label": 0
    },
    "398": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: A Prospective Randomized Study Evaluating the Recurrence Rate of Chronic Subdural Hematoma After Placing a Subperiosteal Drainage Compared to a Subdural Drainage\n\nInclusion criteria:\n\n* Patient at least 18 years of age presenting with a symptomatic chronic subdural hematoma\n* Chronic subdural hematoma verified on cranial CT or MRI\n\nAssessment of eligibility:\n\nThe patient is an 85-year-old man who has been experiencing a gradual decrease in his level of consciousness, which is a symptom of",
        "label": 1
    },
    "399": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The Effect of Anticholinergics on Cognitive Function in the Elderly\n\nSummary: Anticholinergic medication is used to treat overactive bladder (OAB). A known side effect of this medication is cognitive dysfunction. OAB is more prevalent in the elderly population - a group that also has a higher baseline risk of cognitive dysfunction. Our objective is to evaluate the effect of an anticholinergic medication on cognitive function in elderly women.\n\nInclusion criteria:\n\n* Female, 50 or older\n* Diagnosis of OAB (ICS definition)",
        "label": 0
    },
    "400": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)\n\nInclusion criteria:\n\nAll male and female patients who have been prescribed for the first time either Rivaroxaban or standard of care from the date of market authorization of rivaroxaban to Dec 31, 2017\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age (85 years) and recent history of a car accident and decreased level of consciousness make them ineligible for the clinical trial, which is focused",
        "label": 0
    },
    "401": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Memory Aid - Working Memory Training in Patients With Mild Cognitive Impairment.\n\nInclusion criteria:\n\n* Patients who meet the Peterson diagnostic criteria of MCI:\n\t+ Memory complaints (preferably confirmed by an informant).\n\t+ Memory impairment according to age and education.\n\t+ Preserved general cognitive function.\n\t+ Intact activities of daily living, absence of dementia.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent decrease in consciousness and stopping of walking and eating by himself",
        "label": 0
    },
    "402": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: Modafinil Versus Placebo for Hypoactive Delirium in the Critically Ill\n\nInclusion criteria:\n\n* Adult patients \u2265 18 yrs of age, < 76 yrs of age\n* Admitted to MICU (3B and 3C) or SICU (8C, 8D, 11C)\n* Surrogate present to provide informed consent when the patient is not able\n* RASS score of >-3, < +1\n* CAM positive\n* Enteral access\n\nAssessment:\n\nThe patient's age (85 years) exceeds the maximum age",
        "label": 0
    },
    "403": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation - Effects on Cognitive Function\n\nInclusion criteria:\n\n* Endotracheally intubated\n* Expected time on ventilator > 24 hours\n* Age \u2265 18 years\n* Informed consent\n\nAssessment of eligibility:\n\nBased on the patient's history of a recent car accident and gradual decrease in consciousness, it is likely that the patient has a severe brain injury or other life-threatening condition that requires mechanical ventilation. The patient's age",
        "label": 0
    },
    "404": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: An Investigation Into the Mechanism of Inhalation Cough Challenge\n\nInclusion criteria:\n\n* Patients will be required to demonstrate significant cough symptoms by a score greater than 20/70 on the Hull Airways Reflux Questionnaire.\n* All patients must be current non-smokers.\n* Patients must be on stable medication for at least one month.\n* Patients must be able to attend the trials unit on at least 3 occasions.\n* Patients must have normal lung function.\n* Patients must be able to give informed consent.\n\nTrial-level eligibility: 0) Would not",
        "label": 0
    },
    "405": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Cognitive Impairment and Balance in Elderly\n\nSummary: One important issue in older adults with cognitive problems is the higher risk of fall due to decreased motor function and balance. The objective of this study is to evaluate the repercussions of mild cognitive impairment in balance in elderly.\n\nInclusion criteria:\n\n* Nursing home residents.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent decrease in consciousness and inability to walk or eat by himself could be indicative of a cognitive impairment, which",
        "label": 0
    },
    "406": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The DETEcT Study - Delirium in Elderly Patients Admitted to Trauma\n\nInclusion criteria:\n\n* Patients with any medical condition aged 65 years or older\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.\n\nThe patient's age (85 years) meets the inclusion criterion of being 65 years or older. Additionally, the patient's recent decrease in consciousness and inability to walk or eat by themselves suggest a potential medical condition that could be related to the trauma from the car accident, making them a suitable candidate for the study.</s>",
        "label": 2
    },
    "407": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Florbetapir Calibration to the Centiloid Scale\n\nInclusion criteria:\n\n* Cognitively Normal Subjects\n* Males or females \u2265 21 and \u2264 45 years of age\n* Mini-mental state examination (MMSE) \u2265 29\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age (85 years) does not meet the inclusion criteria for the clinical trial, which specifies that cognitively normal subjects must be between 21 and 45 years old. Additionally, the patient's",
        "label": 0
    },
    "408": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Incidence, Long-Term Outcome, and Factor Related to Non-Cardiac Postoperative Delirium in Elderly Patients\n\nSummary: The purpose of this study is to determine the incidence, long-term outcome, and factors related to postoperative delirium in elderly patients after non-cardiac surgery.\n\nInclusion criteria:\n\n* Age >/= 60 years\n* American Society of Anesthesiologists (ASA) physical status 1-3\n* Undergoing scheduled surgery\n* Giving an informed consent\n\nTrial-level eligibility: 1) Would consider referring this patient to",
        "label": 0
    },
    "409": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance\n\nInclusion criteria:\nHealthy, non-pregnant subjects between 18 and 55 years of age.\nSubjects have to achieve a classification of local class based on age-graded time USA Track & Field.\nSubjects who will abstain from taking any nutritional supplements for the duration of the study, including vitamins and mineral supplements (Exception: Ferrous sulfate, Elemental iron, Vitamin D, Calcium).\nSubjects that are taking prescription medications with the exception of birth control.",
        "label": 0
    },
    "410": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Functional Rehabilitation of Upper Limb Apraxia in Patients Poststroke\n\nSummary: The purpose of this study is to analyze the effects of a mixed intervention of occupational therapy (rehabilitative and compensatory approach) at home to upper limb apraxia in mild and moderate patients post-stroke in comparison to a control group with a traditional health educative protocol.\n\nInclusion criteria:\n\n* Mild-moderate stroke after two months of the cerebrovascular attack.\n* Upper limb apraxia lasting at least 2 months.\n* Less than 9 points in the validated Aprax",
        "label": 0
    },
    "411": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery\n\nInclusion criteria:\n\n* Older patient (\u226565 years)\n* Patient with hip fracture and planned hip fracture surgery\n* Patient willing to complete this study.\n\nAssessment of eligibility:\n\nBased on the patient's age (85 years) and the fact that he has a hip fracture and is planned for hip fracture surgery, he meets the inclusion criteria for the clinical trial. However, the patient's current condition, specifically the grad",
        "label": 0
    },
    "412": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Factors Affecting the Incidence of Postoperative Delirium in Frail Elderly\n\nSummary: Postoperative delirium has been found to be associated with increased risk of future neurocognitive decline and mortality, especially in elderly patients. Similarly, Frailty has been found to be associated with an increased risk of postoperative complication, including delirium, in the elderly. The purpose of this study is to determine the factors affecting the incidence of postoperative delirium in frail elderly undergoing non-cardiac surgery in the Singapore population.\n\nInclusion criteria:\n\n* Elderly (>",
        "label": 0
    },
    "413": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)\n\nInclusion criteria:\n\n* Inclusion criteria for patients with PTSD:\n\t+ Age 18-55 years old\n\t+ Currently diagnosed with PTSD and symptomatic with a Clinician-Administered PTSD Scale (CAPS) score > 50.\n* Exclusion criteria for patients with PTSD:\n\t+ Any primary Axis I disorder other than PTSD (e.g. psychosis)\n\t+ Medical or neurological illnesses likely to affect physiology",
        "label": 0
    },
    "414": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury\n\nInclusion criteria:\n\n* Males between 40 to 85 years of age\n* Individuals who participated in contact sports (e.g., active and retired NFL players, NHL players, boxers, NCAA athletes) and other individuals (including but not limited to veterans, breachers, or law enforcement officials with multiple blast exposures) who all have a history of one or more concussions and have a memory or cognitive complaint\n* Individuals with Mild Cognitive Impairment (M",
        "label": 0
    },
    "415": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Dexmedetomidine and Delirium in Patients After Cardiac Surgery\n\nInclusion criteria:\n\n* Patients of 60 years or older who are planning to receive cardiac surgery (CABG and/or valve replacement surgery)\n\nAssessment of eligibility:\n\n* Age: The patient is 85 years old, which meets the inclusion criterion of being 60 years or older.\n* Medical history: The patient has a history of a car accident 3 weeks prior to admission, but there is no mention of cardiac surgery.\n* Current symptoms: The patient is experiencing a grad",
        "label": 0
    },
    "416": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Postoperative Delirium in Hip Arthroplasty Patients\n\nInclusion criteria:\nMale or female, between 30 and 80 years of age\nASA I, II, or III\nCapable and willing to consent\nParticipants literate in English language\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as he is 85 years old, which is above the age limit of 80 years specified in the inclusion criteria. Additionally, the patient's medical history, including a recent car accident and",
        "label": 0
    },
    "417": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Impact of Unenhanced Computed Tomography (CT) in Elderly Patients Admitted to the Emergency Department With Acute Abdominal Pain\n\nInclusion criteria:\n\n* Elderly patients admitted to the emergency department (aged 75 years old and older)\n* Acute abdominal pain\n* Informed consent\n\nExclusion criteria:\n\n* Traumatic pain\n* Symptom duration of more than a week\n* Unability for the patient to give informed consent\n\nAssessment of eligibility:\n\nBased on the patient's age (85 years old) and the presence of acute ab",
        "label": 0
    },
    "418": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.\n\nSummary: Assessment of sedative effects of dexmedetomidine and propofol on the clinical course of delirium and neuroinflammation in patients with SIRS using CAM-ICU scale and protein S100b in serum.\n\nInclusion criteria:\n\n* Presence of delirium\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent decrease",
        "label": 0
    },
    "419": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Effect of Sevoflurane, Propofol, and Dexmedetomidine on Delirium & Neuroinflammation in Mechanically Ventilated Patients\n\nInclusion criteria:\n\n* Presence of delirium\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent decrease in consciousness and lack of recent fever, cough, rash, or diarrhea may indicate a possible neurological cause, which could be related to the car accident 3 weeks prior. The patient's age and recent neurological sympt",
        "label": 0
    },
    "420": {
        "output": "Patient Note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical Trial:\n\nTitle: Validation of a Delirium Monitor\n\nSummary: Delirium is a common disorder in hospitalized patients, but it is often poorly recognized by physicians and nurses, even when screening instruments are used. Electroencephalography (EEG) appears to be a sensitive tool for the diagnosis of delirium. However, standard EEG recording with 25 electrodes is labor-intensive. The study aims to validate the use of a brief EEG registration with three electrodes and automatic processing to distinguish patients with delirium from patients without delirium.\n\nInclusion Criteria:\n\n* Age 60 years and older",
        "label": 0
    },
    "421": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Intelligent Intensive Care Unit\n\nInclusion criteria:\n\n* Intensive care unit patient\n* 18 years of age or older\n* Exclusion Criteria (ICU Patients):\n* Anticipated intensive care unit stay less than one day\n* Less than 18 years of age\n* Inability to wear a motion sensor watch (ActiGraph)\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as they are not an intensive care unit patient, and their age is not specified. Additionally, the patient's",
        "label": 1
    },
    "422": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children\n\nInclusion criteria:\n\n* Children aged 2 through 17 years (17 years included)\n* Suspected fracture of a long bone requiring morphine analgesia (VAS \u2265 60/100 or Evendol \u2265 7/15 at the arrival at the emergency department)\n* Within the first 12 hours after the injury\n* At least one signed parental informed consent\n* Affiliated to health insurance",
        "label": 0
    },
    "423": {
        "output": "Patient Note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical Trial:\n\nTitle: The Use of Modified ride-on Cars to Advance Mobility and Socialization in Young Children With Disabilities\n\nInclusion Criteria:\n\n* Motor delays (sd>1.5) resulting in motor impairments that prevented functional independent mobility, such as rolling, crawling, walking\n* Aged between 12 months to 36 months old\n* Able to tolerate sitting with support for 30 minutes\n* Able to reach objects with either one or two hands\n* Consent of the parents to agree to the testing procedures and participate in the training program at their own house or at the hospital.\n\nTrial-",
        "label": 0
    },
    "424": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Clinical Relevance of Microbleeds In Stroke\n\nInclusion criteria:\n\n* Adult (\u226518y; no upper limit) patients with a clinical diagnosis of non-valvular AF (verified by ECG) with intention to treat with best practice oral anticoagulants (e.g. warfarin)\n* Previous ischaemic stroke or TIA diagnosed by treating clinician\n* All patients must be able to have GRE MRI before (or within 1 week) of starting best practice oral anticoagulant\n\nTrial-level eligibility: 0) Would not refer",
        "label": 0
    },
    "425": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models\n\nInclusion criteria:\n\n* ICU patients aged \u226518 years\n* Surgical, medical, neurology/neurosurgical, or trauma patients\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age and recent history of a car accident suggest that they may meet the inclusion criteria for the clinical trial. However, further investigation is needed to determine if the patient has a surgical, medical",
        "label": 1
    },
    "426": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: The Effects of Combining Modified ride-on Cars With Bimanual Training on Enhancing Mobility, Socialization, Motor Function and Participation in Toddlers With Disabilities\n\nInclusion criteria:\n\n* Motor delays (sd>1.5) resulting in motor impairments that prevented functional independent mobility, such as rolling, crawling, walking\n* Aged between 12 months to 36 months old\n* Able to tolerate sitting with support for 30 minutes\n* Able to reach the objects with either one or two hands\n* Consent of the parents to agree to the testing procedures and participate in",
        "label": 0
    },
    "427": {
        "output": "Patient Note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical Trial:\n\nTitle: Evaluation of Rapid Emergency Echography for Acute Dyspnoea\n\nInclusion Criteria:\nAdmission to the Emergency Department\nAge \u2265 75 years\nAND criteria of acute dyspnoea:\nBreathe rate \u2265 25 cycles/minute\nor PaO2 \u2264 70 mmHg\nor SpO2 \u2264 92% in room air\nor PacO2 \u2265 45 mmHg and pH \u2264 7.35\nAND Electrocardiogram in sinus rhythm at admission\n\nTrial-level eligibility:",
        "label": 1
    },
    "428": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Pilot Study of a Multicomponent Nurse Intervention to Reduce Delirium in Hospitalized Older Adults\n\nInclusion criteria:\n\n* Patients with an age equal or older than 65 years\n* Hospitalized at the Acute Geriatric Unit of the Complejo Hospitalario Universitario of Albacete\n* Valid signed informed consent by the patient or legal representative.\n\nAssessment:\n\nBased on the patient's age (85 years) and hospitalization at the Acute Geriatric Unit, the patient meets the inclusion criteria for the clinical trial. However, the patient's current condition, specifically the gradual",
        "label": 0
    },
    "429": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Ramelteon Prevention of Delirium - RCT\n\nInclusion criteria:\n\n* Age 65+\n* Hospitalized adult population\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age meets the inclusion criteria, but the patient's condition (gradual decrease in level of consciousness, stopped walking and eating) may not align with the clinical trial's focus on preventing delirium. Further investigation is needed to determine if the patient is eligible for the clinical trial.</s>",
        "label": 0
    },
    "430": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury\n\nInclusion criteria:\n\n* Age \u2265 18 to 54: Yes, the patient is 85 years old, which meets the inclusion criteria.\n* Blunt and/or penetrating trauma resulting in long bone or pelvic fractures requiring ORIF or CRPP: No, the patient's medical history does not mention any fractures or injuries.\n* Hemorrhagic shock defined by: i. Systolic BP (SBP) \u2264 90 mmHg or ii. Mean arterial",
        "label": 0
    },
    "431": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Surgical Treatment of Low Energy Pelvic Fractures in the Elderly\n\nInclusion criteria:\n\n* Elderly patients (age \u226555 years) of any ethnic/sociodemographic background\n* Pelvic ring fracture after low energy trauma affecting the posterior ring or both (posterior and anterior ring)\n* Surgical stabilization of the pelvic ring at Basel University Hospital between May 2010 and December 2014\n* Ambulatory before surgery\n* Informed consent for study participation by the patient or legal representatives\n\nTrial-level eligibility: 0)",
        "label": 0
    },
    "432": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\n\nTitle: Delirium at the Intensive Care Unit - a Retrospective Cohort Study\n\nInclusion criteria:\n\n* Patients >18 years of age admitted to the ICU at K\u00f8ge Hospital in the study period\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age and recent admission to the ICU meet the inclusion criteria for the clinical trial. However, the patient's medical history, including a recent car accident and gradual decrease in consciousness, may indicate that they are not in a stable condition to participate in the study. Further investigation is needed to",
        "label": 0
    },
    "433": {
        "output": "Patient note:\n\nAn 85-year-old man is brought to the ER because of a gradual decrease in his level of consciousness. In the last 3 days, he stopped walking and eating by himself. He has had no fever, cough, rash, or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.\n\nClinical trial:\nTitle: Delirium in Elderly Undergoing Cardiac Surgery and the Significance of CholinEsterase Activity\n\nInclusion criteria:\n\n* Written informed consent\n* \u2265 65 years of age\n* Scheduled to undergo elective cardiac surgery (coronary artery bypass graft (CABG), valve surgery, combined CABG-valve surgery) with the use of CPB\n* Both genders\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age (85 years) and the fact that",
        "label": 0
    },
    "434": {
        "output": "Patient Note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical Trial:\nTitle: Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia\n\nInclusion Criteria:\n\n* Histologically proven low-risk gestational trophoblastic neop",
        "label": 1
    },
    "435": {
        "output": "Patient note:\n\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\n\nTitle: Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist\n\nInclusion criteria:\n\n* Female gender\n* Age 33 to 50\n*",
        "label": 0
    },
    "436": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy\n\nSummary: The objective of this study is to evaluate the effects of 10 m",
        "label": 1
    },
    "437": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: Safety of Treatment of Uterine Fibroids With Asoprisnil\n\nSummary: The objective of this study is to determine the long-term safety of asoprisnil in women with symptomatic uterine fibroids who completed the 6-month",
        "label": 0
    },
    "438": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease\n\nSummary: We will use the novel analytical technique - Dual Polarisation Interferometry (DPI), to achieve the detection of the minimal amount of",
        "label": 2
    },
    "439": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future\n\nInclusion criteria:",
        "label": 1
    },
    "440": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: A Trial for Patients With Gestational Trophoblastic Disease\n\nSummary: This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low-risk Gestational Trophoblastic Tumor (GTT) that",
        "label": 2
    },
    "441": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: The Use of Mole Mapping Diagrams to Increase Skin Self-Examination Accuracy\n\nSummary: This study aims to improve Skin Self-Examination accuracy by a simple cost-effective intervention requiring participants to complete a mole-mapping diagram",
        "label": 0
    },
    "442": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis\n\nInclusion criteria:\n\n* Patients aged 18 years or older\n* A history",
        "label": 0
    },
    "443": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids\n\nInclusion criteria:\nMenorrhagia and/or bulk symptoms associated with u",
        "label": 2
    },
    "444": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: Natural History Study of Moles and Suspicious Melanoma\n\nInclusion criteria:\nInfants/Children\nMust be less than or equal to 5 years.\nMust have a large congenital melanocytic nevus (LCMN, diagnosed",
        "label": 0
    },
    "445": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point-of-care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: Fibroid Growth Study\n\nInclusion criteria:\n\n* Women included in the study must be at least 18 years of age, premenopausal, speak English, and have one or more uterine leiomyomas at least 2 cm",
        "label": 1
    },
    "446": {
        "output": "Patient note:\nA 36-year-old woman presents to the emergency department with 12 weeks of amenorrhea, vaginal spotting that has increased since yesterday, lower abdominal tenderness, nausea, and vomiting. The physical exam reveals an overall tender abdomen, 18-week sized uterus, and cervical dilation of 2 cm. The complete blood count and biochemical profile are normal. Point of care pregnancy test with cut-off sensitivity of 25 mIU/ml Beta-HCG is negative. The ultrasound reports an enlarged uterus (12 cm x 9 cm x 7 cms) with multiple cystic areas in the interior. The differential diagnosis includes vesicular mole vs fibroid degeneration.\n\nClinical trial:\nTitle: Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock\u2122 Embolic Agent\n\nSummary: A double-arm (non-inferiority) 44-patient study to assess the",
        "label": 0
    },
    "447": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Human Movement Database\n\nInclusion criteria: Any volunteer of any age from birth to old age who is deemed medically fit to participate and is willing to provide their informed consent will be included in the study.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of neck and shoulder pain, left hand and arm paresthesias, and spastic arm movements may be related to a movement disorder, which is",
        "label": 2
    },
    "448": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Characteristics of Idiopathic Familial Voice Disorders\n\nInclusion criteria:\n\n* Symptoms present during speech and not apparent at rest\n* Symptoms less evident during whisper, singing or falsetto\n* Symptoms become worse with prolonged speaking, practice or anxiety\n* Reflexive and emotional aspects of voice function are unaffected, such as coughing, laughter or crying\n\nExclusion criteria:\n\n* Any patient with a history of airway obstruction",
        "label": 1
    },
    "449": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: 1-Octanol to Treat Essential Tremor\n\nInclusion criteria:\n\n* Patients with essential tremor affecting the upper limbs who are 21 years of age or older.\n* Patients who are not taking medications for essential tremor or any other medical condition for at least 2 weeks.\n* Patients who have not consumed alcohol or cold medications containing alcohol for at least 24 hours prior to the day of the study.\n* Women must not be pre",
        "label": 1
    },
    "450": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Constraint-Based Therapy to Improve Motor Function in Children With Cerebral Palsy\n\nInclusion criteria:\nClinical diagnosis of hemiparetic cerebral palsy consistent with criteria in Swaiman and Russman (1999) and Badawi et al. (1998)\nRecommended for participation in pediatric rehabilitation and/or early intervention\nLives within 50 miles of the Civitan Center at",
        "label": 0
    },
    "451": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Octanol to Treat Essential Tremor\n\nInclusion criteria:\n14 patients with a clinical diagnosis of essential tremor will participate in the study. Selection criterion is essential tremor with a history of ethanol responsiveness. Informed consent will be obtained by any of the co-investigators.\nPatients must be off any medications used to treat essential tremor such as mysoline or propranolol for at least 2 weeks. Patients must withhold ethanol",
        "label": 0
    },
    "452": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor\n\nInclusion criteria:\n\n* Patients with alcohol-responsive Essential Tremor\n* Limb involvement should be a prominent feature of the Essential tremor\n* Patients must be willing and able to safely stop and remain off any medications used to treat essential tremor for at least 4 half-lives\n* Patients must",
        "label": 0
    },
    "453": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Robot-Assisted Motivating Rehabilitation\n\nInclusion criteria:\n\n1. Subjects will be included in the study on the basis of the following criteria:\n2. They must be at least six months post-stroke.\n3. 18 years of age or older with a clinical diagnosis of hemiparesis (as verified by medical record and a medical expert).\n4. They have voluntary control with a low to medium range of motion function (UE-FT<5) and",
        "label": 0
    },
    "454": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb\n\nInclusion criteria:\n\n* Female or male patients \u2265 18 years\n* \u2265 6 months since the last stroke, diagnosed by an appropriate healthcare professional (e.g., neurologist)\n* Focal spasticity with \u2265 2 points on the Ashworth Scale in the wrist flexors with",
        "label": 0
    },
    "455": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Efficacy of Functional Electrical Stimulation (FES) in Persons Receiving Botulinum Neurotoxin for Upper Extremity Spasticity\n\nInclusion criteria:\nMinimum 6 months post injury/insult with unilateral upper limb spasticity of the elbow, wrist and/or finger flexors.\nPreinjection Modified Ashworth scores > 2 in at least one of the following areas: elbow, wrist, or finger flexors.\nSubject",
        "label": 0
    },
    "456": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Evaluation of BOTOX\u00ae With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke Patients\n\nInclusion criteria:\nMale or female, 18 to 70 years of age\nWritten informed consent\nWritten Authorization for Use and Release of Health and Research Study Information has been obtained\nMedically stable condition in the investigator's opinion\nHistory of stroke (hemorrhagic or ischemic) that resulted in a",
        "label": 0
    },
    "457": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Treating Alcohol Withdrawal With Oral Baclofen\n\nInclusion criteria:\nMeet Diagnostic and Statistical Manual, 4th version, revised (DSMr-IV) criteria for alcohol withdrawal syndrome (AWS).\nBe an inpatient at St. Mary's Medical Center (SMMC) or Miller Dwan Medical Center (MDMC) at time of study enrollment.\nHave an alcohol withdrawal score as measured by standard SMMC or MDMC in",
        "label": 0
    },
    "458": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects\n\nInclusion criteria:\n\n* Subjects free of obvious health problems or with a stable condition\n* Male or female subjects aged \u226519 to \u226465 years\n* BMI between \u226518 and \u2264",
        "label": 0
    },
    "459": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Rabies Immunization Concomitant With JEV in Children\n\nInclusion criteria:\nMale and female 12-18 months old toddlers will be included in the study if they;\nare in good health at time of entry into the study as determined by medical history, physical examination and clinical judgment of the investigator;\nare available for all the visits scheduled in the study;\nhave been granted a written informed consent signed by their parents\n\nTrial-level eligibility: 0",
        "label": 0
    },
    "460": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Malaria Vaccine for Children in Mali\n\nInclusion criteria:\nMales or females aged \u2265 1 to < 4 years\nKnown residents of the village of Bancoumana, Mali, or its surrounding area\nGood general health as determined by the screening procedure\nAvailable for the duration of the trial (24 months from enrollment)\nWillingness to have the child participate in the study as evidenced by parents/legal guardians signing or fingerprinting the informed consent document",
        "label": 0
    },
    "461": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Physiotherapeutic Intervention in Children With Chronic Functional Constipation\n\nInclusion criteria:\n\n* Less than 2 per week defecation\n* Fecal incontinence\n* Retentive behavior\n* Pain at defecation\n* Hard stools\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms of neck and shoulder pain, left hand and arm paresthesias,",
        "label": 0
    },
    "462": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Study of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healthy Adults\n\nInclusion criteria:\nAged 18 to 60 years on the day of inclusion\nProvision of a signed Informed Consent Form\nAble to attend all scheduled visits and comply with all trial procedures\nFor a woman of child-bearing potential, avoid becoming pregnant (use of an effective method of contraception or abst",
        "label": 0
    },
    "463": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Brain Computer Interface (BCI) Based Robotic Rehabilitation for Stroke\n\nInclusion criteria:\nDemographics: 21 to 65 years, within 12 months of the first single clinical stroke (ischaemic or haemorrhagic).\nModerate to severe upper extremity (UE) weakness post-stroke.\nFugly-Meyer motor score of the upper limb < 40.\nUpper limb motor power MRC grade",
        "label": 0
    },
    "464": {
        "output": "Patient Note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical Trial:\nTitle: Positive Action for Today's Health\n\nInclusion Criteria:\nAfrican American (3 of 4 grandparents are of African Descent)\nLives in designated census area\nNo plans to move in the next two years\nHas no medical condition that would limit participation in moderate intensity exercise including life-threatening illness (e.g., immobile, severely disabled, or bed ridden)\nAvailable and able to participate in measures and intervention activities over the next 2 years",
        "label": 1
    },
    "465": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Study of Intradermal Administration of PCEC Rabies Vaccine\n\nInclusion criteria:\n\n* Laboratory personnel, epidemiologists, EISOs, veterinary students, interns, and other first responders at CDC; other CDC employees; and healthy volunteer adults.\n* Persons who contact the study coordinator will be assessed for possible occupational exposure to rabies using the risk assessment form (appendix E). The volunteers reporting occupational exposure will",
        "label": 0
    },
    "466": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO\u00ae, JESPECT\u00ae) in a Pediatric Population in Non-endemic Countries\n\nInclusion criteria:\nMale or female healthy children and adolescents aged >=2 months to <18 years at the time of first vaccination\nWritten informed consent by the subject's legal representative(s), according to local requirements, and written informed assent of the subject, if",
        "label": 0
    },
    "467": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea\n\nInclusion criteria:\nMale or female age \u226518 and \u2264 50 years.\nGeneral good health, without clinically significant medical history, physical examination findings or clinical laboratory abnormalities per clinical judgment of PI.\nNegative serum pregnancy test before first (",
        "label": 0
    },
    "468": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Postoperative Distress and Cosmetic Outcomes After Open Versus Robotic Thyroidectomy\n\nInclusion criteria:\n(a) a minimally invasive follicular thyroid carcinoma \u22644 cm in diameter, or\n(b) a papillary thyroid carcinoma \u22642 cm in diameter.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms and diagnosis do not",
        "label": 0
    },
    "469": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Improving Hand Use in Multiple Sclerosis\n\nInclusion criteria:\n\n* Diagnosis of non-relapsing multiple sclerosis (primary progressive MS, secondary progressive MS)\n* Reduced use of one of the hands because of MS\n* Ability to pick up and release a small object with the more-affected hand when requested\n* Can travel to the treatment program at the University of Alabama at Birmingham (UAB)\n* Can undergo treatment for 2 weeks (",
        "label": 0
    },
    "470": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults\n\nInclusion criteria:\nMale or female subject aged \u226518 to \u226455 years\nSubjects free of obvious health-problems or with stable conditions or medications\nBody mass index between \u226518 to \u226430 kg/m2\nAbstin",
        "label": 0
    },
    "471": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: A Trial of Levodopa in Angelman Syndrome\n\nInclusion criteria:\nAge between 4 years and 12 years (i.e., before the 13th birthday)\nMolecular confirmation of the diagnosis of AS, which may include abnormal methylation studies or UBE3A mutation analyses - only subjects with a molecular diagnosis will be allowed to enroll\nNot on LD, CD, or any dopamine agonists in the",
        "label": 0
    },
    "472": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Immune Response After Booster Vaccination in HIV-Infected Patients Who Received Rabies Primary Vaccination\n\nInclusion criteria:\nHIV-infected patients 18-60 years of age\nEver received primary rabies immunization\n\nAssessment of eligibility:\n\n1. Age: The patient is 28 years old, which meets the inclusion criterion of being between 18 and 60 years old.\n2. HIV",
        "label": 1
    },
    "473": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area\n\nInclusion criteria:\nConsenting adult males aged 18-50 years in good health and healthy children aged 2-6 years with consenting parents.\n\nAssessment of eligibility:\n\n1. Age: The patient is 28 years old, which is within the age range of 1",
        "label": 0
    },
    "474": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Observational Study of Botox\u00ae Treatment for Patients With Upper Limb Adult Spasticity\n\nInclusion criteria:\n\n* Adult patients with upper limb spasticity following a stroke\n* Eligible to receive botulinum toxin Type A\n* No previous botulinum toxin Type A therapy\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of",
        "label": 0
    },
    "475": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Enriched Environments for Upper Limb Stroke Rehabilitation\n\nInclusion criteria:\nInclusion Criteria for patients wth stroke:\nAge 40-80 years\nsustained a single stroke between 3-24 months prio t study leading to upper limb paresis\nhave at least Stage 3/7 arm control (mild to moderate motor deficits) on the Chedoke-McMaster Scale.\n<81 yrs old to minimize conf",
        "label": 0
    },
    "476": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults\n\nInclusion criteria:\nFemale and male subjects who must be healthy and must be:\nBetween 18 and 60 years of age inclusive and who have given their written informed consent;\nAvailable for all visits and telephone calls scheduled for the study",
        "label": 0
    },
    "477": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV\n\nInclusion criteria:\nHealthy\nCan visit according to the protocol\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of neck and shoulder pain, left hand and arm paresthesias, and spastic arm movements, sweating, increasing agitation and anxiety, malaise,",
        "label": 0
    },
    "478": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso\n\nInclusion criteria:\nHealthy infant/child aged 5-17 months at the time of first study vaccination\nInformed consent of parent/guardian\nInfant / child and parent/guardian resident in the study area villages and anticipated to be available for vaccination and follow-up\n\nTrial-level",
        "label": 0
    },
    "479": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury\n\nInclusion criteria:\nIncomplete traumatic Spinal Cord Injury (at least 18 months prior and stable for 6 months)\nModerate to severe lower-limb spasticity\nAble to give informed consent and willing to comply with protocol\n\nTrial-level eligibility: 1",
        "label": 0
    },
    "480": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Effects of Intensive Robot-assisted Therapy in Patients With Subacute Stroke\n\nInclusion criteria:\nfirst episode of unilateral stroke\ntime since stroke less than 3 months, i.e., acute or subacute stage\ninitial motor part of upper limb of FMA score ranging from 10 to 40, indicating severe to moderate movement impairment\nno serious cognitive impairment (i.e., Mini Mental State Exam score >",
        "label": 0
    },
    "481": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: The Protection Effect of Speeda\u00ae Rabies Vaccine for Human Use\n\nInclusion criteria:\nParent/legal acceptable representatives of children or the adult participants are willing and able to understand the protocol requirements and provide informed consent signed\nParticipant is considered to be in good health, including the body and mental status, based on reported medical history and limited physical examination, and lives in the local area for \u2265 12 months before being injured\nThe man-killer could found and detect whether it carries the virus",
        "label": 0
    },
    "482": {
        "output": "Sure, I'd be happy to help you with that! Here's the assessment of eligibility for the patient note you provided:\n\nPatient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen\n\nInclusion criteria:\nAged 2 to 17 years on the day of inclusion\nInformed consent form has been signed and dated by the parent(s) (and subject, if",
        "label": 0
    },
    "483": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) for Treatment of Tremor\n\nInclusion criteria:\n\n* Men and women, between 18 and 80 years, inclusive\n* Patients who are able and willing to give consent and able to attend all study visits\n* A diagnosis of ET as confirmed from clinical history and examination by a movement disorder neurologist\n* Tremor refractory to",
        "label": 0
    },
    "484": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Robot-assisted Rehabilitation of Hand by Paralysis of the Upper Limb After Stroke\n\nInclusion criteria:\na history of acute phase of stroke (less than 12 months post onset),\nfirst stroke episode,\nno history of peripheral nerve injury or musculoskeletal disease in the affected upper extremity,\nno contracture of the affected wrist or fingers (Modified Ashworth < 3),\nno history of any invasive procedure (Botul",
        "label": 0
    },
    "485": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib\n\nInclusion criteria:\nPhase Ia Inclusion criteria:\nHealthy volunteers aged 18-45 years\nGeneral good health based on history and clinical examination\nWritten informed consent obtained before any study procedure\nFemale volunteers practicing contraception before and up to 13 weeks after the last immunisation\nAvailable to particip",
        "label": 0
    },
    "486": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Safety and Efficacy of BOTOX\u00ae (Botulinum Toxin Type A) in Korea\n\nInclusion criteria:\nPatients treated with BOTOX\u00ae (botulinum toxin Type A) as prescribed according to standard of care in clinical practice for primary axillary hyperhidrosis, focal spasticity or moderate to severe glabellar lines.\n\nAssessment of eligibility:\n\n1. Does the patient have primary ax",
        "label": 0
    },
    "487": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial: Title: ASIS for Botox in Upper Limb Spasticity\n\nInclusion criteria:\n\n* Adults with a history of stroke that resulted in a unilateral, upper-limb focal spasticity\n* Wrist flexor tone of more than 2 and finger flexor tone of more than 2 as measured by the Ashworth Scale\n* Ability to understand and follow verbal directions\n* At least 1 functional disability item (hygiene, dressing, pain, or limb post",
        "label": 0
    },
    "488": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration\n\nInclusion criteria:\nAdult male or female over 40 years of age.\nPatient should be in sufficiently good health to reasonably expect survival for at least four years after treatment\nAxial myopia of equal to or greater than -8 diopters and/or axial length equal to or greater than 28 mm\nClinical findings consistent with MMD with evidence of one",
        "label": 0
    },
    "489": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects \u2265 1 Years of Age\n\nInclusion criteria:\nHealthy males and females \u2265 1 years of age\nIndividuals/individual's parents or legal guardians who have given written consent\nIndividuals in good health\nIndividuals who can comply with study procedures\n\nTrial-level el",
        "label": 0
    },
    "490": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy\n\nInclusion criteria:\nAged sixteen or older\nSpastic Cerebral Palsy with a stable condition\nMotor disability unilateral or predominantly unilateral\nTroubles of speech clinically evident\nNormal or Slightly sub-normal I.Q\nNo psychiatric disorders\n\nAssessment of eligibility:\n\n1.",
        "label": 0
    },
    "491": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults\n\nInclusion criteria:\n\n* Compliant with protocol procedures and available for clinical F/U until the protocol-defined end of the trial\n* Physical examination and laboratory results without clinically significant findings\n* Body Mass Index (BMI) \u2265 18.0 and \u2264 32.0 kg/m2",
        "label": 1
    },
    "492": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: RNActive\u00ae Rabies Vaccine (CV7201) in Healthy Adults\n\nInclusion criteria:\nHealthy male and female volunteers aged 18 to 40 years inclusive\nCompliant with protocol procedures and available for clinical follow-up through the last planned visit (V9)\nPhysical examination and laboratory results without clinically significant findings\nBody Mass Index (BMI) \u2265 18.0 and \u2264 32.0 kg/",
        "label": 0
    },
    "493": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Observation Study an Immunogenicity Modified TRC-ID Regimen With CPRV With or Without Rabies Immunoglobulin in Children\n\nInclusion criteria:\n\n* Age 1-15 years\n* Healthy children\n* Signed informed consent from their parents\n* Willing to participate in this study and be able to receive the vaccination and collect blood samples as per the study plan.\n\nTrial-level eligibility: 0) Would not refer this patient for",
        "label": 0
    },
    "494": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Robot Aided Rehabilitation - Intervention\n\nInclusion criteria:\nFirst focal unilateral lesion, ischemic or hemorrhagic\nHad a stroke 1-12 months prior to enrollment\nRated between stages 2-4 on the Chedoke McMaster Stroke Assessment Impairment Inventory: Stage of Recovery of the Arm and Hand\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial",
        "label": 0
    },
    "495": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Robot Aided Rehabilitation - Multi-joint Evaluations\n\nInclusion criteria:\nFirst focal unilateral lesion, ischemic or hemorrhagic\nHad a stroke less than a month prior to enrollment\nRated between stages 1-4 on the Chedoke McMaster Stroke Assessment Impairment Inventory: Stage of Recovery of the Arm\nRated between stages 1-4 on the Chedoke McMaster Stroke Assessment Imp",
        "label": 0
    },
    "496": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis\n\nInclusion criteria:\nMale and non-pregnant females aged \u2265 18 to \u2264 60 years on the day of inclusion\nAble to comprehend and give informed consent\nAble to attend all scheduled visits and to comply with all trial procedures\nSubject in good health, based on medical history and physical examination\n\nTrial-level eligibility: 0) Would not refer this patient",
        "label": 1
    },
    "497": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Essential Tremor\n\nInclusion criteria:\nEssential Tremor diagnosed by criteria listed in the Consensus statement of the Movement Disorders Society on Tremor\nAge 18 - 85 years of age\nMotor skills allowing for capability to complete evaluations\nMedically cleared for undergoing anesthesia and DBS surgery\n\nTrial-level eligibility:",
        "label": 0
    },
    "498": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Effect of Osteopathic Manipulative Medicine on Motor Function and Quality of Life in Cervical Dystonia\n\nInclusion criteria:\nclinical diagnosis of cervical dystonia or spasmodic torticollis\nages 2-100\n\nAssessment of eligibility:\n\n1. Does the patient have a clinical diagnosis of cervical dystonia or spasmodic torticollis?\nYes, the patient's symptoms of",
        "label": 0
    },
    "499": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Palestinian Perineum and Birth Complication Study\n\nInclusion criteria:\nall midwives and physicians working on labor ward in the participating hospitals.\nall women giving birth in the participating hospitals.\nboth genders are included in the staff, and among the newborns\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms and medical history do not match the inclusion criteria for the clin",
        "label": 0
    },
    "500": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects\n\nInclusion criteria:\nAged from 10 to 60 years old\nSubjects or legal guardians can and will comply with the requirements of the protocol\nSubjects or legal guardians are able to understand and sign the informed consent\nHealthy subjects judged from medical history after investigator's inquiry\nSubjects with temperature <=37.",
        "label": 0
    },
    "501": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults\n\nInclusion criteria:\nHIV-infected patients\nAge 18-60 years\nReceived primary rabies immunization\n\nAssessment of eligibility:\n\n1. Age: The patient is 28 years old, which meets the inclusion criteria of being between 18 and 60 years old.\n2.",
        "label": 0
    },
    "502": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Immediate Effects Cervicothoracic Manipulation Versus Passive Upper Trapezius Stretch\n\nInclusion criteria:\n1. No current history or past history of neck pain; able to lie on back or stomach without difficulty\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of neck and shoulder pain, left hand and arm paresthesias, and spastic arm movements may be related",
        "label": 0
    },
    "503": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing, and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.\n\nInclusion criteria:\nProvide signed and dated informed consent form.\nWilling to comply with all study procedures and be available for the duration of the study.\nMale or female, aged \u2265 18 to \u2264 60 years on day of inclusion.\nIn good general health based on medical history and physical exam.\n\nTrial-level eligibility: 0)",
        "label": 0
    },
    "504": {
        "output": "Patient note:\nA 28-year-old female with neck and shoulder pain and left hand and arm paresthesias three weeks after returning from a trip to California where she attended a stray animal recovery campaign. Her physical exam was unremarkable except for slight tremors and almost imperceptible spasticity. She was prescribed NSAIDS and a topical muscle relaxant. She was brought in to the ER three days later with spastic arm movements, sweating, increasing agitation and anxiety, malaise, difficultly swallowing and marked hydrophobia, and was immediately hospitalized.\n\nClinical trial:\nTitle: Effectiveness of Radial Extracorporeal Shockwave Therapy on Tennis Elbow\n\nInclusion criteria:\nAged > 18 years old\nLateral elbow pain lasting > 3 months\nPain induced by direct compression on the lateral epicondyle or common extensor tendon, resistant wrist extension and pronation in the elbow extension position, or static stretching of common extensor tendon through the palmer flexion in wrist pronation and elbow extension position",
        "label": 0
    },
    "505": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Molecular and Clinical Studies of Primary Immunodeficiency Diseases\n\nInclusion criteria:\nPatients with a clinical history or signs and symptoms suggestive of a primary immune deficiency syndrome and their family members are eligible for inclusion in this study.\n\nExclusion criteria:\nInability of the subject or the subject's parent/guardian to provide informed consent.\nPatients infected with the Human Immunode",
        "label": 2
    },
    "506": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Epi Cystic Hydatid Disease Peru\n\nInclusion criteria:\nLiving in study area (Cooperative Tupac Amaru).\nOlder than five-years old.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as they are not living in the study area (Cooperative Tup",
        "label": 1
    },
    "507": {
        "output": "Patient note:\n\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and a positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\n\nTitle: STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency\n\nInclusion criteria:\n\n* Inclusion criteria:\n\nA subject is eligible for the study if all of the following criteria are met:\n\n* Has given written informed consent prior to screening.\n* Is male or female aged 18 through 75 years.\n* Has CVID diagn",
        "label": 1
    },
    "508": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States\n\nInclusion criteria:\nAll patients must have a known or suspected immune defect with hyper-IgM syndrome and/or disorders of immunoglobulin production. There will be no limit on age, sex, race, or disability.\n\nExclusion criteria:\nThe presence of an acquired abnormality, which leads to immune defects,",
        "label": 1
    },
    "509": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration\n\nInclusion criteria:\nFemale or male, aged between 18 and 90 years.\nWritten informed consent.\nAbscess formation or abdominal cyst scheduled to drainage.\nPlasma creatinine <1.5 mg/dL\n\nT",
        "label": 1
    },
    "510": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery\n\nInclusion criteria:\n\n* DISEASE CHARACTERISTICS:\n\t+ Diagnosis of cancer of the biliary tract by 1 of the following methods:\n\t\t- Hist",
        "label": 0
    },
    "511": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Early Versus Interval Appendectomy for Ruptured Appendicitis in Children\n\nInclusion criteria:\nClinical diagnosis of ruptured appendicitis\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's diagnosis of a ruptured liver abscess, which is not the same as a ruptured appendicitis, makes them inel",
        "label": 0
    },
    "512": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Efficacy and Safety of Vivaglobin\u00ae in Previously Untreated Patients With Primary Immunodeficiency\n\nInclusion criteria:\n\n* Written informed consent, age-adapted\n* Male or female aged 1 to 70 years\n* Diagnosis of primary humoral immunodeficiency\n* No prior immunoglobulin substitution therapy\n* IgG level of <5 g/L at",
        "label": 0
    },
    "513": {
        "output": "Patient Note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical Trial:\nTitle: Efficacy and Safety of Primovist in Chinese Patients\n\nInclusion Criteria:\nPatients between 18 and 75 years of age inclusive.\nPatients (men or women) with at least one focal liver lesion, either identified or suspected by ultrasound (US), Computed Tomography (CT)/spiral-CT, conventional angiography, CT-angiography (CTA), CT-arter",
        "label": 0
    },
    "514": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam\n\nInclusion criteria:\nAdult patients ( > 18 years) requiring surgical intervention within 24 hours of diagnosis, for localized IAI infections (i.e extending beyond the organ wall but confined near the hollow viscus, mild to moderate in severity):\nAcute appendic",
        "label": 1
    },
    "515": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Prognosis of Failure Treatment of Amebic Liver Abscess\n\nInclusion criteria:\nClinical, ultrasonographic and serologic diagnosis (ELISA) of amebic liver abscess.\nBoth genders\nOlder 15 years\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's history of C",
        "label": 0
    },
    "516": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Correlation of Location of Abdominal Tenderness With Acute CT Abnormalities in Emergency Department Patients\n\nInclusion criteria:\nAll consecutive emergency department patients undergoing abdominal CT for non-traumatic abdominal pain and tenderness will be prospectively enrolled, with the following exceptions. For study purposes, abdominal pain and tenderness is defined as pain and tenderness to direct palpation in the region anterior",
        "label": 0
    },
    "517": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Study on Laparoscopic Operation for Perforated Appendicitis\n\nInclusion criteria:\nAll patients admitted to the emergency station of our hospital expressing pain other than the right lower abdominal quadrant.\nThe results of a clinical examination favored the diagnosis of perforated acute appendicitis, and the result of abdominal computed tomography revealed signs of acute appendicitis and intra-abdominal fluid accumulation",
        "label": 0
    },
    "518": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Intraperitoneal Local Anaesthetic in Colonic Surgery\n\nInclusion criteria:\nConsecutive patients undergoing open colonic resection at MSC under the ERAS program.\n\nAssessment:\n\n* Patient's age: 48 years old\n* Patient's gender: Male\n* Patient's medical history: Common variable immunodeficiency (CVID)\n* Patient's",
        "label": 0
    },
    "519": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Clinical Impact of Routine Abdominal Drainage After Laparoscopic Cholecystectomy\n\nInclusion criteria:\npatients with gallbladder stones and laparoscopic cholecystectomy\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's diagnosis of a ruptured liver abscess and recent surgery makes",
        "label": 0
    },
    "520": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer\n\nInclusion criteria:\npatients with operable local gastric adenocarcinoma\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as they have a history of common variable imm",
        "label": 0
    },
    "521": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Clipless Laparoscopic Cholecystectomy Using Harmonic Scalpel in Cirrhotic Patients a Prospective Randomized Study\n\nInclusion criteria:\npatients with liver cirrhosis with symptomatic gall bladder stone\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's history of common variable immun",
        "label": 1
    },
    "522": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Adult Dengue Platelet Study\n\nInclusion criteria:\nAge \u2265 21 years\nProbable or confirmed dengue\na) Confirmed dengue: laboratory confirmation of acute dengue by either i) positive polymerase chain reaction (PCR) for viral ribonucleic acid (RNA), or ii) positive NS1 antigen test with a compatible clinical syndrome\nb) Probable den",
        "label": 0
    },
    "523": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Perforated Appendicitis With Delayed Presentation\n\nInclusion criteria:\n\n* All children with a delayed diagnosis of perforated appendicitis. Delayed diagnosis will be defined as symptoms for 4 or more days. Duration of symptoms will be defined as the time pain started.\n* Confirmed diagnosis of perforated appendicitis. The diagnosis of perforated appendicitis will be based on diagnostic",
        "label": 0
    },
    "524": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections\n\nInclusion criteria:\nMale or female, from 18 to 90 years of age, inclusive\nOne of the following diagnoses (in which there is evidence of intraperitoneal infection) including:\n(a",
        "label": 1
    },
    "525": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Prophylactic Fenestration of the Peritoneum in Kidney Transplantation\n\nInclusion criteria:\nAdult recipients of kidney transplants from deceased donors\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's diagnosis of common variable immunodeficiency (CVID) and the presence of a ruptured liver abscess make them",
        "label": 0
    },
    "526": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus in Principle (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients\n\nInclusion criteria:\nA) Patients presenting with the following history:\nHistologically-proven colorectal adenocarcinoma\nPresenting at the time of resection of the primary with one of",
        "label": 0
    },
    "527": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection\n\nInclusion criteria:\n- Pregnant Women aged 14 years and over at \u2265 24 weeks' viable gestation who will undergo unscheduled/non-elective cesareans with either:\n* Labor (spontaneous or induced): active labor (ongoing contractions and",
        "label": 0
    },
    "528": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Once-daily Therapy for Streptococcal Pharyngitis\n\nInclusion criteria:\nAge of 6 to 15 years old.\nThe criteria in clinical examination including objective signs (fever, Erythema or exudate of tonsils, enlarged lymph nodes) and subjective sign(sore throat). Neck tenderness, abdominal pain, and pharynx petechia were also",
        "label": 0
    },
    "529": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease\n\nInclusion criteria:\n\n1. Liver volume \u2265 4 liters\n2. \u2265 20 liver cysts\n3. Symptomatic patients defined as at least 2 out of 5 of the following symptoms related to mass effect irrespective of the intensity:\n\t* Abdominal distention perce",
        "label": 0
    },
    "530": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions\n\nInclusion criteria:\n\n* Patients diagnosed with de novo FLL at standard ultrasound\n* Age > 18 years, male and female gender\n* Informed consent for the contrast enhanced study\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's",
        "label": 0
    },
    "531": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Assessment of Peritoneal Immune Response in Patients With Severe Intra-abdominal Sepsis Managed With Laparostomy and Vacuum Assisted Closure (VAC)\n\nInclusion criteria:\n\n* Patient > 18 years old\n* Patient or relatives signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures\n\nTrial-level eligibility",
        "label": 0
    },
    "532": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis\n\nInclusion criteria:\nAge >18 years\nClinically diagnosed liver cirrhosis by any of the following: ultrasound/MRI/ CT/ + tissue biopsy.\nMELD score \u2265 18 and <35\nAbility to sign an informed consent",
        "label": 0
    },
    "533": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Antibiotics Versus Surgery in Acute Appendicitis\n\nInclusion criteria:\n\n* Patients between 18 and 65 years old\n* First episode of suspected AA diagnosed by Andersson's score or combination with abdominal ultrasound\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age and diagnosis of",
        "label": 0
    },
    "534": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Proteomics & Glyco-Proteomic Analysis of Follicular Fluid\n\nInclusion criteria:\n\n* Inclusion criteria: Female patients undergoing controlled ovarian hyperstimulation (COH), transvaginal oocyte aspiration (TVA), and Saline Infused Sonography (SIS) with UL collection\n* Age <35 y/o at time of in vitro fertilization (IVF) cycle",
        "label": 0
    },
    "535": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Clinical Trial of Bilhvax, a Vaccine Candidate Against Schistosomiasis\n\nSummary: The purpose of this clinical study is to evaluate the safety and immunogenicity in adult healthy volunteers of the vaccine candidate against schistosomiasis named Bilhvax.\n\nInclusion criteria:\n\n* Caucasian volunteers\n* No smoker\n* Biological parameters (ha",
        "label": 0
    },
    "536": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer\n\nInclusion criteria:\nInclusion Criteria:\nGastric cancer patients who are eligible for curative surgery\nAge 25-90\n\nAssessment:\nBased on the patient's history of common variable immun",
        "label": 0
    },
    "537": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration\n\nInclusion criteria:\n\n* Patients of both sexes aged \u2265 18 years.\n* Standard analytical parameters, defined by:\n\t+ Leukocytes \u2265 3000\n\t+ Neutrophils \u2265 1500\n\t+ Platelets \u2265 100",
        "label": 1
    },
    "538": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Operative Treatment of Endometriosis Patients in Turku University Hospital\n\nInclusion criteria:\n\n* Endometriosis\n* Adnexal finding\n* Laparoscopic sterilization\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as they do not have endometriosis, adnexal finding",
        "label": 0
    },
    "539": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease\n\nInclusion criteria:\n\n* Has documented chronic granulomatous disease\n* Age 18 - 75\n* Has a liver abscess infected with Staphylococcus aureus or other microorganism susceptible to RFA, but is not an optimal candidate for curative surgical resection either due to location",
        "label": 0
    },
    "540": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Effects of Drainage in Laparoscopic Cholecystectomy\n\nInclusion criteria:\nacutely inflamed gallbladder\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's diagnosis of a ruptured liver abscess and history of common variable immunodeficiency (CVID) do not meet the inclusion criteria of the clinical trial",
        "label": 0
    },
    "541": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Prevalence of Colon Cancer in Pyogenic Liver Abscess\n\nInclusion criteria:\nPyogenic liver abscess radiologically and bacteriologically diagnosed\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's history of common variable immunodeficiency (CVID) and the current presentation of acute abdominal pain, fever, and",
        "label": 1
    },
    "542": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts\n\nInclusion criteria:\nAll patients who are diagnosed with a dominant liver cyst with an indication for aspiration and sclerotherapy are suitable for inclusion in this study.\nIn order to be eligible to participate in this study, a subject must meet all of the following criteria:\nAge",
        "label": 0
    },
    "543": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Significance of Peritoneal Washing Cytology Before and After Neoadjuvant Chemotherapy in Patients With Esophagogastric-junction Cancer\n\nInclusion criteria:\n\n* Patients with biopsy-verified GEJ-cancer referred to the department of surgical gastroenterology, Rigshospitalet, which is considered resectable at MDT-conference.\n* >18",
        "label": 0
    },
    "544": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled Trial\n\nInclusion criteria:\n\n* Patients who have T3 (subserosal) or T4 (serosal) disease based on CT scan and intra-operative inspection with any N staging and M0 gastric cancer.\n* Patients planned for open or laparoscopic gastrect",
        "label": 0
    },
    "545": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism\n\nSummary: The aim of this study is to compare microwave thermal coagulation and partial splenic embolization in the management of hypersplenism in patients with cirrhosis.\n\nInclusion criteria:\n\n* Liver Cirrhosis\n* Hypersplenism\n\nTrial-level eligibility:",
        "label": 0
    },
    "546": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Use of Hypertonic Saline After Damage Control Laparotomy to Improve Early Primary Fascial Closure\n\nInclusion criteria:\nAll admissions of trauma patients who sustain trauma necessitating damage control laparotomy.\nMale and female patients 18 years or older.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient",
        "label": 2
    },
    "547": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475\n\nInclusion criteria:\n\n* Be willing and able to provide written informed consent/assent for the trial.\n* Be 18 years of age on day of signing informed consent.\n* Have histologically or cytologically confirmed breast cancer. O",
        "label": 0
    },
    "548": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: BP as a New Device for Surgery and Solid Cancer and Hematopoietic System Tumors Treatment. Effects of BP Implantation\n\nInclusion criteria:\nInclusion Criteria: animal model: New Zeeland female rabbits of 3000 gr of body weight\n\nExclusion Criteria: any kind of illness in rabbit subjects\n\nTrial-level eligibility: 0) Would not",
        "label": 0
    },
    "549": {
        "output": "Patient note:\nA 48-year-old white male with history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Myometrial Thickness as a Predictor for the Latency Interval in PPROM\n\nInclusion criteria:\nsingleton pregnancy with a definite history of current PPROM for the study group\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's diagnosis of common variable immunodeficiency (CVID) and the presence of acute abdominal",
        "label": 0
    },
    "550": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise\u00ae 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms\n\nInclusion criteria:\n\n* Subject \u2265 18 years old.\n* Subjects with non-ruptured or ruptured intracranial aneurysm that is",
        "label": 0
    },
    "551": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Natural History of Noncirrhotic Portal Hypertension\n\nInclusion criteria:\nAge 12 years or above, male or female\nKnown diagnosis of NCPH, or to be at risk for NCPH by virtue of underlying disease processes such as but not limited to; CGD, SCD, Mastocytosis, CVID, CF, and CHF.\n\nExclusion criteria:\nEvidence of other forms of liver",
        "label": 1
    },
    "552": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy\n\nInclusion criteria:\n\n* Aged > 18 years old\n* Capable of providing informed consent.\n* Histologically confirmed peritoneal carcinomatosis from appendiceal, colorectal, ovarian, or primary mesothelioma, with no systemic metast",
        "label": 0
    },
    "553": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Consequences of DNA Repair and Telomere Defects on the Function of the Immune System: Application to CVID and Immune Deficiencies With Dysmorphic Syndromes\n\nInclusion criteria:\nImmune Deficiency and early BMF in childhood\nCommon Variable Immunodeficiency (CVID)\nGenetic patients\n\nAssessment of eligibility:\n\n1. Does the",
        "label": 1
    },
    "554": {
        "output": "Patient note:\nA 48-year-old white male with a history of common variable immunodeficiency (CVID) with acute abdominal pain, fever, dehydration, HR of 132 bpm, BP 80/40. The physical examination is remarkable for tenderness and positive Murphy sign. Abdominal ultrasound shows hepatomegaly and abundant free intraperitoneal fluid. Exploratory laparotomy reveals a ruptured liver abscess, which is then surgically drained. After surgery, the patient is taken to the ICU.\n\nClinical trial:\nTitle: Aspiration Treatment of Perianal Abscess\n\nSummary: The purpose of this study is to compare aspiration and oral antibiotics with surgical incision in the treatment of perianal abscesses in terms of recurrence and subsequent fistula formation. Included patients will be randomized to either aspiration or incision.\n\nInclusion criteria:\n\n* \u226518 yrs old\n* Perianal abscess (without",
        "label": 0
    },
    "555": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Cyclophosphamide and Fludarabine to Treat Lupus Nephritis\n\nInclusion criteria:\n\n* Patients must be 18 years of age or older and able to provide",
        "label": 0
    },
    "556": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure\n\nInclusion criteria:\n\n* PROTOCOL ENTRY CR",
        "label": 0
    },
    "557": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Study of Morphine in Postoperative Infants to Allow Normal Ventilation\n\nInclusion criteria:\n\n* Age: Less than 12 months (Part I) or less than 3 months (Part II",
        "label": 1
    },
    "558": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy\n\nInclusion criteria:\n\n* Histologically confirmed IgA nephropathy, diagnosed",
        "label": 0
    },
    "559": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Study of Triostat in Infants During Heart Surgery\n\nInclusion criteria:\n\n* Diagnosis of one of the following:\n\t+ Ventricular septal defect (VSD)",
        "label": 0
    },
    "560": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery\n\nInclusion criteria:\n\n1. Scheduled cardiac surgery with hypothermic CPB to",
        "label": 0
    },
    "561": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique\n\nSummary: To assess the influence of seasonal variations in Schist",
        "label": 0
    },
    "562": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: The Circadian Rhythm of Urine Output in Healthy Infants\n\nSummary: The purpose of this study is to describe the 24-hour urine output including the urinary excretion of",
        "label": 0
    },
    "563": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients\n\nInclusion criteria:\n\n* Cessation of hemof",
        "label": 1
    },
    "564": {
        "output": "Patient Note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical Trial:\nTitle: Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage\n\nInclusion Criteria:\n\n* Greater than 18 years of",
        "label": 0
    },
    "565": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Enteroaggregative E.Coli (EAEC)\n\nInclusion criteria:\n\n* Sign an Institutional Review Board-approved consent prior to any study-related activities.\n* Initiate",
        "label": 0
    },
    "566": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis\n\nInclusion criteria:\n\n* Diagnosis of Gastroschisis\n* Birth We",
        "label": 0
    },
    "567": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants\n\nInclusion criteria:\nAge younger than one year\nCorrective open heart surgery with",
        "label": 1
    },
    "568": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Belatacept in Liver Transplant Recipients\n\nInclusion criteria:\nFirst-time recipient of deceased donor liver transplant\nAge 18-70\nHepatitis C virus",
        "label": 0
    },
    "569": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery\n\nInclusion criteria:\n\n* Age over 18 years\n* Planned CABG or val",
        "label": 0
    },
    "570": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery\n\nInclusion criteria:\n\n* Cardiac surgery\n* At least one risk factor for",
        "label": 2
    },
    "571": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Acute Kidney Injury in Neonates\n\nInclusion criteria:\nFamilies of infants (birthweight >1500g) be asked to participate in the study.\n\nT",
        "label": 1
    },
    "572": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome\n\nInclusion criteria:\n\n* Proteinuria over 0.25 g/mm",
        "label": 1
    },
    "573": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Does Massage With or Without Aromatherapy Reduce Infant's Distress?\n\nInclusion criteria:\nInfants aged 6 to 36 months admitted to the Intensive Care-S",
        "label": 0
    },
    "574": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Zinc and Copper Absorption in Neonates With Bilious Losses\n\nInclusion criteria:\nPresence of ileostomy due to any disease or condition (i.e., nec",
        "label": 0
    },
    "575": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life\n\nInclusion criteria:\nInfants born at >2",
        "label": 1
    },
    "576": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery\n\nInclusion criteria: Patient selection will be determined by an assessment of the risk of systemic ventric",
        "label": 0
    },
    "577": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery\n\nInclusion criteria:\n\n* Inclusion Criteria for Adults: (must have at least one of",
        "label": 1
    },
    "578": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions\n\nInclusion criteria:\nAged 18-45 years.\nWere",
        "label": 0
    },
    "579": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal",
        "label": 0
    },
    "580": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery\n\nInclusion criteria:\nPatient undergoing heart surgery on cardiopul",
        "label": 1
    },
    "581": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (",
        "label": 0
    },
    "582": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Preoperative Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass\n\nSummary: Randomized controlled trial of the use of glucocorticoids to improve",
        "label": 0
    },
    "583": {
        "output": "Patient Note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical Trial:\nTitle: Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C\n\nInclusion Criteria:\n\n* Study subject must have read, understood and provided",
        "label": 0
    },
    "584": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Relative Adrenal Insufficiency in Preterm Very Low Birth Weight Infants With Shock\n\nInclusion criteria:\nAll preterm (28 to 34 week gestation) very low",
        "label": 1
    },
    "585": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Defining Normal Citrulline Levels as a Diagnostic Tool for Screening of Gastrointestinal Disease in Premature Infants\n\nInclusion criteria:\n1. Premature infants with gest",
        "label": 0
    },
    "586": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome\n\nIn",
        "label": 0
    },
    "587": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Test of Discomfort and Malaise of Two Different Urine Catheters in Healthy Volunteers\n\nInclusion criteria:\n\n* Inclusion Criteria:\n\t+ 18",
        "label": 0
    },
    "588": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin\n\nInclusion criteria:\n\n* Writ",
        "label": 0
    },
    "589": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease\n\nInclusion criteria:\nMale and females,",
        "label": 0
    },
    "590": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: NGAL, an Early Predictive Marker of Acute Kidney Injury After Cardiac Surgery in Neonates and Infants\n\nInclusion criteria:\n\n* Inclusion criteria",
        "label": 1
    },
    "591": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Bosutinib For Autosomal Dominant Polycystic Kidney Disease\n\nInclusion criteria:\nMales and females, 18 to 50 years old at the time of consent",
        "label": 0
    },
    "592": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant\n\nInclusion criteria:\n\n* Gestational age <29 weeks\n* E",
        "label": 0
    },
    "593": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Seattle Cardiorenal Remote Ischemic Preconditioning Trial\n\nInclusion criteria:\nAge birth to 18 years\nCardiac surgery with planned cardiopulmonary bypass",
        "label": 0
    },
    "594": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Ketorolac in Postoperative Infants: Pharmacokinetics and Safety\n\nInclusion criteria:\nNon-prematurely-born infants admitted to hospital following surgery ages",
        "label": 2
    },
    "595": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)\n\nInclusion criteria:",
        "label": 0
    },
    "596": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury\n\nInclusion criteria:\nAge < 18 years, including the newborn;\nAcute kidney injury",
        "label": 1
    },
    "597": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria\n\nInclusion criteria:\nPatient age >12 years\nPresence of severe or moderately severe P.",
        "label": 0
    },
    "598": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Plasma and Hemodynamic Markers During Hepatectomy\n\nInclusion criteria:\nPatient with neoplastic liver tumors undergoing elective hepatectomy.\n\nAssess",
        "label": 0
    },
    "599": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Sodium Supplementation and Growth in Very Low Birth Weight Infants\n\nInclusion criteria:\ninfants born at less than 32 weeks postmenstrual age\n\nTrial-",
        "label": 0
    },
    "600": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X\n\nInclusion criteria:\n\n* Age > 18 years\n* Corrected visual",
        "label": 0
    },
    "601": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Renal Protection During Deceased Brain Dead Donor Kidney Trans",
        "label": 0
    },
    "602": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: Renal Effects of Levosimendan in Cardiac Surgery Patients\n\nInclusion criteria:\n\n* Patients undergoing cardiac surgery (OPS 5-35 bis",
        "label": 0
    },
    "603": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Screening and Identification of Human Urate Transporter hURAT1 MicroRNA\n\nInclusion criteria:\nA\u3001B group were enrolled standards: \u2460 aged 18-65 years",
        "label": 0
    },
    "604": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Incidence and Spectrum of Acute Kidney Injury in Cirrhotics and Assessment of New Biomarkers as Early Predictors of Acute Kidney Injury\n\nInclusion criteria",
        "label": 0
    },
    "605": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery\n\nInclusion criteria:\nSubjects age \u226418 years\nSubjects scheduled",
        "label": 0
    },
    "606": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Incidence, Risk Factors, and Risk Model of Acute Kidney Injury in Pediatric Patients Who Undergoing Surgery for Congenital Heart Disease\n\nInclusion criteria:",
        "label": 0
    },
    "607": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Predicting Acute Kidney Injury After Coronary Artery Bypass Graft\n\nInclusion criteria:\npatients who underwent coronary artery bypass surgery during between 2",
        "label": 0
    },
    "608": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Influence of Tidal Volume During Mechanical Ventilation on Postoperative Clinical Outcome in Pediatric Patients Undergoing Congenital Heart Surgery\n\nInclusion criteria:\npediatric",
        "label": 0
    },
    "609": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study",
        "label": 0
    },
    "610": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Evaluation of a Novel Electronic Urine Output Monitor (eUOM)\n\nInclusion criteria:\nPatient must \u2265 18 years of age\nPatient has a Foley c",
        "label": 0
    },
    "611": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)\n\nInclusion criteria:\nPost-menopausal women\nAsymptomatic microscopic hem",
        "label": 0
    },
    "612": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Usefulness of Neutrophil Gelatinase-associated Lipocalin(NGAL) to Confirm Acute Kidney Function Decrease of the Patients Who Had Non-cardiac Surgery",
        "label": 0
    },
    "613": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Pharmacology of Aminophylline for Acute Kidney Injury in Neonates\n\nInclusion criteria:\nNeonate < 3 months post natal age\nDiagnosed with ac",
        "label": 0
    },
    "614": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression\n\nInclusion criteria:\n\n*",
        "label": 1
    },
    "615": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Follow-up of AKI in Neonates During Childhood Years\n\nInclusion criteria:\n\n* Premature birth for Premature groups\n* UVA NICU admission prior to 2 days of",
        "label": 0
    },
    "616": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed Conditions\n\nInclusion criteria:\n\n* Inclusion Criteria:\n* Volunteers who met the following criteria",
        "label": 0
    },
    "617": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Delayed Renal Allograft Function and Furosemide Treatment\n\nInclusion criteria:\nAge \u2265 18 years\nPatient with ESRD who has been on RRT (",
        "label": 0
    },
    "618": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Narrow Band Imaging in Flexible Cystocopy\n\nInclusion criteria:\nPatients undergoing flexible cystoscopy because of haematuria or previous NMIBC\n\nTrial-level",
        "label": 0
    },
    "619": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Algorithm for Oliguria in Septic Shock\n\nInclusion criteria:\nCritically ill, adult patients AND with acute oliguric renal failure AND within 6 hours of presentation\n\nTrial",
        "label": 0
    },
    "620": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery\n\nInclusion criteria",
        "label": 0
    },
    "621": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: A Trial to Assess Optimal Postoperative Feeding Regiments Following Pyloromyotomy\n\nInclusion criteria:\nSubjects to be included in the study include infants who have a diagnosis of",
        "label": 0
    },
    "622": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates\n\nInclusion criteria:\nAll infants born or admitted to a level 2 or 3 NICU will",
        "label": 0
    },
    "623": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Renal Insufficiency Following Contrast Media Administration Trial III\n\nInclusion criteria:\nAll consecutive patients with chronic kidney disease (CKD) scheduled for coronary and/or peripheral ang",
        "label": 0
    },
    "624": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Efficacy of Dexmedetomidine for Postoperative Analgesia in Infantile Cataract Surgery\n\nInclusion criteria:\nASA physical status grade I and II infants (",
        "label": 0
    },
    "625": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment\n\nInclusion criteria:\n\n* Lifelong residents",
        "label": 0
    },
    "626": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients\n\nInclusion criteria:\n\n* Patients admitted to the ICU in the",
        "label": 0
    },
    "627": {
        "output": "Patient note:\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\nTitle: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting\n\nInclusion criteria: Patients with bladder",
        "label": 0
    },
    "628": {
        "output": "Patient note:\n\nA 6-month-old male infant has a urine output of less than 0.2 mL/kg/hr shortly after undergoing major surgery. On examination, he has generalized edema. His blood pressure is 115/80 mm Hg, his pulse is 141/min, and his respirations are 18/min. His blood urea nitrogen is 33 mg/dL, and his serum creatinine is 1.3 mg/dL. Initial urinalysis shows specific gravity of 1.017. Microscopic examination of the urine sample reveals 1 WBC per high-power field (HPF), 18 RBCs per HPF, and 5 granular casts per HPF. His fractional excretion of sodium is 3.3%.\n\nClinical trial:\n\nTitle: The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery\n\nInclusion criteria:\n\n* Children aged less than 7 years old",
        "label": 1
    },
    "629": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus\n\nInclusion Criteria:\n\n* DISEASE CHARACTERISTICS: Histologically confirmed epidermoid carcinoma or adenocarcinoma of the esophagus eligible for potentially curative radiotherapy\n* Disease in one of the following categories:\n\t+ Newly diagnosed\n\t+ Locoregional failure after prior resection with curative intent\n\t+ Positive microscopic margin after palliative resection of all gross disease\n\t+ D",
        "label": 1
    },
    "630": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus\n\nInclusion criteria:\n\n* DISEASE CHARACTERISTICS: Histologically confirmed esophageal squamous cell cancer that is stage T2-3 Nx M0\n* PATIENT CHARACTERISTICS: Age: 18 to 75 Performance status: WHO 0-2 Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: No second malignancy within 5 years except: Basal cell skin",
        "label": 1
    },
    "631": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery\n\nInclusion Criteria:\n\n* DISEASE CHARACTERISTICS: Histologically confirmed esophageal or non-small cell lung carcinoma\n* PATIENT CHARACTERISTICS: Age: 18 and over, Performance status: Karnofsky 70-100%, Life expectancy: Not specified, Hematopoietic: WBC at least 4,000/mm3, Platelet count at least 160,",
        "label": 1
    },
    "632": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer\n\nInclusion Criteria:\n\n* DISEASE CHARACTERISTICS:\n\t+ Histologically confirmed adenocarcinoma, squamous cell, adenosquamous, or undifferentiated carcinoma of the esophagus or gastroesophageal junction\n\t+ Potentially resectable disease\n\t+ No malignant celiac node involvement\n\t+ No cervical esophageal carcinoma\n* PATIENT CHARACTERIST",
        "label": 1
    },
    "633": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Theory-Based Interventions for Smoking and Obesity (Challenge) Trial\n\nInclusion Criteria:\n\n* Eligibility criteria for the smoking cessation studies were: between 18 and 60 years old, a minimum 2-year history of smoking, a current level of smoking > 10 cigarettes per day, and agreement to participate in the study.\n* Eligibility requirements for the weight loss studies were: between 18 and 60 years old, body mass index (weight/height2) > 27.0, 20 percent or",
        "label": 0
    },
    "634": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.\n\nInclusion Criteria:\n\n* Biopsy-proven carcinoma of the oesophagus.\n* Not a candidate for radical/curative treatment due to the advanced nature of the disease, presence of metastases, or intercurrent illness.\n* Symptomatic patients with dysphagia scores of \u2265 1 (able to eat only some solids).\n* Performance status ECOG \u2264 2.\n* Patients must begin treatment within 2 weeks",
        "label": 1
    },
    "635": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia\n\nInclusion criteria:\nPatients aged 18-90 presenting with dysphagia or food impaction\nAbility to undergo esophagogastroduodenoscopy and biopsies\nNo significant cardiopulmonary disease, or other contraindication to EGD\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which is within the inclusion criteria of 18-90 years.\n2. Present",
        "label": 2
    },
    "636": {
        "output": "Sure, I can help you with that. Based on the patient's note and the clinical trial you provided, here is my assessment of the patient's eligibility for the clinical trial:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.\n\nThe patient's history of progressive dysphagia and recent significant weight loss suggests that they may be at risk for aspiration. The patient's age and medical history, including heavy smoking and drinking, also increase the risk of aspiration. The patient's symptoms and medical history meet the inclusion criteria for the clinical trial, which includes patients with chronic pharyngeal dysphagia due to brain injury. The patient's age, 52, falls within the inclusive ages of 20 to 90 required for participation in the clinical trial.\n\nAdditionally, the patient does not have any exclusion criteria, such as a history of epileptic seizure, cardiac rhythm condition, or severe oral phase swallowing deficits that prevent bolus retention in the oral cavity.",
        "label": 0
    },
    "637": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.\n\nInclusion criteria:\n\n* Non-pregnant, non-breastfeeding females;\n* 18- 45 years old\n* Body mass index between 20 and 32 kg/m2\n* No alarm indicators on clinical assessment (weight loss of more than 7kg, bleeding, recent recurrent vomiting, progressive dysphagia).\n* No history suggestive of small bowel obstruction\n\nTrial-level eligibility: 1)",
        "label": 0
    },
    "638": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: TRIAD Burden of Illness Mucositis Study\n\nInclusion Criteria:\n18 years or older\nAbility to understand the protocol and willing to provide written informed consent\nMembership in one of the following sub-cohorts:\nHistologically proven oral cavity or oropharyngeal cancers planned to receive a full cycle of daily single fraction radiation therapy (with or without boost) or IMRT +/- chemotherapy.\nHistologically proven laryngeal or hypopharyngeal cancers planned to receive a full cycle of daily single fraction radiation (with or",
        "label": 1
    },
    "639": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients\n\nInclusion Criteria:\n\n* Patients with either:\n\t+ Histologically proven stage I, II, IIIa NSCLC who have undergone a complete surgical resection of the primary tumor\n\t+ Stage I or II HNSCC who have undergone definitive local treatment (surgery or radiation therapy)\n* HNSCC patients: Definitive local treatment <= 12 months prior to trial enrollment. NSCLC patients: Surgery <= 12",
        "label": 0
    },
    "640": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients\n\nInclusion criteria:\n18 years or older\nDiagnosed with head and neck cancer including the lip, oral cavity, salivary glands, paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx, and thyroid\nAll histological types of cancer\nAll tumour stages according to American Joint Committee for Cancer (AJCC) Staging\nAll forms of RT including standard or investigational and/or concurrent standard or investigational chemotherapy for head",
        "label": 1
    },
    "641": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat\n\nInclusion criteria:\nThe patient must have a diagnosis of pharyngitis with objective findings of tonsillo-pharyngitis.\nThe patient is willing to take nothing by mouth including inhaled treatments except trial medication during the two hours while at the site and following trial drug administration (e.g. not smoking, food, drink, candy, lozenges, chewing gum). The patient will be allowed food and drink between hours 2 and 24, but no other oral or in",
        "label": 0
    },
    "642": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer\n\nInclusion criteria:\n\n* Age \u2265 18 years.\n* Must have persistent, recurrent or progressive ovarian cancer or primary peritoneal cancer after prior treatment with platinum and taxol compounds.\n* Histologic confirmation of the original primary tumor is required.\n* Prior bilateral oophorectomy is required.",
        "label": 0
    },
    "643": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Smoking Status and Body Image in Oral Cancer Patients\n\nInclusion criteria:\n18 years of age or older\nAble to provide written informed consent to participate\nDiagnosis of head and neck malignancy involving an oral cavity site without previous treatment\nCurrent treatment plan includes surgical intervention\nEnglish speaking\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which meets the inclusion criterion of being 18 years of age or older.\n2. Diagnosis: The patient has a history of heavy smoking and drinking, and describes progressive d",
        "label": 0
    },
    "644": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer\n\nInclusion criteria:\n\n* Histological or cytological diagnosis of non-small cell lung cancer.\n* Malignant pleural effusion proven by cytological examination.\n* Patient must have stage IIIB or IV disease with malignant pleural effusion.\n* We plan to recruit 16 patients who have smoked cigarettes of at least 20 pack per year, 16 patients who do not smoke but have been exposed to second hand smoking by living",
        "label": 1
    },
    "645": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Oropharyngeal Function After Radiotherapy With IMRT\n\nInclusion criteria:\nThe target population for this study is 125 patients with stages III or IV squamous cell lesions of the oral cavity, oropharynx, pharynx or larynx, or unknown primary.\n\nAssessment:\nBased on the patient's history of progressive dysphagia and weight loss, it appears that they may meet the inclusion criteria for the clinical trial. The patient's age and history of heavy smoking and drinking may also be relevant to the study, as the trial aims",
        "label": 1
    },
    "646": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat\n\nInclusion criteria:\n\n1. Patients having a sore throat with acute viral pharyngitis.\n2. Female and male ambulant patients between the ages of 18 and 65.\n3. The throat pain intensity is rated at least severe on the VRS (PI).\n4. Written Informed Consent is given by the patient.\n5. Compliance by the patient seems guaranteed.\n\nTrial",
        "label": 0
    },
    "647": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers\n\nSummary: The goal of this study is to see if giving patients information about how smoking affects oral health will help them quit smoking. What we learn from this study will help researchers find new ways to help smokers.\n\nInclusion criteria:\n\n* Patient seeking routine dental care at NYU College of Dentistry and meets medical clearance for routine care\n* Active smokers (active smoking as self-reported regular use of at least 10 cigarettes",
        "label": 0
    },
    "648": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer\n\nInclusion criteria:\n\n* DISEASE CHARACTERISTICS:\n\t+ Histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx\n\t+ No histologic diagnosis other than squamous cell carcinoma\n\t+ A primary site must be identified\n\t+ Must have locoregionally confined stage III (excluding T1-2, N1) or",
        "label": 1
    },
    "649": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer\n\nInclusion criteria:\n\n* Histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus or rectum\n* Planning to receive neoadjuvant treatment, including radiotherapy or chemoradiotherapy\n* Not pregnant or nursing\n* No blood disorder\n* Not deprived of freedom or protected by law\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial",
        "label": 1
    },
    "650": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat\n\nInclusion criteria:\nIncluded patients had moderate to severe pain, as measured by the Sore Throat Pain Intensity Scale (STPIS) on swallowing \u226566 mm on a 100-mm visual analogue scale (VAS) and a minimum of 4 points on the 10-point Tonsillo-Pharyngitis Score (TPS) but who were not coughing or experien",
        "label": 0
    },
    "651": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Sexual Behavior in Head and Neck Cancer Patients\n\nInclusion criteria:\nPatients with newly diagnosed, previously untreated squamous cell carcinoma of the head and neck (SCCHN) who are candidates for the molecular epidemiology study LAB00-062 of head and neck cancer.\nMust have the ability to understand and provide informed consent.\nPatients must be 18 years and older.\nAbility to read, write, and speak English.\nResident of the United States.\nAgrees to have tumor tissue, if available, tested for HPV",
        "label": 1
    },
    "652": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Evaluation of Polyflex Stenting in Esophageal Cancer Patients\n\nSummary: To evaluate the effectiveness of an esophageal stent as a way to maintain nutrition during radiation and/or chemotherapy treatment.\n\nInclusion criteria:\n\n1. 18 years of age and older\n2. Willing and able to provide informed consent\n3. Willing to comply with follow-up requirements\n4. Biopsy-confirmed esophageal cancer (adenocarcinoma or squamous cell carcinoma) in mid or distal esophagus (clinical",
        "label": 1
    },
    "653": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial: Title: Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts\n\nInclusion criteria:\n\n* Inclusion Criteria:\n* Man or woman <18-75> years old\n* Oculopharyngeal muscular dystrophy confirmed by genetic diagnosis (mutation of the GCG) on the chromosome 14)\n* Oculopharyngeal muscular dystrophy with UES dysfunction\n* salivary or alimentary stasis at fibroscopy of sw",
        "label": 0
    },
    "654": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma\n\nInclusion Criteria:\n\n* Histologically confirmed metastatic, or recurrent esophageal squamous cell carcinoma\n* Age > 18 years\n* ECOG performance status 0 - 2\n* At least one measurable lesion(s) by RECIST criteria\n* Life expectancy \u2265 3 months\n* Patients may have received prior adjuvant chemotherapy with 5-FU with cisplatin as long as it",
        "label": 1
    },
    "655": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Trial Using 125I Embedded Stent in Patients With Advanced Esophageal Cancer\n\nInclusion Criteria:\n\n1. Histologically confirmed primary cancer of esophagus\n2. Must be dysphagia caused by esophageal cancer\n3. Without esophageal fistulas\n4. Must be an inpatient\n5. Life expectancy is over 6 months\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.\n\nThe patient's progressive dysphagia, which started with",
        "label": 1
    },
    "656": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma\n\nInclusion criteria:\n\n* Histologically proven resectable adenocarcinoma of the lower oesophagus and gastric-oesophageal junction\n* Tumour stage: T2-3 N0-1 M0, as assessed by endoscopic ultrasound and CT-scan of thorax and abdomen and ultrasound neck region. For the patients treated in this study, the gastro-oesoph",
        "label": 1
    },
    "657": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer\n\nInclusion criteria:\n\n* DISEASE CHARACTERISTICS:\n\t+ Histologically proven adenocarcinoma, squamous cell carcinoma, or adenosquamous carcinoma of the esophagus\n\t+ Locally advanced disease (any T, N0 or N1, M0 or M1a)\n\t+ No metastatic disease, except for tumor involvement of the upper third of the esophagus",
        "label": 1
    },
    "658": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Effect of Varenicline on Reactivity to Smoking and Drinking Cues\n\nInclusion Criteria:\n\n* Inclusion Criteria: Heavy Smokers/Heavy Drinkers\n\t+ Treatment seeking smokers\n\t+ Age 18 to 65 years\n\t+ Smoke \u2265 10 cigarettes per day\n\t+ Fagerstrom Test of Nicotine Dependence score > 3\n\t+ Alcohol Use Disorders Identification Test (AUDIT) > 8\n\t+ Drink > 25 drinks per week for males or >",
        "label": 0
    },
    "659": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis\n\nInclusion Criteria:\nMale and female volunteers \u226518 years old.\nPatients with known or suspected Eosinophilic Esophagitis.\nPatients undergoing upper endoscopy for recent food impaction or complaint of dysphagia.\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.\n\nThe patient's symptoms of progressive dysphagia, difficulty swallow",
        "label": 0
    },
    "660": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers\n\nInclusion criteria:\n\n* Adults > 45 years of age, to be age matched with a previously enrolled cohort of current and ex-smokers with airflow obstruction and moderate atypia on sputum cytology, to be included in the following groups.\n* Non-smoking (less than 100 cigarettes per lifetime) controls >50 years of age, to be age matched with a previously enrolled cohort with airflow obstruction",
        "label": 0
    },
    "661": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery\n\nInclusion criteria:\n\n* DISEASE CHARACTERISTICS: Diagnosis of adenocarcinoma of the esophagus, Stage I-IV disease\n* PATIENT CHARACTERISTICS: Not specified\n* PRIOR CONCURRENT THERAPY: Not specified\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient'",
        "label": 1
    },
    "662": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Nontypeable H. Influenzae in Healthy Adults\n\nInclusion criteria:\nInclusion Criteria for Inoculated Volunteers:\nHealthy 18-54 years old (male or female) with no chronic medical conditions with the exception of well-controlled hypertension\nAvailability for study visits over the next 1 month\nNormal hemoglobin, white blood cell count, creatinine, alanine aminotransferase (ALT), platelet count\nSigned informed consent form\nIn good health as determined by medical history and physical exam on the screening",
        "label": 0
    },
    "663": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Triamcinolone Paste to Reduce the Incidence of Postoperative Sore Throat\n\nInclusion criteria:\nASA physical status I-II, aged between 20 and 70 years\nscheduled for elective laparoscopic cholecystectomy under general anesthesia with endotracheal intubation\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which is within the inclusion criteria of 20-70 years.\n2. ASA physical status: The patient has a history of heavy smoking and drinking",
        "label": 0
    },
    "664": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Efficacy and Safety of Varenicline Among HIV-infected Patients\n\nInclusion criteria:\nHIV-infected patients\nadults\nregular smokers (at least 10 cigarettes a day during the last year)\nmotivated to stop smoking\nfollowed in one of the participating clinical ward,\nsigned written inform consent\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's history of heavy smoking and drinking may make them a good candidate for the clinical",
        "label": 0
    },
    "665": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers\n\nInclusion criteria:\nAge 18-50 years, inclusive.\nExpressed interest and ability to fulfill the study requirements.\nBe in general good health as determined by a screening evaluation within 30 days of the first dose of LGG or placebo.\nAble to ingest the study drug (LGG or placebo) dissolved in a small amount of cow's milk or soy milk orally (no feeding tube).\nWilling",
        "label": 0
    },
    "666": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications\n\nInclusion criteria:\nPatients diagnosed with advanced NSCLC stage IIIB/IV who have not received previous chemotherapy, radiotherapy, or both, and who have tumor tissue embedded in paraffin blocks or formalin-fixed. These patients must sign an informed consent letter.\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which meets the",
        "label": 0
    },
    "667": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Post Operative Sore Throat and Dexamethasone\n\nInclusion criteria:\nFemale patients undergoing outpatient laparoscopic gynecologic surgery\nASA PS I and II\nAge between 18 and 64 years\nFluent in English\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient note describes a 52-year-old African American man with a history of heavy smoking and drinking, who is experiencing progressive dysphagia. The patient's symptoms and history",
        "label": 0
    },
    "668": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: A Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent\n\nInclusion Criteria:\n\n* Endoscopically and histologically confirmed cancer of the esophagus\n* Progressive dysphagia caused by esophageal cancer, and the dysphagia grade of level \u2162 or level \u2163[STOOLER stand]\n* In barium meal of esophagus, severe stricture of the cancer makes the barium difficult to pass through and the superior normal esophagus broadens\n* The bulk and shape",
        "label": 1
    },
    "669": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Comparison Between Two Methods of Throat Swabbing\n\nInclusion criteria:\npatients with sore throat, classified 2-3 according to Cantor's criteria\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of progressive dysphagia and weight loss may be indicative of a throat infection, which could make them eligible for the clinical trial. However, further investigation is needed to confirm the diagnosis and ensure that the patient meets the trial's inclusion criteria. The patient'",
        "label": 0
    },
    "670": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations\n\nInclusion criteria:\n\n* Male and female patients aged over 18 years\n* Histologically proven lung adenocarcinoma\n* Clinical stage IIIB/IV\n* ECOG performance status 0-2\n* Had no prior anticancer agent, radiation or surgical therapy for lung adenocarcinoma\n* At least one measurable lesion (",
        "label": 0
    },
    "671": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Improve the Treatment of Thoracic Esophageal Cancer\n\nInclusion Criteria:\nAge \u2264 70 years old\nKarnofsky Performance Status (KPS) \u2265 80\nPathological diagnosis is squamous cell carcinoma of thoracic esophageal which is treated initially\nClinical stage is cT13N01 according to the results of endoscopic ultrasonography, chest and abdomen CT, and neck ultrasonic\nThe preoperative evaluation of organ function is tolerant of surgery and chemotherapy\nThe subject",
        "label": 1
    },
    "672": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Treating Adults at Risk for Weight Gain With Interactive Technology\n\nInclusion Criteria:\n\n* 18 to 35 years old\n* BMI > 22 kg/m2\n* Self-report smoking > 10 cigarettes each day\n* Have access to a telephone and the internet\n* Demonstrate ability to access a specific web site\n* Demonstrate ability to receive and respond to email\n* Willing to accept random assignment\n* Intending to be available for a 24-month intervention\n* At risk for weight gain (e.g",
        "label": 0
    },
    "673": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy\n\nInclusion Criteria:\n\n* Histologically confirmed esophageal cancer or gastroesophageal junction tumor\n* Failure after no more than 2 prior chemotherapy regimens and 1 chemoradiation course\n* Measurable or evaluable disease by CT scan\n* Patients with brain metastases must be stable and have received cranial irradiation prior to entry\n* WHO performance status 0-2\n* Serum bilirubin \u2264 3",
        "label": 1
    },
    "674": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Lidocaine: Effect of Lidocaine in Chronic Cough\n\nInclusion criteria:\nMale and female subjects, age 18 years and over.\nHistory of cough for more than 8 weeks.\nNormal chest x-ray\nChronic idiopathic cough or chronic cough resistant to treatment of specific triggers.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's history of progressive dysphagia and weight loss may be related to a respiratory or gastrointestinal dis",
        "label": 0
    },
    "675": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Adjunctive Neuromuscular Electrical Stimulation for the Rehabilitation of Swallowing\n\nInclusion criteria:\n\n* Stroke identified by neurological and radiological examination\n* Oropharyngeal dysphagia as confirmed by clinical and radiological examination\n* No prior history of oropharyngeal dysphagia by patient and/or caregiver report\n* No previous head/neck surgery or trauma that may impact swallowing ability\n* No other/concomitant neurological disorders (e.g. Parkinson's",
        "label": 0
    },
    "676": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer\n\nInclusion criteria:\n\n* Histologically documented diagnosis of esophageal cancer\n* Disease must be encompassed in a radiotherapy field. Patients with celiac, perigastric, mediastinal, or supraclavicular adenopathy are eligible\n* Age: 70-85 years\n* Written informed consent\n* Performance status of 0 to 2\n* Neutrophil count >1.5 x 10 to the",
        "label": 0
    },
    "677": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer\n\nInclusion criteria:\n\n* Patients with a confirmed diagnosis of advanced, measurable or evaluable, nonresectable and/or metastatic non-hematologic malignancy, which has shown to be progressive in the last 6 months as demonstrated by serial imaging\n* Patients who have failed conventional treatment or for whom no therapy of proven efficacy exists or who are not amenable to established treatment options\n* Tumour tissue must be available for the determination of E-",
        "label": 0
    },
    "678": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer\n\nInclusion Criteria:\n\n* Histologically confirmed adenocarcinoma of the stomach or gastro-oesophageal junction with inoperable locally advanced or recurrent and/or metastatic disease not amenable to curative therapy.\n* Measurable disease, according to the Response Evaluation Criteria in Solid Tumours (RECIST), assessed using imaging",
        "label": 1
    },
    "679": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Optimal Management of Malignant Dysphagia\n\nInclusion Criteria:\nAge \u226518 years\nConfirmed esophageal/gastroesophageal (GEJ) cancer (Siewert Type I and Type II only) of any histology on biopsy\nDysphagia score \u22652\nStage IV cancer/Metastatic disease\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.\n\nThe patient's progressive dysphagia, weight loss, and history of heavy smoking and drinking suggest",
        "label": 1
    },
    "680": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial: Title: Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX\n\nInclusion criteria:\nHistologically confirmed adenocarcinoma of the stomach or gastro-oesophageal junction with inoperable locally advanced or recurrent and/or metastatic disease, not amenable to curative therapy.\nMeasurable disease, according to the Response Evaluation Criteria in Solid Tumors (RECIST), assessed using imaging techniques (",
        "label": 1
    },
    "681": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux\n\nInclusion Criteria:\n\n* Patients with age of 12-75 years old (inclusive)\n* Patients with at least one symptom consistent with LPR, including hoarseness, throat clearing, throat pain, globus sensation in the throat, or chronic cough \u2267 4 weeks before entering study\n* Patients with a total reflux symptom index (RSI) >10 (based on a self-admin",
        "label": 0
    },
    "682": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain\n\nInclusion criteria:\nHealthy, ambulatory, male and female subjects \u2265 18 years of age\nPresence of sore throat due to upper respiratory tract infection (URTI)\nOnset of sore throat pain within six days of the screening period\nBaseline sore throat pain intensity score \u2265 60 mm on the Sore Throat Pain Intensity Scale\nHave a score",
        "label": 0
    },
    "683": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer\n\nInclusion criteria:\nAll patients with end stage inoperable esophageal cancer deemed candidates for intraluminal esophageal palliative stent insertions.\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which meets the inclusion criteria of being 18 years or older.\n2. Medical history: The patient has a history of heavy smoking and drinking, which may increase the risk of complications during the stent insertion procedure.",
        "label": 1
    },
    "684": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: The Use of Functional Confections in Promoting Oral Health\n\nInclusion criteria:\n\n* Submit to a 24-hour urine cotinine test which will be used to determine smoking status.\n* Meet one of the following smoking criteria:\n\t+ Non-smoker\n\t+ Does not currently smoke or has no history of smoking or using tobacco-related products (cigarettes, cigars, pipe, snuff, or chewing tobacco) or smoking any non-tobacco related products and urine cotinine (less than 100 ng/mL",
        "label": 0
    },
    "685": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Tumor Markers in Lung Cancer: DCAMLK-1LK-1\n\nInclusion criteria:\n>45 years of age\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age (52 years) meets the inclusion criterion of being over 45 years old. However, the patient's medical history, specifically the progressive dysphagia, may be a concern for participation in the clinical trial. Further investigation is needed to determine if the patient's condition would interfere with the trial'",
        "label": 0
    },
    "686": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI\n\nInclusion criteria:\nSubject must have one or more symptoms per category (see also screening assessment of cold symptoms, section 6.1):\n\n* Mild to moderate body pain, headache, fever or sore throat\n* Nasal congestion (blocked nose) with or without rhinorrhea (runny",
        "label": 0
    },
    "687": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Evaluation of Two Different Thickening Products in Patients With Dysphagia\n\nInclusion criteria:\nHistory of dysphagia necessitating a dynamic fluoroscopic swallow study\nAge > 18 years\nAbility to complete a comprehensive dynamic fluoroscopic swallow study\nAbility to provide informed consent for study participation\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's history of progressive dysphagia and weight loss meets the inclusion criteria for the clinical trial. However",
        "label": 2
    },
    "688": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma\n\nInclusion Criteria:\n\n* Histological or cytologic diagnosis of Esophageal squamous cell carcinoma\n* ECOG performance status 0-2\n* Age: 18-70 years\n* Joined the study voluntarily and signed informed consent form\n* Patients must not have received any prior anticancer therapy\n* Resectable disease, Stage IIA-IIIC, T2N0M",
        "label": 1
    },
    "689": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer\n\nInclusion criteria:\n\n* Patients who have histologically confirmed diagnosis of esophageal cancer without prior palliative treatment or an interval of at least 6 months from the last operation, adjuvant radiation therapy and adjuvant chemotherapy. If patients received adjuvant chemotherapy, paclitaxel and cisplatin must be excluded from the regiment or the total dosage of cisplatin must be less than 300mg/m2.\n* Patients must be",
        "label": 1
    },
    "690": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Neuromuscular Electrical Stimulation (NMES) Treatment Technique Therapy in the Management of Young Infants With Severe Dysphagia\n\nInclusion criteria:\nInfants with severe dysphagia on VFFS as defined by dysphagia resulting in aspiration with swallow of at least 2 food textures (e.g. thin and thick liquid).\nWe will include children with dysphagia due to a central neurologic deficit. The neurologic diagnosis will be based on the diagnosis from the treating physician.\n\nAssessment of",
        "label": 0
    },
    "691": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Satiety Innovation- Study 793. University of Aberdeen\n\nInclusion criteria:\nMales and females\n18-65 years old\nBody Mass Index (BMI) 27-35kg/m2\nOverall healthy\nWeight Stable (<3 kg change in the past 4 months, before the trial).\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which is within the inclusion criteria of 18-65 years old.\n2. Gender: The patient is a male, which is within the inclusion criteria",
        "label": 0
    },
    "692": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Combined NMES, FEES and Traditional Swallowing Rehabilitation in the Treatment of Stroke-related Dysphagia\n\nInclusion criteria:\n\n* Age between 20-85 years old\n* First-time stroke confirmed by computed tomography or magnetic resonance image\n* Dysphagia > 3 weeks, with preservation of the swallowing reflex\n* Currently on a restricted diet, with a Functional Oral Intake Scale (FOIS) score of 5 or less\n* Mini-Mental State Examination (MMSE)> 2",
        "label": 0
    },
    "693": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer.\n\nInclusion criteria:\n\n* Oesophageal cancer\n* Multidisciplinary team decision to offer neoadjuvant chemotherapy prior to surgery\n\nAssessment of eligibility:\n\n* Does the patient have oesophageal cancer? Yes\n* Is the patient scheduled to receive neoadjuvant chemotherapy prior to surgery? Yes\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.",
        "label": 1
    },
    "694": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma\n\nInclusion criteria:\n\n* Stage T2-3N0M0 disease of TESCC patients confirmed by pathology studies who received R0 operations in Cancer Institute & Hospital\uff0cCAMS\uff1b\n* KPS\u226570 before radiotherapy;\n* Did not receive neoadjuvant or adjuvant treatment;\n* No clear recurrent or metastatic lesions before radiotherapy;\n* Intensity modulated radiation therapy(IMRT) is accepted;\n* Regular",
        "label": 1
    },
    "695": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: The Effect of Caphosol\u00ae on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy\n\nInclusion criteria:\n18 years or older\nPatients with histologically proven (N)SCLC (all histological subtypes), treated with concurrent chemo- and radiotherapy.\nAbility to understand the protocol and willing to provide written informed consent\n\nTrial-level eligibility: 1) Highly likely to refer this patient for this clinical trial.\n\nThe patient's history of progressive dysphagia, weight loss, and",
        "label": 1
    },
    "696": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Cigarette Smoking and Oral Microbiota\n\nInclusion criteria:\n\n* Age \u2265 18 years\n* Multiple sclerosis (MS) diagnosis\n* Lower urinary tract symptoms with or without treatment\n* Expanded Disability Status Scale score between 1 and 6.5\n\nExclusion criteria:\n\n* Pregnant women\n* Other racial groups\n* Antibiotic usage in the last three months\n* Previous diagnosed major periodontal disease or cancer\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial",
        "label": 0
    },
    "697": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: The Effects of Cold Liquids on the Swallowing Mechanism in Preterm Infants\n\nInclusion Criteria:\nInfants born prematurely, as defined by birth at less than 37 weeks gestational age, referred for a videofluoroscopic swallow study (VFSS) due to suspected pharyngeal phase dysphagia.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age and history of dysphagia may meet the inclusion criteria for the clinical trial. However",
        "label": 0
    },
    "698": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Comparative Effectiveness of Adding Weight Control to Smoking Cessation Quitlines\n\nInclusion criteria:\n\n* Participating Client\n* Not Re-Enrolling\n* USA Resident\n* Wants to quit in the next 30 days\n* Use Cigarettes (other types ok, but must use cigarettes)\n* 18 years or older\n* Speak English\n* Provide Phone\n* Provide Email Address\n* Use 10 cigarettes per day or more\n* BMI of 18.5 or above\n* No history of anorexia or bulim",
        "label": 0
    },
    "699": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Financial Incentives for Maintenance of Weight Loss\n\nSummary: This study aims to evaluate the effectiveness of financial incentives in improving and maintaining weight loss.\nInclusion criteria: Inclusion Criteria:\nAdults age 30-80\nBMI between 30 and 45 prior to starting Weight Watchers\nHave a documented weight loss of at least 5kg in the past 4-6 months before enrolling\nStable health\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe",
        "label": 0
    },
    "700": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Comparison of the Effect of Magnesium Sulfate and Dexamethasone on Postoperative Sore Throat After Spinal Surgery in Prone Position With Tracheal Intubation: a Double-blind, Randomized, Noninferiority Clinical Trial\n\nInclusion criteria:\nASA I-II patients aged between 20 and 65 years undergoing 1 or 2 level posterior spinal fusion in prone position with tracheal intubation\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe",
        "label": 0
    },
    "701": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Young Adults' Responses to Anti-smoking Messages\n\nInclusion criteria:\nU.S. participants 18-25 years of age who are part of the Survey Sampling International (SSI) panel\nNever smoker (never puffed a cigarette) or former smoker (have at least puffed a cigarette but have not smoked in the past 30 days)\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age (52) and smoking history (heavy sm",
        "label": 0
    },
    "702": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method\n\nInclusion criteria:\n\n* Primary diagnosis: pharyngitis confirmed by a Tonsillo-Pharyngitis Assessment \u2265 5\n* Complaint of sore throat with an onset \u2264 4 days prior to randomization\n* Have at least one symptom of upper respiratory tract infection (URTI) on the URTI Questionnaire (e.g., sore throat, runny nose, cough, fever)\n* Have moderate or severe",
        "label": 0
    },
    "703": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Pancreatic Insufficiency Secondary to Tobacco Exposure\n\nInclusion criteria:\nMale or female at least 30 years of age\nAble to read, understand, and sign informed consent\nPatients with a negligible smoking history (defined as no smoking for the past 7 years, and a total smoking history \u2264 5 pack-years) OR patients with AT LEAST a 20 pack-year smoking history\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's history of heavy sm",
        "label": 0
    },
    "704": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Evaluating the Clinical Efficacy and Safety of Colflex\n\nSummary: This study is designed to test the safety and efficacy of Colflex, an oral spray created by Innotech Nutrition, on human subjects to measure changes on frequency/duration of colds and sore throats, as well as dental and oral health changes.\n\nInclusion criteria:\n\n* Availability to give written consent\n* Age 18-60, men and women (who are not pregnant or nursing)\n* People in good health\n* Able to follow protocol\n* Must be",
        "label": 0
    },
    "705": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan\n\nInclusion Criteria:\n\n* Age \u2265 21 years\n* History of heavy smoking and drinking\n* Presence of precursor lesions or cancer in the mouth or throat\n* No history of head and neck cancer\n\nExclusion Criteria:\n\n* Age < 21 years\n* No history of heavy smoking and drinking\n* No presence of precursor lesions or cancer in the mouth or throat\n* History of head and neck cancer\n\nTrial-level eligibility:",
        "label": 0
    },
    "706": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: The Effect of a Carbohydrate Drink on Cognitive Function and Exercise Performance\n\nInclusion criteria:\nhealthy, 18 to 35 year old man or woman.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age (52) and medical history (heavy smoking and drinking, progressive dysphagia, and weight loss) do not meet the inclusion criteria for the clinical trial, which requires healthy individuals between the ages of 18 and 35. Additionally, the patient'",
        "label": 0
    },
    "707": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose\n\nInclusion criteria:\nHistologically proven adenocarcinoma of the gastro-oesophageal junction\nAge 18 years or older\nInternational Union Against Cancer (UICC) T2-4 N0-2 M0, potentially resectable disease treated by the CROSS regimen\nWHO 0-2\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which meets the inclusion criterion of",
        "label": 1
    },
    "708": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Impact of Size of Gastric Sleeve on the Weight Loss. Correlation With Gastric Function and Endocrine-metabolic Changes.\n\nInclusion Criteria:\n\n* Age more than 18 years and less than 65 years\n* BMI more than 40 kg/m2 or more than 35 kg/m2 with comorbidities likely to improve after weight loss.\n* Morbid obesity established at least five years.\n* Continued failures to adequately supervised conservative treatments\n* Absence of endocrine disorders that are",
        "label": 0
    },
    "709": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Biomarker Feedback for Smoking Cessation\n\nInclusion criteria:\nMale or female cigarette smokers, 18-75 years\nSmoked an average of less than 10 cigarettes per day during the past month\nA personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which is within the inclusion criteria of 18-75 years.\n2. Smoking history: The patient has a history of heavy",
        "label": 2
    },
    "710": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients\n\nInclusion Criteria:\n\n1. Profound oropharyngeal feeding tube dependent dysphagia of greater than 12 months duration, as documented by the prevalence of aspiration on fluoroscopic swallow study.\n2. Must be receiving 100% of nutritional requirements by enterogastric tube.\n3. 18 years of age and older, acceptable forms of documentation for verification of age include birth certificate, passport",
        "label": 0
    },
    "711": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Dexamethasone and Wound Healing After Thyroid Surgery\n\nInclusion Criteria:\nElective total thyroidectomy or hemithyroidectomy with lymphadenectomy for thyroid cancer\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms of progressive dysphagia and weight loss are not related to thyroid cancer or surgery, and therefore, they do not meet the inclusion criteria for the clinical trial. The patient's history of heavy smoking and drinking may",
        "label": 0
    },
    "712": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Effects of Oropharyngeal Strengthening on Dysphagia in Patients Post-stroke\n\nInclusion Criteria:\n\n* Clinical diagnosis of unilateral ischemic stroke by attending physician (according to the National Institute of Health Stroke Scale (NIHSS))\n* Within 6 months of acute stroke diagnosis\n* A score of 3 or higher on the Penetration-Aspiration scale OR a score of 2 on the Residue scale at any location (oral cavity, valleculae, or pharynx) that is instrumentally documented by",
        "label": 0
    },
    "713": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: DYsphAgia In Mechanically Ventilated ICU patientS\n\nInclusion criteria: Inclusion Criteria: all adult ICU patients post mechanical ventilation (observational analysis)\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which meets the inclusion criterion of age \u2265 18 years.\n2. Medical history: The patient has a history of heavy smoking and drinking, which may increase the risk of dysphagia. However, this does not necessarily exclude them from the study.\n3. Symptoms: The patient experiences progressive dys",
        "label": 0
    },
    "714": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer\n\nInclusion criteria:\n\n* Pathologically confirmed esophageal carcinoma\n* Stage I\uff5eIva By EUS and CT/MRI, without contraindication for radical radiotherapy\n* Aged \u2265 70 and < 85 years, behavioral status evaluation ECOG scores 0-2\n* In 7 days after being screened, subjects should follow the status: WBC \u2265 3.0 x 10^9/L; AN",
        "label": 0
    },
    "715": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome\n\nInclusion criteria:\nMen and women ages 18 and older\nAmerican Society of Anesthesiologists physical status classification system I and II (healthy patient or patient with mild systemic disease)\nPatient coming for elective surgery (except head and neck) requiring general anesthesia\nPatients staying for at least 24 hours postoperatively\nPatients provide informed consent\nPatients presenting for surgery >1 hour in length and <6 hours.\n\nAssessment:\nThe patient is",
        "label": 0
    },
    "716": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma\n\nInclusion criteria:\nPatients \u2265 18 years\nhistologically confirmed inoperable locally advanced, recurrent, or metastatic adenocarcinoma of the stomach or gastro-oesophageal junction;\nECOG (Eastern Cooperative Oncology Group) performance status 0-2;\nadequate renal, hepatic, and h",
        "label": 1
    },
    "717": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Brain Regulation of Appetite in Twins\n\nInclusion criteria:\nAbility and willingness to come with their twin to the University of Washington (Seattle)\nAdditional Criteria for Aim 1 random sample only: Member of randomly selected MZ pair or\nAdditional criteria for Aim 2 random sample only: One member of MZ or same-sex DZ pair with BMI of at least 30 kg/m^2\nAdditional criteria for Aim 3 sample only: Member of randomly selected MZ pair, and not BMI discordant \u2265 5 kg/m^2\n\nT",
        "label": 0
    },
    "718": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Effect of Saline Lubrication on Post-intubation Complications\n\nInclusion criteria:\npatients aged between 20-80 years who were scheduled for surgery under general anesthesia requiring orotracheal intubation\n\nAssessment of eligibility:\n\n1. Age: The patient is 52 years old, which is within the inclusion criteria of 20-80 years.\n2. Medical history: The patient has a history of heavy smoking and drinking, which may increase the risk of postoperative complications. However, this does not exclude them from the study.\n3.",
        "label": 0
    },
    "719": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Brief Tobacco Cessation Intervention\n\nInclusion criteria:\nOutpatients aged 18 years or above\nSmoke on at least 1 day in the past 30 days\nChinese residents able to communicate in Chinese (Mandarin or Cantonese)\nHas a telephone\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's history of heavy smoking and drinking may make them a suitable candidate for a smoking cessation intervention. However, the patient's primary complaint of progressive dysph",
        "label": 0
    },
    "720": {
        "output": "Patient Note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical Trial:\nTitle: Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus\n\nInclusion Criteria:\n\n* Histologically verified adenocarcinoma of the esophagus according to the UICC definition (TNM7)\n* Pre-treatment stage cT1N+, M0 or cT2-4a, N0/+, M0\n* Age \u226518 years\n* No prior abdominal or thoracic radiotherapy\n* ECOG Performance status 0-",
        "label": 1
    },
    "721": {
        "output": "Patient note:\nA 52-year-old African American man with a history of heavy smoking and drinking, describes progressive dysphagia that began several months ago. He first noticed difficulty swallowing meat. His trouble swallowing then progressed to include other solid foods, soft foods, and then liquids. He is able to locate the point where food is obstructed at the lower end of his sternum. He has lost a total of 25 pounds.\n\nClinical trial:\nTitle: Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer\n\nInclusion criteria:\n\n* Pathologically or cytology diagnosed phase II-III esophageal carcinoma or IV thoracic segments carcinoma with the supraclavicular lymph nodes metastasis.\n* With the measureable lesion of the newly diagnosed the esophageal carcinoma.\n* Age 18-75 years old\n* ECOG\u22642\n* Expect survival date \u22653 months\n* Without serious diseases of important organs\n* Sign",
        "label": 1
    },
    "722": {
        "output": "Patient note:\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: A Study of the Long-Term Outcomes of HIV-Positive Patients\n\nInclusion criteria:\n\n* Patients may be eligible for this study if they:\n\t+ Are 13 years of age or older (consent of parent or guardian required if under the age of 18).\n\t+ Are HIV-positive.\n\t+ Have either: (1) no previous experience with anti-HIV treatment (defined as no previous protease inhibitor or nonnucleoside",
        "label": 0
    },
    "723": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme\n\nInclusion criteria:\n\n* DISEASE CHARACTERISTICS:\n\t+ Histologically or cytologically confirmed glioblastoma multiforme\n\t+ Some oligodendroglial elements allowed, provided they make up < 25% of the tumor\n\t+ Recurrent disease documented by MRI after prior radiotherapy",
        "label": 0
    },
    "724": {
        "output": "Patient note:\n\nAn 8-year-old male presents to the ER with fever, dyspnea, and cough. He has a history of loose stools and is in respiratory distress with bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises\n\nInclusion criteria:\n\n* Patient must have a diagnosis of SCD (known SS, S-Beta-thalassemia or other hemoglobinopathies causing sickle cell disease).\n* Must present to the ED/EC or other appropriate unit in VOC.\n* Greater than or equal to 10 years old.\n* Written informed consent/assent has been obtained.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as they are not diagnosed with sickle cell disease (SCD), and they are under the",
        "label": 0
    },
    "725": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Caspofungin Study for Fungal Infections in Adults in Critical Care Settings\n\nInclusion criteria:\n\n* Non-pregnant subjects >/= 18 years of age\n* Admission to the ICU during the preceding 3 days (minimum of 2 days in ICU) and expected to stay in the ICU for at least 2 additional days\n* Subjects must have at least one of the following:\n\t+ Received at least one other dose of any",
        "label": 0
    },
    "726": {
        "output": "Patient note:\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Collection of Blood Samples From HIV Infected People\n\nInclusion criteria:\n\n* Presently participating, previously participated in, or has given informed consent for participation in a qualifying CPCRA clinical trial\n* Signed informed consent\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms and diagnosis do not match the inclusion criteria for the clinical trial. The patient has a respiratory infection and bilateral lung in",
        "label": 0
    },
    "727": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections\n\nInclusion criteria:\n\n* Male and female adult outpatients diagnosed with AECB or CAP\n* Informed consent must be obtained in writing for all subjects upon enrollment.\n* Subjects will have a diagnosis of AECB or CAP, as defined below.\n* AECB",
        "label": 0
    },
    "728": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.\n\nInclusion criteria:\n\n* Male and female children will be eligible for participation in this study if:\n\t+ They are 1 year (from the 1st birthday) to 6 years (to the last day before the 6th birthday) old;\n\t+ They are",
        "label": 0
    },
    "729": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.\n\nInclusion criteria:\n\n* Male and female children will be eligible for participation in this study if:\n\t+ They are 6 years (from the 6th birthday) to 16 years old (to the last day before the 16th birthday).\n\t+ They",
        "label": 0
    },
    "730": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR\n\nInclusion criteria:\n\n* Male and female volunteers were eligible for participation in this study if they:\n\t+ Were 16 years (from the 16th birthday) to 65 years (to the last day before the 65th birthday) old\n\t+ Were clinically healthy\n\t+ Had a negative",
        "label": 0
    },
    "731": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years\n\nInclusion criteria:\n\n* Male and female children and adolescents aged 1 year (from the 1st birthday) to < 16 years (to the last day before the 16th birthday)\n* Clinically healthy\n* Parents/legal guardians understand the nature of the study and agree to its provisions\n* Written informed",
        "label": 0
    },
    "732": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)\n\nInclusion criteria:\n\n* Participated in Baxter study 209 and:\n* They and/or their parents / legal guardians understand the nature of the study and agree to its provisions\n* Written informed consent is available from the parents / legal guardians according to national law\n* Written informed assent is available from the child/adoles",
        "label": 0
    },
    "733": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)\n\nInclusion criteria:\n\n* Male and female subjects who:\n\t+ Received 2 vaccinations with FSME-IMMUN 0.5 mL during Study 225\n\t+ Understand the",
        "label": 0
    },
    "734": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children\n\nInclusion criteria:\n\n* Male and female children who participated in Study 146A if:\n\t+ They and/or their parents/legal guardians understand the nature of the study and agree to its provisions\n\t+ Written informed consent is available from the",
        "label": 0
    },
    "735": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever\n\nInclusion criteria:\n\n* Suspected exposure to tick-borne relapsing fever\n* After returning from field exercise in a tick-borne relapsing fever-infected area\n* Having a tick bite or staying in the field in close proximity to a subject with a tick bite sign\n\nAssessment of eligibility:\n\nBased on the patient",
        "label": 1
    },
    "736": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children\n\nSummary: The purpose of this study is to evaluate the safety, immunogenicity, and tolerability of TBE vaccines administered to children.\n\nInclusion criteria:\n\n* Healthy male and female children, 1 to 10 years of age.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further",
        "label": 0
    },
    "737": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants\n\nInclusion criteria:\n\n* Coenrollment in the SMART study\n* Parent or guardian willing to provide informed consent, if applicable\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's symptoms and diagnosis do not match the inclusion criteria for the clinical trial. The patient has",
        "label": 0
    },
    "738": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants\n\nSummary: The purpose of this study is to compare the effects of two different anti-HIV drug regimens on HIV transmission risk behavior among SMART study participants.\n\nInclusion criteria:\n\n* Coenrollment in the SMART study\n* Parent or guardian willing to provide informed consent, if applicable\n\nTrial-level eligibility: 0",
        "label": 0
    },
    "739": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Effects of Anti-HIV Therapy on Nervous System Function\n\nSummary: The purpose of this study is to observe the way two different anti-HIV treatment strategies affect nerve and brain function in adults with HIV.\n\nInclusion criteria:\n\n* Coenrollment in the SMART study\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age (8 years old) does not meet the inclusion criteria of",
        "label": 0
    },
    "740": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical Trial:\n\nTitle: Randomized Controlled Trial (RCT) in Children With Severe Pneumonia\n\nInclusion Criteria:\n\n* Age: 2 to 59 months\n* Sex: Both boys and girls\n* Severe pneumonia according to WHO criteria (Severe pneumonia is defined as cough or difficult breathing with lower chest wall in drawing with or without fast breathing which is defined as the respiratory rate \u2265 50 breaths per minute for children aged 2-11",
        "label": 0
    },
    "741": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule\n\nInclusion criteria:\n\n* Male and female subjects aged \u2265 16 years (from the 16th birthday) at screening\n* Clinically healthy (i.e., the physician would have no reservations vaccinating with FSME-IMMUN 0",
        "label": 0
    },
    "742": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects\n\nInclusion criteria:\n\n* Healthy Males or Females aged 18 to 55 years, inclusive\n* Capable of understanding and complying with the protocol requirements and be available for the duration of the protocol\n\nTrial-level eligibility: 0) Would not refer this patient for",
        "label": 0
    },
    "743": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)\n\nInclusion criteria:\n\nSubjects who participated in Study 223 will be eligible for participation in this study if:\n\n* They understand the nature of the study, agree to its provisions, and provide written informed consent\n* They received the first booster vaccination with FSME-IMMUN 0.5ml during the course of Study",
        "label": 0
    },
    "744": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Transmission and the Respiratory Tract in Cryptosporidiosis\n\nInclusion criteria:\nMale and female children aged 9-36 months at the time of enrollment\nPresence of acute or persistent diarrhea (diarrhea defined as 3 or more loose stools in the previous 24 hours AND not considered normal for that child if the child is exclusively breastfed OR any number of bloody stools in the previous 24 hours; less than or equal to",
        "label": 0
    },
    "745": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Zambia Integrated Management of Malaria and Pneumonia Study\n\nInclusion criteria:\n\n* Age between 6 months and 5 years\n* Present with history of fever or reported fever\n* Present with cough or difficult breathing\n\nAssessment of eligibility:\n\nBased on the patient's age (8 years) and presenting symptoms (fever, dyspnea, and cough), he meets the inclusion criteria for the clinical trial. The patient's",
        "label": 0
    },
    "746": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US\n\nInclusion criteria:\n\n* Healthy, as determined by medical history, clinical examination, and biological safety parameters.\n* Aged 18 to 45 years on the day of inclusion.\n* Provision of informed consent signed by the participant or another legally acceptable representative.\n* For a woman of child-b",
        "label": 0
    },
    "747": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Gulf War Digestive Health Study\n\nInclusion criteria:\n\n* Men and women aged 32-75 years\n* Rome III criteria for diarrhea-predominant IBS\n* Symptom onset after an apparent episode of acute gastroenteritis\n* Symptoms of > 3 months duration\n* Normal endoscopic appearance of the colonic mucosa\n* Negative markers for celiac disease and inflammatory bowel disease\n* Normal thyroid function and ser",
        "label": 0
    },
    "748": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Human Immune Responses to Yellow Fever Vaccination\n\nInclusion criteria:\n\n* Able to understand and give informed consent\n* Age 18-45 years\n* If possible, participants agree not to take any vaccines within 30 days before or 30 days after yellow fever vaccination\n* Women of childbearing potential must agree to use effective birth control throughout the duration of the study. A negative urine pregnancy test must be documented prior to v",
        "label": 0
    },
    "749": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Assessment of Cough and Wheeze With Breath Sound Documenting Device\n\nSummary: The study goal is to create a database of respiratory sounds recordings, to evaluate and validate the WIM technology, and to evaluate the efficacy of a specific treatment by comparing the severity of the respiratory symptoms before and after the administration of the treatment.\n\nInclusion criteria:\n\n* Patient and/or parents/guardian signed informed consent\n* Patients with cough or shortness of breath\n\nT",
        "label": 2
    },
    "750": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Na\u00efve Adults\n\nInclusion criteria:\n\n* Healthy as determined by medical history, clinical examination, and biological safety parameters\n* Aged 18 to 45 years on the day of inclusion\n* Informed consent form signed\n* Able to attend all scheduled visits and to comply with all trial procedures\n* For a woman of child-bearing potential",
        "label": 0
    },
    "751": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children\n\nInclusion criteria:\nMale and female children will be eligible for participation in this study if:\n\n* They are aged >= 1 year (from the 1st birthday) to 11 years (to the last day before the 12th birthday) at screening.\n* Their parents/legal guardians provide written informed consent.\n* Children provide",
        "label": 0
    },
    "752": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Trial of Amoxicillin Compared With Placebo for Pneumonia in Children Aged 2-59 Months\n\nInclusion criteria:\nChildren aged 2 to 59 months attending the outpatient's clinics of participating sites\nWHO defined non-severe pneumonia\nAccessibility for follow-up\nWritten informed consent by a parent or legal guardian\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation",
        "label": 0
    },
    "753": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents, and Young Adults (Follow-Up to Study 700401)\n\nInclusion criteria:\n\n* Subjects who participated in precursor Study 700401 and meet ALL of the following criteria are eligible for participation in this study:\n* Subject / parent(s) / legal guardian(",
        "label": 0
    },
    "754": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Chest Physiotherapy in Pediatrics Patients With Pneumonia\n\nInclusion criteria:\n\n* Children aged 1 to 12 years with acute community-acquired pneumonia (cough, tachypnea, fever, and with a chest radiography with lobar, segmental or bronchopneumonia within the first 48 hours)\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.\n\nThe patient",
        "label": 2
    },
    "755": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Paracetamol as Antipyretic and Analgesic Medication\n\nSummary: The present study is aiming to unravel the clinical efficacy of intravenously administered paracetamol as antipyretic and analgesic medication in various medical conditions.\n\nInclusion criteria:\n\n* Age greater than or equal to 18 years\n* Written informed consent by the patients\n* Medical condition necessitating the administration of antipyretic or analgesic",
        "label": 0
    },
    "756": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)\n\nInclusion criteria:\n\n* Adults, equal to or more than 18 years old\n* Patients with respiratory tract infections, including any of the following:\n\t+ Acute tracheitis, acute tracheobronchitis\n\t+ Acute sinusitis\n\t+ Chron",
        "label": 0
    },
    "757": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Probiotics in Preventing Antibiotic Associated Diarrhoea Including Clostridium Difficile Infection\n\nInclusion criteria:\n\n* Male/female patients, above 55 years of age\n* Patient has given written informed consent/Assent to take part in the study\n* Patients are receiving antibiotics as inpatients\n* Patients prescribed therapy with single or multiple antibiotics (oral or IV) will be included\n* Antibi",
        "label": 0
    },
    "758": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians\n\nInclusion criteria:\n\n* Inclusion Criteria:\n\nClinic practices within Denver Health's Webb Center for Primary Care,\nClinic practices within the University of Colorado - Anschutz Campus: General Internal Medicine Clinic,\nClinic practices within the High Plains Network, and\nClinical practices within the Wilmington Health Associates System\n\nThe antibiotic prescri",
        "label": 1
    },
    "759": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Phase I Study of ETEC Vaccine\n\nInclusion criteria:\n\n* Male or female ages 18-45, inclusive.\n* Provide written informed consent before initiation of any study procedures.\n* Healthy as judged by the Principal Investigator (PI) and determined by medical history, physical examination, and medication history.\n* Within 45 days of vaccination, have normal screening laboratories for white blood cells (WBC), hemoglobin (",
        "label": 0
    },
    "760": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Study to Evaluate the Effectiveness of Rotarix\u2122 Against Severe Gastroenteritis Among Hospitalized Children in Brazil\n\nInclusion criteria:\n\n* Male or female child born after 6 March 2006 and at least 12 weeks of age.\n* Subject admitted to the study clinics/hospitals for severe gastroenteritis during the study period.\n* Onset of severe gastroenteritis \u2264 14 days prior to admission.\n* Laboratory confirmed rot",
        "label": 0
    },
    "761": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab Emirates\n\nInclusion criteria:\n\n* A male or female < 5 years of age at the time of admission to the study hospital for acute gastroenteritis.\n* Written informed consent obtained from the parent or guardian of the subject.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation",
        "label": 0
    },
    "762": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan\n\nSummary: The purpose of this study is to evaluate the epidemiology and baseline disease burden of rotavirus gastroenteritis in children < 6 years of age, in Japan.\n\nInclusion criteria:\n\n* A male or female child aged <6 years at the time of admission to the hospital. A child will become inelig",
        "label": 0
    },
    "763": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Intestinal Barrier Function and Probiotics.\n\nInclusion criteria:\n\n* Healthy as assessed by the health and lifestyle questionnaire, physical examination, and results of the pre-study laboratory tests\n* Males, Age >= 21 and <= 40 years at Day 01 of the study\n* Body Mass Index (BMI) >= 20 and < 33 kg/m2\n* Normal Dutch eating habits as assessed by P906",
        "label": 0
    },
    "764": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania\n\nInclusion criteria:\n\n* A male or female child aged < 5 years at the time of admission. A child becomes ineligible on the day of her/his fifth birthday.\n* A subject, who during the study period:\n\t+ Is hospitalized for acute gastroenteritis\n\t+ Visits an emergency room for acute g",
        "label": 0
    },
    "765": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Antibiotic Efficacy in Pneumonitis Following Paraffin (Kerosene) Ingestion in Children\n\nInclusion criteria:\n\n* Ingestion in the preceding 24 hours\n* Presence of respiratory symptoms and/or signs at presentation\n* Informed consent obtained from parent or legal guardian\n* Resident within the Red Cross Hospital drainage area and able to come for two follow-up appointments\n\nTrial-level eligibility: 1) Would consider referring this patient to",
        "label": 1
    },
    "766": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Etiology of Diarrhea in Guinea-Bissau and in Finland\n\nInclusion criteria:\nAccepting to participate and willing to deliver 2 stool samples.\nWith diarrhea: the first 10 children and 10 adults presenting each month at the health facility Without diarrhea: In Bissau matched controls drawn from the registration system at Bandim Health Project. In Finland, controls selected at the health facilities participating.\n\nTrial-level eligibility:",
        "label": 1
    },
    "767": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Ibuprofen, Acetaminophen, and Dipyrone to Fever Control in Children\n\nInclusion criteria:\n\n* Male and female children aged 06 months to 06 years old\n* Weight above 5 kilograms\n* Axillary temperature above 37.5 degrees Celsius\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age and axillary temperature meet the",
        "label": 0
    },
    "768": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Is it Effective to Treat Patients With Blastocystis Hominis Infection?\n\nSummary: The objective of this study is to determine whether in the setting of primary health care it is effective to treat with metronidazole returning travelers with gastrointestinal symptoms and B. hominis in the stool or not.\n\nInclusion criteria:\n\n* Inclusion Criteria:\n\t+ \u2265 18 years\n\t+ Gastrointestinal symptoms for more than",
        "label": 0
    },
    "769": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Bi-Level Positive Airway Ventilation for Acute Chest Syndrome\n\nInclusion criteria:\n\n* Patients diagnosed with Hemoglobin SS (HB SS), the most common type of sickle cell disease\n* Patients diagnosed with Hemoglobin SC (HB SC), the second most common type of sickle cell disease.\n* Patients diagnosed with Hemoglobin sickle beta-zero thalassemia (HB SB0thal) or Hemoglobin sick",
        "label": 0
    },
    "770": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease\n\nInclusion criteria:\n\n* Signed and dated",
        "label": 0
    },
    "771": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Chest Imaging, Breath, and Biomarkers in a Screening Trial\n\nInclusion criteria:\n\n* Ages 40-75 years\n* Current or ex-smoker with >25 pack years and a family history of lung cancer (parent or sibling) OR\n* Current or ex-smoker with >25 pack years and COPD OR\n* Current or ex-smoker with a >35 pack year history (for ages 60-75)\n* Sub",
        "label": 0
    },
    "772": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea\n\nInclusion criteria:\n\n* Men / Women aged 18 and over\n* Successful treatment of clinically diagnosed CDAD using standard therapy (metronidazole or vancomycin given according to standard local hospital guidelines)\n\nExclusion criteria:\n\n* Woman of childbearing potential and not willing to use at least one highly effective contraceptive method throughout the study\n* Male with",
        "label": 0
    },
    "773": {
        "output": "Patient note:\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Study of the Safety and Efficacy of Antibiotic X in Children With Community-Acquired Pneumonia\n\nInclusion criteria:\n\n* Age \u2265 6 months and \u2264 17 years\n* Diagnosis of community-acquired pneumonia\n* Symptoms of pneumonia (cough, fever, chest pain, difficulty breathing) for \u2264 72 hours\n* No previous treatment with antibiotics in the past 7 days\n* No underlying medical conditions that may",
        "label": 2
    },
    "774": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis\n\nSummary: This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.\n\nInclusion criteria:\n\n* Subjects must be 18 years of age or older.\n* Ability to provide written informed consent",
        "label": 0
    },
    "775": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Safety of Sublingual dmLT for ETEC\n\nInclusion criteria:\n\n* Male or female ages 18-45, inclusive.\n* Provide written informed consent before initiation of any study procedures.\n* General good health, without significant medical illness, clinically significant physical examination findings, or screening laboratory values outside the site's normal limits.\n* Within 46 days of vaccination, have normal screening laboratories for white blood cells (WBC",
        "label": 0
    },
    "776": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Epidemiological Study on Community Acquired Pneumonia\n\nInclusion criteria:\n\n* Age \u2265 18\n* Infiltrate on chest X-ray\n* Further inclusion criteria: cough or production of purulent sputum or pathologic lung auscultation (crackles) or fever\n\nAssessment of eligibility:\n\nBased on the patient's symptoms and the clinical trial's inclusion criteria, it appears that the patient may meet the criteria",
        "label": 0
    },
    "777": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Chest Ultrasound of ER Patients With Cough or SOB\n\nInclusion criteria:\n\n* Presenting to the Emergency Department with cough, wheezing, and/or dyspnea (shortness of breath)\n* Referred for CXR and/or CT scan\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's symptoms of dyspnea, cough, and fever,",
        "label": 2
    },
    "778": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\nTitle: Short-course Antimicrobial Therapy for Paediatric Respiratory Infections\n\nInclusion criteria:\nChildren aged 6 months to 10 years presenting with CAP will be eligible. CAP will be defined if all of the four following numeric criteria are met:\nfever (>37.5 C axillary, > 37.7 C oral, or >38 C rectal) recorded in the ED or at home in the 48h prior to presentation",
        "label": 2
    },
    "779": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Yellow Fever Vaccination Under Low Dose Methotrexate Therapy\n\nInclusion criteria:\n\n* Informed Consent as documented by signature\n* Indication for yellow fever vaccination according to Swiss FOPH recommendations\n* Individuals under low-dose MTX (\u226420mg/week) therapy or healthy individuals\n* Male and Female travelers \u226518 years to <60 years of age\n\nTrial-level eligibility",
        "label": 0
    },
    "780": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea, and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers\n\nInclusion criteria:\n\n* Subjects are male or female aged \u2265 18 years at time of dosing\n* Subjects are travelers attending travelers' vaccination clinics\n* Subjects are eligible for typhoid vaccination, according to standard practice\n* Subjects are expected to be able to provide follow-up information\n* Subject",
        "label": 0
    },
    "781": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Assessing the Health Impact of a Combined Water and Sanitation Intervention in Rural Odisha, India\n\nSummary: This is a matched-cohort study designed to assess the health impact of a rural demand-driven water and sanitation intervention that provides piped treated water and household-level pour-flush latrines and bathing rooms, as implemented by Gram Vikas.\n\nInclusion criteria:\n\n* Households in participating villages will be eligible to participate in the study if",
        "label": 0
    },
    "782": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever\n\nInclusion criteria:\n\n* Patients have fever more than one week\n* Temperature is higher than 38\u2103 Celsius degree\n* Full of physical examination and laboratory examination have been carried out after one week, but still cannot make a definite diagnosis\n\nTrial-level eligibility: 1) Would consider referring this patient to",
        "label": 1
    },
    "783": {
        "output": "Patient note:\n\nAn 8-year-old male presents in March to the ER with fever up to 39 C, dyspnea and cough for 2 days. He has just returned from a 5-day vacation in Colorado. Parents report that prior to the onset of fever and cough, he had loose stools. He denies upper respiratory tract symptoms. On examination, he is in respiratory distress and has bronchial respiratory sounds on the left. A chest x-ray shows bilateral lung infiltrates.\n\nClinical trial:\n\nTitle: Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic\n\nSummary: This study will evaluate the clinical effectiveness of, and patient satisfaction with, pre-travel consultations provided by a pharmacist with specialty training in travel medicine and the authorization to prescribe medications and administer vaccinations.\n\nInclusion criteria:\n\n* Receiving a pre-travel consultation at the Travel Health Network clinic in St. Albert, Alberta, Canada",
        "label": 0
    },
    "784": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries, including upper and lower extremity fractures. She is fully awake and alert and reports that she was not wearing a seatbelt. Her blood pressure is 134/74 mmHg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Preventing Chronic Whiplash Pain\n\nInclusion criteria:\nHave whiplash injury following a motor vehicle accident in the prior 4 to 10 weeks\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's recent car accident and multiple injuries, including whiplash, meet the inclusion criteria for the clinical trial. However, the patient's current condition, including her tender abdomen and lack of bowel sounds, may require further evaluation and stabilization before particip",
        "label": 0
    },
    "785": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries, including upper and lower extremity fractures. She is fully awake and alert and reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: The Impact of Sleep Disorders on Motor Vehicle Accidents\n\nInclusion criteria:\nInclusion Criteria: Drivers admitted as a result of motor vehicle accidents\nExclusion Criteria: Drivers aged < 18 years\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age (32 years) meets the inclusion criteria (drivers aged \u2265 18 years). The patient has been admitted to the ER following a car accident, which meets the inclusion criteria (",
        "label": 2
    },
    "786": {
        "output": "Sure, I'd be happy to help you with that! Here's the assessment of eligibility for the given patient note and clinical trial:\n\nPatient Note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical Trial:\nTitle: ED Intervention to Reduce Risky Behaviors in Drivers\n\nInclusion Criteria:\nScreen Positive for a drinking problem in the ED\n\nAssessment of Eligibility:\nBased on the patient note, the patient does not meet the inclusion criteria for the clinical trial. The patient has sustained multiple injuries in a car accident and does not have a drinking problem. Therefore, the",
        "label": 0
    },
    "787": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries, including upper and lower extremity fractures. She is fully awake and alert and reports that she was not wearing a seat belt. Her blood pressure is 134/74 mmHg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Effects of Pain on Driving Performance and Cognition.\n\nInclusion criteria:\n\n* Age \u2265 18 years\n* Driving license\n* Driving experience\n* Normal vision\n* Right-handed\n* Fluently Dutch speaking\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nThe patient's age, driving experience, and normal vision meet the inclusion criteria. However, the patient's current physical condition, including multiple fractures and abdominal tendern",
        "label": 0
    },
    "788": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Ischemic Preconditioning of Liver in Cadaver Donors\n\nInclusion criteria:\n- Deceased donor livers allocated to adult (> 18 years of age) recipients at the research site.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age and the fact that she is a cadaver donor meet the inclusion criteria for the clinical trial. However, the patient's multiple injuries, including upper and lower extremity fractures, and her tender abd",
        "label": 0
    },
    "789": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort\n\nInclusion criteria:\nAge 21 - 75\n\nExclusion criteria:\nHeight greater than 6'2, BMI greater than 45. Specified acute or chronic medical conditions.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's age meets the inclusion criteria, but she has sustained multiple injuries, including upper and lower extremity fractures, which may exclude her from",
        "label": 1
    },
    "790": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Michigan Driver Education Study\n\nInclusion criteria:\nTeens between the ages of 15 years 0 months and 16 years 6 months enrolled in a licensed driver education course are eligible to participate.\n\nExclusion criteria:\nAdolescents over the age of 16 years 6 months or those whose parent or legal guardian does not attend the driver education course session to which they are specifically invited will be deemed ineligible for the study.\n\nTrial-level eligibility: 0) Would not refer this patient for this clin",
        "label": 0
    },
    "791": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries, including upper and lower extremity fractures. She is fully awake and alert and reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Effect of Experience on Driving Performance in New Teenage Drivers\n\nInclusion criteria:\nRecruitment of teen participants will occur by arrangement with local driving schools in Montgomery County, VA.\nPotential participants aged 16 or 17 who have held their driver's license for one month or less may be eligible.\nParticipants may be recruited during their training, and will only be eligible after they have met all requirements for licensure, and after both parental consent and teen assent are obtained.\nIf the",
        "label": 0
    },
    "792": {
        "output": "Sure, I'd be happy to help you with that! Here's the assessment of eligibility for the given patient note and clinical trial:\n\nPatient Note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical Trial:\nTitle: Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks\n\nInclusion Criteria:\n\n* Age \u2265 18 years\n* Multiple sclerosis (MS) diagnosis\n* Lower urinary tract symptoms with or without treatment\n* Expanded Disability Status Scale score between 1 and",
        "label": 0
    },
    "793": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries, including upper and lower extremity fractures. She is fully awake and alert and reports that she was not wearing a seatbelt. Her blood pressure is 134/74 mmHg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Intra Ocular Pressure During Robotic Prostatectomy\n\nInclusion criteria:\nMale, aged 18 or older\nScheduled for Robotic Prostatectomy Surgery\nASA Classification of I, II, or III\nGood comprehension of written and spoken English.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient's gender and age do not meet the inclusion criteria for the clinical trial, which specifically includes male patients aged 18 or older. Additionally, the patient's medical",
        "label": 0
    },
    "794": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation\n\nInclusion criteria:\n(cases; n = 14 total; 10 with predominantly physical and 4 with predominantly irritant triggers):\nA significant history of chronic and/or recurrent nasal symptoms (rhinorrhea, blockage, sneezing, or pruritus) in response to:\nChanges in temperature and/or humidity predominantly (physical triggers; n = 10); or\nTwo",
        "label": 0
    },
    "795": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries, including upper and lower extremity fractures. She is fully awake and alert and reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem\n\nInclusion criteria:\n\n* Hospitalized men or women >/=18 years of age\n* Expected duration of treatment with intravenous antibiotics anticipated to be >/= 5 full days but not exceeding 14 days\n* Ability to provide documented and signed written informed consent\n* Confirmed or suspected intra-abdominal infection defined as follows:\n\t+ For a confirmed intra-ab",
        "label": 0
    },
    "796": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Enhancing ADHD Driving Performance With Stimulant Medication\n\nInclusion criteria:\nADHD diagnosis\nValid driver's license\nNot taking any medication for their ADHD\nHave access to a car of which they are the primary driver\nHave a history of approximately two driving collisions or citations\nHave a history of responsiveness to methylphenidate\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.\n\nThe patient does not meet the inclusion criteria for the clinical trial as she does not have",
        "label": 0
    },
    "797": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries, including upper and lower extremity fractures. She is fully awake and alert and reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study\n\nInclusion criteria:\nAnticipating a 10-15% drop-out rate, we will induct 30 neurologically normal subjects (age 18 (21) -60) to obtain 25 evaluable subjects who are legally licensed to drive in their state of residence and have been actively driving under appropriate legal guidelines for at least 5 years (to minimize performance variations of novice drivers).\n\nTrial-level elig",
        "label": 0
    },
    "798": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Correlation of Location of Abdominal Tenderness With Acute CT Abnormalities in Emergency Department Patients\n\nInclusion criteria:\nAll consecutive emergency department patients undergoing abdominal CT for non-traumatic abdominal pain and tenderness will be prospectively enrolled, with the following exceptions. For study purposes, abdominal pain and tenderness is defined as pain and tenderness to direct palpation in the region anterior to the mid-axillary line bilaterally, and extending from the costal margins to the inguinal ligaments",
        "label": 0
    },
    "799": {
        "output": "Sure, I'd be happy to help you with that! Here's the assessment of eligibility for the patient note you provided:\n\nPatient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Plating of Humeral Shaft Fractures in Multiple Trauma Patients.\n\nInclusion criteria:\nage > 18 years\npatients with past (acute) traumatic humeral shaft fracture(s) treated with open reduction and internal fixation (ORIF)\npatients for whom the above fracture has healed\npatients willing and able to provide informed consent and able to participate in",
        "label": 0
    },
    "800": {
        "output": "Patient note:\nA 32-year-old woman is admitted to the ER following a car accident. She has sustained multiple injuries including upper and lower extremity fractures. She is fully awake and alert, and she reports that she was not wearing a seat belt. Her blood pressure is 134/74 mm Hg, and her pulse is 87/min. Physical examination reveals a tender abdomen with guarding and rebound in all four quadrants. She has no bowel sounds.\n\nClinical trial:\nTitle: Comparison of Balloon Kyphoplasty and Vertebroplasty in Subacute Osteoporotic Vertebral Fractures\n\nInclusion criteria:\n\n* Patient is able to undergo the vertebroplasty or Balloon kyphoplasty procedure\n* Patient has read and signed the informed consent\n* Male or female, 50 years or older\n* One or two non-traumatic vertebral fracture(s):\n\t+ Of osteoporotic origin (low-speed trauma such",
        "label": 0
    }
}